bakfs2017_6k.htm - Generated by SEC Publisher for SEC Filing
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16
OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of March, 2018

(Commission File No. 1-14862 )

 

 
BRASKEM S.A.
(Exact Name as Specified in its Charter)
 
N/A
(Translation of registrant's name into English)
 


Rua Eteno, 1561, Polo Petroquimico de Camacari
Camacari, Bahia - CEP 42810-000 Brazil
(Address of principal executive offices)



Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ___X___       Form 40-F ______

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1). _____

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7). _____

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ______       No ___X___

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____.


 
 

                                                 

 

 

 

 

Braskem S.A.

Financial Statements

at December 31, 2017

and Independent Auditors' Report

 

 

 

 


 
 

 

 

Independent auditor’s report in the individual and consolidated financial statements

 

To Shareholders, Members of the Board and Management

Braskem S.A.

Camaçari - Bahia

 

Opinion

We have audited the individual and consolidated financial statements of Braskem S.A. (“the Company”), respectively referred to as Parent and Consolidated, which comprise the statement of financial position as at December 31, 2017, the statements of profit or loss and other comprehensive income, changes in equity and cash flows for the year then ended, and notes, comprising significant accounting policies and other explanatory information.

 

Opinion on the individual financial statements

In our opinion, the accompanying individual financial statements present fairly, in all material respects, the financial position of the Braskem S.A. (“the Company”) as at December 31, 2017, and of its financial performance and its cash flows for the year then ended in accordance with Accounting Practices Adopted in Brazil.

 

Opinion on the consolidated financial statements

In our opinion, the accompanying consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Braskem S.A. as at December 31, 2017, and of its consolidated financial performance and its cash flows for the year then ended in accordance with Accounting Practices Adopted in Brazil and with International Financial Reporting Standards (IFRS), issued by the International Accounting Standards Board (IASB).

 

Basis for Opinion

We conducted our audit in accordance with Brazilian and International Standards on Auditing. Our responsibilities under those standards are further described in the Auditors’ Responsibilities for the Audit of the Individual and Consolidated Financial Statements section of our report. We are independent of the Company and its subsidiaries in accordance with the relevant ethical requirements included in the Accountant Professional Code of Ethics (“Código de Ética Profissional do Contador”) and in the professional standards issued by the Brazilian Federal Accounting Council (“Conselho Federal de Contabilidade”) and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

 

 


 
 

 

Key Audit Matters

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the individual and consolidated financial statements of the current period. These matters were addressed in the context of our audit of the individual and consolidated financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.

 

Recoverable value of intangible assets with indefinite useful life (goodwill) and deferred tax assets - notes 3.4 (b), 14 (a) and 21.2 (individual and consolidated)

The Company maintains a significant balance of intangible assets with indefinite useful life, in connection with the goodwill on business combination, allocated to operating segments of Polyolefins, Vinyls and Chemicals (cash generating unit Químicos Sul). The Company also holds a significant balance of deferred tax asset, generated by tax losses and temporary differences.

 

The recoverability of these assets is based on analyses and projections of cash flow and generation of results. Due to uncertainties inherent to the process of determining future cash flows and some assumptions - such as discount rates, which are the basis for evaluation of recoverable value of such assets -, we considered this matter as significant for our audit.

 

How our audit conducted this issue

We understood the process and evaluated the design of internal controls related to the preparation and review of the business plan, budgets and impairment analysis provided by the Company. We used the support of our specialists in corporate finance, we have evaluated assumptions and methodologies used by the Company to forecast cash flows for each segment, such as discount rate based on average capital cost (WAAC), growth rate for the next 5 years, expected sales volume and margin, among others. Also with the assistance of our specialists, sensitivity analyses were conducted in relation to the main assumptions used by management. We also evaluated disclosures made by the Company, including those related to sensitivity analysis, which demonstrate the impact on recoverable value resulting from possible and reasonable changes in key assumptions used by the Company.

 

Based on evidence from the procedures summarized above, we consider that, in relation to its recoverability, the value of intangible assets with indefinite useful life (goodwill) and deferred tax assets, as the related disclosures, are acceptable in the context of individual and consolidated financial statements taken as a whole, for the year ended December 31, 2017.

 

Fair value of derivative financial instruments and designation of hedge accounting - notes 3.6, 4.1 and 19 (individual and consolidated)

The Company uses derivative financial instruments to manage risks related toexchange rate changes and interest rates of loans and financing. These instruments are recorded at fair value based on the market prices of the own instrument or similar instruments or according to pricing techniques, which consider market curves of interest rate and exchange rate. The Company designates derivative financial instruments as hedge instruments when adopting hedge accounting policy, and regularly performs effectiveness tests on designated hedge relations.

 

In view of relevance and complexity of estimates made to measure fair value of derivative financial instruments and possible impact that changes in pricing assumptions and techniques used to measure such value would have on the Company’s income and financial position, and also considering the complexity involved in designation and regular measurement of effectiveness of hedge accounting relation held by the Company, we consider those as a significant matter for our audit.

 

 


 
 

 

 

How our audit conducted this issue

We understood the process and evaluated design and implementation of internal controls related to the process of evaluating derivative financial instruments and hedge accounting. Our audit engagements work also included tests on samples of transactions with these financial instruments and, with the involvement of our valuation specialists in derivative financial instruments, we recalculated them based on pricing techniques and data and information sources independently defined, and compared our results with those recorded by the Company. Also with the assistance of these specialists, we evaluated the sufficiency of the documentation prepared by the Company supporting the designation as hedge accounting, particularly designations containing the descriptions of all strategies and methodologies adopted for measurement of effectiveness. Also with the assistance of our specialists, sensitivity analyses were conducted in relation to the fair value of derivative financial instruments. We also evaluated the adequacy of disclosures made by the Company involving transactions with derivative financial instruments and hedge accounting, including those related to sensitivity analysis of these instruments.

 

Based on the evidences obtained through the procedures summarized above, we considered acceptable the balances of derivative financial instruments, as well as the designations maintained as hedge accounting in the context of the individual and consolidated financial statements taken as a whole, for the year ended December 31, 2017.

 

Other matters

 

Statements of value added

The individual and consolidated statements of value added (DVA) for the year ended December 31, 2017, prepared under the responsibility of the Company’s management, and presented herein as supplementary information for IFRS purposes, have been subject to audit procedures jointly performed with the audit of the Company's financial statements. In order to form our opinion, we assessed whether those statements are reconciled with the financial statements and accounting records, as applicable, and whether their format and contents are in accordance with criteria determined in the Technical Pronouncement 09 (CPC 09) - Statement of Value Added issued by the Committee for Accounting Pronouncements (CPC). In our opinion, the statements of value added have been fairly prepared, in all material respects, in accordance with the criteria determined by the aforementioned Technical Pronouncement, and are consistent with the overall individual and consolidated financial statements.

 

Other information accompanying the individual and consolidated financial statements and the auditor's report

Management is responsible for the other information comprising the management report.

Our opinion on the individual and consolidated financial statements does not cover the other information and we do not express any form of assurance conclusion thereon.

 

In connection with our audit of the individual and consolidated financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the individual and consolidated financial statements or our knowledge obtained in the audit, or otherwise appears to be materially misstated. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

 

 


 
 

 

 

Responsibilities of Management and Those Charged with Governance for the Individual and Consolidated Financial Statements

Management is responsible for the preparation and fair presentation of the individual financial statements in accordance with Accounting Practices Adopted in Brazil, and consolidated financial statements in accordance with Accounting Practices Adopted in Brazil and with International Financial Reporting Standards (IFRS) issued by the International Accounting Standards Board (IASB), and for such internal control as management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

 

In preparing the individual and consolidated financial statements, management is responsible for assessing the Company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to liquidate the Company and subsidiaries or to cease operations, or has no realistic alternative but to do so.

 

Those charged with governance are responsible for overseeing the Company’s and subsidiaries financial reporting process.

 

Auditors’ Responsibilities for the Audit of the Individual and Consolidated Financial Statements

Our objectives are to obtain reasonable assurance about whether the individual and consolidated financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors’ report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with Brazilian and international standards on auditing will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

 

As part of an audit in accordance with Brazilian and international standards on auditing, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

 

·            Identify and assess the risks of material misstatement of the individual and consolidated financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

 

 

 
 

 

·            Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s and its subsidiaries internal control.

·            Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.

·            Conclude on the appropriateness of management’s use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company’s and its subsidiaries ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditors’ report to the related disclosures in the individual and consolidated financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditors’ report. However, future events or conditions may cause the Company and subsidiaries to cease to continue as a going concern.

·            Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the individual and consolidated financial statements represent the underlying transactions and events in a manner that achieves fair presentation.

·            Obtain sufficient appropriate audit evidence regarding the financial information of the entities or business activities within the Group to express an opinion on the individual and consolidated financial statements. We are responsible for the direction, supervision and performance of the group audit. We remain solely responsible for our audit opinion.

 

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

 

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

 

 

 

 


 
 

 

From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the individual and consolidated financial statements of the current period and are therefore the key audit matters. We describe these matters in our auditors’ report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.

 

 

São Paulo, March 28, 2018.

 

 

KPMG Auditores Independentes
CRC 2SP014428/O-6
Original report in Portuguese signed by
Anselmo Neves Macedo
Accountant CRC 1SP160482/O-6

 

 

 


 
 

 

Braskem S.A.

 

Balance sheet at December 31

All amounts in thousands of reais                                                                                                                                                                                   

 

 

 

Consolidated

 

Parent company

Assets

Note

 

2017

 

2016

 

2017

 

2016

   

 

               

Current assets

 

               
 

Cash and cash equivalents

6

 

           3,775,093

 

                6,701,864

 

           1,953,056

 

                    3,561,431

 

Financial investments

7

 

           2,302,672

 

                1,190,483

 

           1,833,320

 

                       741,086

 

Trade accounts receivable

8

 

           3,281,196

 

                1,634,137

 

           1,824,740

 

                       952,689

 

Inventories

9

 

           6,846,923

 

                5,238,014

 

           4,800,860

 

                    3,795,899

 

Taxes recoverable

11

 

           1,349,064

 

                1,355,695

 

              830,152

 

                       543,275

 

Dividends and interest on capital

10

 

                10,859

 

                     14,986

 

                10,859

 

                         31,421

 

Prepaid expenses

 

 

              134,337

 

                   101,747

 

              105,255

 

                         83,252

 

Related parties

10(b)

 

 

 

 

 

                30,478

 

                       172,344

 

Derivatives operations

19.2

 

                  3,793

 

                       8,387

 

                  3,793

 

                           8,387

 

Other receivables

 

 

              288,391

 

                   180,915

 

              232,532

 

                       128,231

   

 

 

 

 

 

 

 

 

 

   

 

 

      17,992,328

 

            16,426,228

 

      11,625,045

 

               10,018,015

   

 

               

Non-current assets held for sale

5

 

 

 

                   359,704

 

 

 

                       263,912

   

 

               
   

 

 

      17,992,328

 

            16,785,932

 

      11,625,045

 

               10,281,927

Non-current assets

 

               
 

Financial investments

7

 

                10,336

 

 

 

 

 

 

 

Trade accounts receivable

8

 

                37,496

 

                     70,236

 

           1,336,229

 

                    2,794,889

 

Advances to suppliers

9

 

                46,464

 

                     61,533

 

                46,464

 

                         61,533

 

Taxes recoverable

11

 

           1,023,633

 

                1,088,353

 

           1,023,245

 

                       998,039

 

Deferred income tax and social contribution

21.2(b)

 

           1,165,726

 

                1,653,115

 

 

 

                         42,459

 

Judicial deposits

 

 

              289,737

 

                   233,320

 

              278,006

 

                       226,894

 

Related parties

10(b)

 

 

 

 

 

                16,053

 

                         14,472

 

Insurance claims

 

 

                39,802

 

                     50,653

 

                39,802

 

                         50,653

 

Derivatives operations

19.2

 

                32,666

 

                     29,308

 

 

 

 

 

Other receivables

 

 

              112,997

 

                   140,971

 

              109,129

 

                       129,704

 

Investments in subsidiaries and jointly-controlled investments

12

 

              101,258

 

                     92,313

 

           4,915,609

 

                    4,132,529

 

Property, plant and equipment

13

 

         29,761,610

 

              29,336,710

 

         16,326,216

 

                  15,963,127

 

Intangible assets

14

 

           2,727,497

 

                2,809,087

 

           2,501,503

 

                    2,521,243

   

 

 

 

 

 

 

 

 

 

   

 

 

      35,349,222

 

            35,565,599

 

      26,592,256

 

               26,935,542

   

 

               

Total assets

 

 

      53,341,550

 

            52,351,531

 

      38,217,301

 

               37,217,469

 

The Management notes are an integral part of the financial statements.

1


 
 

 

Braskem S.A.

 

Balance sheet at December 31

All amounts in thousands of reais

Continued

 

       

 Consolidated

 

 Parent company

Liabilities and shareholders' equity

Note

 

2017

 

2016

 

2017

 

2016

   

 

               

Current liabilities

 

               
 

Trade payables

 

 

          5,265,670

 

           6,545,136

 

          1,198,842

 

           2,056,661

 

Borrowings

15

 

          1,184,781

 

           2,594,463

 

             382,304

 

           2,117,409

 

Braskem Idesa borrowings

16

 

          9,691,450

 

         10,437,791

 

 

 

 

 

Debenture

17

 

               27,183

 

 

 

 

 

 

 

Derivatives operations

19.2

 

                 6,875

 

                29,042

 

 

 

 

 

Payroll and related charges

 

 

             630,517

 

              562,455

 

             493,098

 

              431,688

 

Taxes payable

20

 

          1,261,204

 

           1,153,760

 

             774,391

 

              424,088

 

Dividends

 

 

                 3,850

 

                  3,083

 

                 3,709

 

                  3,083

 

Advances from customers

 

 

             353,222

 

              203,216

 

             187,304

 

                28,200

 

Leniency agreement

23.3

 

             257,347

 

           1,354,492

 

             202,892

 

              948,286

 

Sundry provisions

22

 

             178,676

 

              112,891

 

             125,130

 

                87,084

 

Accounts payable to related parties

10(b)

 

 

 

 

 

             783,181

 

              956,609

 

Other payables

 

 

             276,957

 

              476,262

 

             104,181

 

              295,233

   

 

 

 

 

 

 

 

 

 

   

 

 

     19,137,732

 

       23,472,591

 

        4,255,032

 

         7,348,341

   

 

               

Non-current liabilities held for sale

5

 

 

 

                95,396

 

 

 

 

   

 

               
   

 

 

     19,137,732

 

       23,567,987

 

        4,255,032

 

         7,348,341

Non-current liabilities

 

               
 

Trade payables

 

 

             259,737

 

              201,686

 

        13,845,472

 

           8,832,553

 

Borrowings

15

 

        22,176,640

 

         20,736,604

 

          2,823,692

 

           6,463,032

 

Debenture

17

 

             286,141

 

                        

 

 

 

 

 

Derivatives operations

19.2

 

 

 

              861,302

 

 

 

              861,302

 

Taxes payable

20

 

               52,802

 

                24,097

 

               50,815

 

                23,830

 

Accounts payable to related parties

10(b)

 

 

 

 

 

          7,197,573

 

           8,234,053

 

Loan to non-controlling shareholders of Braskem Idesa

 

 

          1,756,600

 

           1,620,519

 

 

 

 

 

Deferred income tax and social contribution

21.2(b)

 

             940,079

 

              510,523

 

             715,938

 

 

 

Post-employment benefits

 

 

             193,775

 

              162,136

 

               83,233

 

                71,899

 

Provision for losses on subsidiaries

 

 

 

 

 

 

             102,750

 

                92,365

 

Advances from customers

 

 

 

 

              162,955

 

                       

 

 

 

Contingencies

23

 

          1,092,645

 

              985,237

 

          1,084,528

 

              926,819

 

Leniency agreement

23.3

 

          1,371,767

 

           1,498,738

 

          1,322,051

 

           1,400,224

 

Sundry provisions

22

 

             234,996

 

              206,245

 

             213,318

 

              169,499

 

Other payables

 

 

             148,286

 

                92,792

 

                 5,048

 

                  6,070

   

 

 

 

 

 

 

 

 

 

   

 

 

     28,513,468

 

       27,062,834

 

     27,444,418

 

       27,081,646

   

 

               

Shareholders' equity

25

               
 

Capital

 

 

          8,043,222

 

           8,043,222

 

          8,043,222

 

           8,043,222

 

Capital reserve

 

 

             232,430

 

              232,430

 

             232,430

 

              232,430

 

Revenue reserves

 

 

          3,945,898

 

              834,616

 

          3,945,898

 

              834,616

 

Equity valuation adjustments

 

 

        (5,653,880)

 

          (6,321,859)

 

        (5,653,880)

 

          (6,321,859)

 

Treasury shares

 

 

             (49,819)

 

               (49,819)

 

             (49,819)

 

                    (927)

   

 

 

 

 

 

 

 

 

 

 

Total attributable to the  Company's shareholders

 

 

          6,517,851

 

           2,738,590

 

          6,517,851

 

           2,787,482

   

 

               
 

Non-controlling interest in subsidiaries

 

 

           (827,501)

 

          (1,017,880)

 

 

 

 

   

 

               
   

 

 

       5,690,350

 

         1,720,710

 

        6,517,851

 

         2,787,482

   

 

               

Total liabilities and shareholders' equity

 

 

     53,341,550

 

       52,351,531

 

     38,217,301

 

       37,217,469

                                                                 

The Management notes are an integral part of the financial statements.

2


 
 

 

Braskem S.A.

 

Statement of operations

Years ended December 31

All amounts in thousands of reais, except earnings (loss) per share

 

 

 

 

 

 

Consolidated

 

 

 

Parent company

 

 

Note

 

2017

 

2016

 

2017

 

2016

 

 

2.4(b)

 

 

 

Adjusted

 

 

 

Adjusted

 

 

27

 

      49,260,594

 

      47,663,988

 

      36,481,806

 

      35,178,466

Cost of products sold

 

0

 

       (36,400,748)

 

       (34,985,569)

 

       (28,929,876)

 

       (27,003,424)

 

 

0

 

 

 

 

 

 

 

 

 

 

0

 

      12,859,846

 

      12,678,419

 

        7,551,930

 

        8,175,042

 

 

0

 

 

 

 

 

 

 

 

 

 

0

 

 

 

 

 

 

 

 

Selling and distribution

 

0

 

         (1,459,608)

 

         (1,403,673)

 

            (925,663)

 

            (971,422)

General and administrative

 

0

 

         (1,434,272)

 

         (1,285,613)

 

            (865,085)

 

            (719,270)

Research and development

 

0

 

            (167,456)

 

            (162,010)

 

            (105,286)

 

            (104,832)

Results from equity investments

 

12(c)

 

                39,956

 

                30,078

 

           2,441,996

 

              955,535

Other income (expenses), net

 

29

 

            (479,404)

 

         (3,905,954)

 

            (449,092)

 

         (3,237,435)

 

 

0

 

 

 

 

 

 

 

 

 

 

0

 

        9,359,062

 

        5,951,247

 

        7,648,800

 

        4,097,618

 

 

0

 

 

 

 

 

 

 

 

 

 

30

 

 

 

 

 

 

 

 

Financial expenses

 

0

 

         (3,747,217)

 

         (3,570,962)

 

         (2,627,262)

 

         (2,847,039)

Financial income

 

0

 

              603,630

 

              690,122

 

              545,262

 

              632,452

Exchange rate variations, net

 

0

 

            (798,762)

 

         (3,210,417)

 

            (878,154)

 

         (2,054,042)

 

 

0

 

 

 

 

 

 

 

 

 

 

0

 

       (3,942,349)

 

       (6,091,257)

 

       (2,960,154)

 

       (4,268,629)

 

 

0

 

 

 

 

 

 

 

 

 

 

0

 

        5,416,713

 

          (140,010)

 

        4,688,646

 

          (171,011)

 

 

0

 

 

 

 

 

 

 

 

Current and deferred income tax and social contribution

 

21.1

 

         (1,292,268)

 

            (616,046)

 

            (614,532)

 

            (271,419)

 

 

0

 

 

 

 

 

 

 

 

 

 

0

 

        4,124,445

 

          (756,056)

 

        4,074,114

 

          (442,430)

 

 

0

 

 

 

 

 

 

 

 

 

 

5

 

 

 

 

 

 

 

 

Profit from discontinued operations

 

0

 

                13,499

 

                40,760

 

                13,499

 

                30,958

Current and deferred income tax and social contribution

 

0

 

                (4,623)

 

              (13,901)

 

                (4,623)

 

                       

 

 

0

 

                  8,876

 

                26,859

 

                  8,876

 

                30,958

 

 

0

 

 

 

 

 

 

 

 

 

 

0

 

        4,133,321

 

          (729,197)

 

        4,082,990

 

          (411,472)

 

 

0

 

 

 

 

 

 

 

 

 

 

0

 

 

 

 

 

 

 

 

Company's shareholders

 

0

 

           4,082,990

 

            (411,472)

 

                         

 

                      

Non-controlling interest in subsidiaries

 

0

 

                50,331

 

            (317,725)

 

 

 

 

 

 

0

 

 

 

 

 

 

 

 

 

 

0

 

        4,133,321

 

          (729,197)

 

 

 

 

 

 

The Management notes are an integral part of the financial statements.

3


 
 

 

Braskem S.A.

 

Statement of comprehensive income

Years ended December 31

All amounts in thousands of reais

 

         

 

 

Consolidated

 

 

 

Parent company

     

Note

 

2017

 

2016

 

2017

 

2016

     

 

               

Profit (loss) for the year

 

 

 

        4,133,321

 

          (729,197)

 

            4,082,990

 

               (411,472)

     

 

               

Other comprehensive income:

 

 

               

Items that will be reclassified subsequently to profit or loss

 

 

               
 

Fair value of cash flow hedge

 

 

 

              605,204

 

              215,510

 

                  540,628

 

                  266,995

 

Income tax and social contribution

 

 

 

            (203,186)

 

              (75,333)

 

                (183,813)

 

                   (90,778)

 

Fair value of cash flow hedge - Braskem Idesa

 

 

 

 

 

 

 

                    48,432

 

                   (38,614)

 

Income tax and social contribution

 

 

 

 

 

 

 

                  (14,530)

 

                    11,584

 

Fair value of cash flow hedge from jointly-controlled

 

 

 

                  3,534

 

                (3,309)

 

                      3,534

 

                     (3,309)

     

 

 

              405,552

 

              136,868

 

                  394,251

 

                  145,878

     

 

               
 

Exchange variation of foreign sales hedge

 

19.4(a.i)

 

            (397,045)

 

           4,121,849

 

                (397,045)

 

               4,121,849

 

Sales Hedge - transfer to profit or loss

 

19.4(a.i)

 

           1,022,830

 

           1,297,910

 

               1,022,830

 

               1,297,910

 

Income tax and social contribution on exchange variation

 

 

 

            (212,767)

 

         (1,842,718)

 

                (212,767)

 

              (1,842,718)

 

Exchange variation of foreign sales hedge - Braskem Idesa

 

19.4(a.ii)

 

              472,717

 

         (1,995,065)

 

                  354,538

 

              (1,496,298)

 

Sales Hedge - transfer to profit or loss - Braskem Idesa

 

19.4(a.ii)

 

              163,696

 

                59,834

 

                  122,772

 

                    44,875

 

Income tax on exchange variation - Braskem Idesa

 

 

 

            (190,924)

 

              581,304

 

                (143,193)

 

                  435,978

     

 

 

              858,507

 

           2,223,114

 

                  747,135

 

               2,561,596

     

 

               
 

Foreign subsidiaries currency translation adjustment

 

 

 

                   (602)

 

              339,296

 

                    51,445

 

                    63,697

     

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

        1,263,457

 

        2,699,278

 

            1,192,831

 

             2,771,171

     

 

               

Items that will not be reclassified to profit or loss

 

 

               
 

Defined benefit plan actuarial loss, net of taxes

 

 

 

                (5,750)

 

                (4,119)

 

                    (5,750)

 

                     (4,119)

 

Post-employment plans - Health plan, net of taxes

     

                (2,904)

 

 

 

                    (2,904)

 

 

     

 

               
 

Total

 

 

 

                (8,654)

 

                (4,119)

 

                    (8,654)

 

                     (4,119)

     

 

               

Total comprehensive income for the year

 

 

 

        5,388,124

 

        1,965,962

 

            5,267,167

 

             2,355,580

     

 

               

Attributable to:

 

 

               
 

Company's shareholders

 

 

 

           5,267,167

 

           2,355,580

       
 

Non-controlling interest in Braskem Idesa

 

 

 

              120,957

 

            (389,618)

       
     

 

 

 

 

 

       

Total comprehensive income (loss) for the year

 

 

 

        5,388,124

 

        1,965,962

       
                       
                       
                       
                 

 

 

Parent company

                 

 2017

 

2016

     

Note

         

Basic and diluted

 

Basic and diluted

Profit (loss) per share attributable to the shareholders of the Company

 

 

               

of continued operations at the end of the year (R$)

 

26

               

(expressed in reais)

 

 

               
 

Earnings per share - common

 

 

         

                    5.1214

 

                   (0.5562)

 

Earnings per share - preferred shares class "A"

 

 

         

                    5.1214

 

                   (0.5562)

 

Earnings per share - preferred shares class "B"

 

 

         

                    0.6069

 

 

 

 

The Management notes are an integral part of the financial statements.

4


 
 

  

Braskem S.A.

 

Statement of changes in equity

All amounts in thousands of reais

 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated

     

Attributed to shareholders' interest

         
             

Revenue reserves

             

Total

       
                         

Additional

 

Equity

     

Retained

 

Braskem

 

Non-controlling

 

Total

         

Capital

 

Legal

 

Tax

 

Retention

 

dividends

 

valuation

 

Treasury

 

earnings

 

shareholders'

 

interest in

 

shareholders'

 

Note

 

Capital

 

reserve

 

reserve

 

incentive

 

of profits

 

proposed

 

adjustments

 

shares

 

(losses)

 

interest

 

subsidiaries

 

equity

 

 

                                               

At December 31, 2015

 

 

8,043,222

 

232,430

 

229,992

 

 

 

2,404,663

 

247,364

 

(9,060,710)

 

(49,819)

 

(416,768)

 

1,630,374

 

(684,885)

 

945,489

 

 

                                               
 

 

                                               

Comprehensive income for the year:

 

                                               
  Profit for the year

 

   

(411,472)

 

(411,472)

 

(317,725)

 

(729,197)

Exchange variation of foreign sales hedge, net of taxes

 

   

2,561,596

   

2,561,596

 

(338,482)

 

2,223,114

Fair value of cash flow hedge, net of taxes

 

   

145,878

   

145,878

 

(9,010)

 

136,868

Foreign subsidiaries currency translation adjustment  

 

 

 

 

 

 

 

 

 

 

 

 

63,697

 

 

 

 

 

63,697

 

275,599

 

339,296

   

 

 

 

 

 

 

 

 

 

 

 

 

2,771,171

 

 

 

(411,472)

 

2,359,699

 

(389,618)

 

1,970,081

                 

Equity valuation adjustments:

 
Realization of additional property, plant and equipment price-level restatement, net of taxes    

(27,236)

   

27,236

 
Realization of deemed cost of jointly-controlled investment, net of taxes    

(965)

   

965

 
Actuarial loss with post-employment benefits, net of taxes  

 

 

 

 

 

 

 

 

 

 

 

 

(4,119)

 

 

 

 

 

(4,119)

 

 

 

(4,119)

   

 

 

 

 

 

 

 

 

 

 

 

 

(32,320)

 

 

 

28,201

 

(4,119)

 

 

 

(4,119)

   

Contributions and distributions to shareholders:

 
Absorption of losses and adjustments    

(800,039)

   

800,039

 
Capital increase

 

     

56,623

 

56,623

Additional dividends approved by the General Meeting

 

   

(247,364)

   

(247,364)

 

 

 

(247,364)

Interim dividends approved by Board of Directors

 

 

 

 

 

 

 

 

 

 

(1,000,000)

 

 

 

 

 

 

 

 

 

(1,000,000)

 

 

 

(1,000,000)

 

 

 

 

 

 

 

 

 

 

 

(1,800,039)

 

(247,364)

 

 

 

 

 

800,039

 

(1,247,364)

 

56,623

 

(1,190,741)

 

 

                                               

At December 31, 2016

 

 

8,043,222

 

232,430

 

229,992

 

 

 

604,624

 

 

 

(6,321,859)

 

(49,819)

 

 

 

2,738,590

 

(1,017,880)

 

1,720,710

 

 

                         

Comprehensive income for the year:

 

                   
Loss for the year

 

     

4,082,990

 

4,082,990

 

50,331

 

4,133,321

Exchange variation of foreign sales hedge, net of taxes

 

   

747,135

   

747,135

 

111,372

 

858,507

Fair value of cash flow hedge, net of taxes

 

   

394,251

   

394,251

 

11,301

 

405,552

Foreign currency translation adjustment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

51,445

 

 

 

 

 

51,445

 

(52,047)

 

(602)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,192,831

 

 

 

4,082,990

 

5,275,821

 

120,957

 

5,396,778

 

 

   

Equity valuation adjustments:

 

   
Realization of additional property, plant and equipment price-level restatement, net of taxes

 

   

(26,847)

   

26,847

 
Realization of deemed cost of jointly-controlled investment, net of taxes

 

   

(963)

   

963

 
Actuarial gains post-employment benefits of subsidiaries , net of taxes      

(5,750)

 

 

 

 

 

(5,750)

   

(5,750)

Post-employment benefits - health plan, net of taxes      

(2,904)

     

 

 

(2,904)

   

(2,904)

       

(36,464)

   

27,810

 

(8,654)

   

(8,654)

Contributions and distributions to shareholders:

     
Prescribed dividends      

482

 

482

   

482

Tax incentive reserve

28(a)

     

71,745

   

(71,745)

 
Prepaid dividends

25(e.1)

       

(1,000,000)

 

(1,000,000)

   

(1,000,000)

Legal reserve

25(e.1)

   

204,150

   

(204,150)

 
Additional dividends proposed

25(e.1)

   

1,500,000

   

(1,500,000)

 
Retained earnings

25(e.1)

   

1,335,387

 

 

   

(1,335,387)

 
Goodwill on the acquisition of a subsidiary under common control

1(a.ii)

   

(488,388)

   

(488,388)

   

(488,388)

Non-controlling interest in subsidiaries      

69,422

 

69,422

     

204,150

 

71,745

 

1,335,387

 

1,500,000

 

(488,388)

   

(4,110,800)

 

(1,487,906)

 

69,422

 

(1,418,484)

                                           

At December 31, 2017

 

8,043,222

 

232,430

 

434,142

 

71,745

 

1,940,011

 

1,500,000

 

(5,653,880)

 

(49,819)

 

 

 

6,517,851

 

(827,501)

 

5,690,350

 

The Management notes are an integral part of the financial statements.

5


 
 

 

Braskem S.A.

 

Statement of changes in equity

All amounts in thousands of reais

Continued

 

     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Parent Company

             

Revenue reserves

 

             
                         

Additional

 

Equity

     

Retained

 

Total

         

Capital

 

Legal

 

Tax

 

Retention

 

dividends

 

valuation

 

Treasury

 

earnings

 

shareholders'

 

Note

 

Capital

 

reserve

 

reserve

 

incentive

 

of profits

 

proposed

 

adjustments

shares

 

(losses)

 

equity

At December 31, 2015

 

8,043,222

 

232,430

 

229,992

 

 

 

2,404,663

 

247,364

 

(9,060,710)

(927)

 

(416,768)

 

1,679,266

                                       

Comprehensive income for the year:

         
  Profit for the year    

(411,472)

 

(411,472)

Exchange variation of foreign sales hedge, net of taxes    

2,561,596

 

2,561,596

Fair value of cash flow hedge, net of taxes    

145,878

 

145,878

Foreign subsidiaries currency translation adjustment  

 

 

 

 

 

 

 

 

 

 

 

 

63,697

 

 

 

 

63,697

   

 

 

 

 

 

 

 

 

 

 

 

 

2,771,171

 

 

(411,472)

 

2,359,699

                                       

Equity valuation adjustments:

   
Realization of additional property, plant and equipment price-level restatement, net of taxes    

(27,236)

 

27,236

 
Realization of deemed cost of jointly-controlled investment, net of taxes    

(965)

 

965

 
Actuarial loss with post-employment benefits, net of taxes  

 

 

 

 

 

 

 

 

 

 

 

 

(4,119)

 

 

 

 

(4,119)

   

 

 

 

 

 

 

 

 

 

 

 

 

(32,320)

 

 

28,201

 

(4,119)

       

Contributions and distributions to shareholders:

     
Absorption of losses and adjustments    

(800,039)

   

800,039

 
Additional dividends approved by the General Meeting    

(247,364)

 

 

(247,364)

Interim dividends approved by Board of Directors  

 

 

 

 

 

 

 

 

(1,000,000)

 

 

 

 

 

 

 

 

 

(1,000,000)

   

 

 

 

 

 

 

 

 

(1,800,039)

 

(247,364)

 

 

 

 

 

800,039

 

(1,247,364)

                                         

At December 31, 2016

 

8,043,222

 

232,430

 

229,992

 

 

 

604,624

 

 

 

(6,321,859)

 

(927)

 

 

 

2,787,482

                                         

Comprehensive income for the year:

     
Loss for the year      

4,082,990

 

4,082,990

Exchange variation of foreign sales hedge, net of taxes    

747,135

   

747,135

Fair value of cash flow hedge, net of taxes    

394,251

   

394,251

Foreign currency translation adjustment  

 

 

 

 

 

 

 

 

 

 

 

 

51,445

 

 

 

 

 

51,445

   

 

 

 

 

 

 

 

 

 

 

 

 

1,192,831

 

 

 

4,082,990

 

5,275,821

   

Equity valuation adjustments:

 
Realization of deemed cost of jointly-controlled investment, net of taxes    

(26,847)

   

26,847

 
Realization of additional property, plant and equipment price-level restatement, net of taxes    

(963)

   

963

 
Actuarial gains post-employment benefits of subsidiaries , net of taxes    

(5,750)

   

(5,750)

Post-employment benefits - health plan, net of taxes  

 

 

 

 

 

 

 

 

 

 

 

 

(2,904)

 

 

 

 

 

(2,904)

   

 

 

 

 

 

 

 

 

 

 

 

 

(36,464)

 

 

 

27,810

 

(8,654)

Contributions and distributions to shareholders:

   
Prescribed dividends    

482

 

482

Addition by incorporation of subsidiary

1(a.iv)

   

(48,892)

 

 

 

(48,892)

Goodwill on the acquisition of a subsidiary under common control

1(a.ii)

   

(488,388)

   

(488,388)

Tax incentive reserve

28(a)

   

71,745

   

(71,745)

 

 

Prepaid dividends

25(e.1)

     

(1,000,000)

 

(1,000,000)

Legal reserve

25(e.1)

   

204,150

   

(204,150)

 
Additional dividends proposed

25(e.1)

   

1,500,000

   

(1,500,000)

 
Retained earnings

25(e.1)

 

 

 

 

 

 

 

 

 

1,335,387

 

 

 

 

 

 

 

(1,335,387)

 

 

   

 

 

 

 

204,150

 

71,745

 

1,335,387

 

1,500,000

 

(488,388)

 

(48,892)

 

(4,110,800)

 

(1,536,798)

                                         

At December 31, 2017

 

8,043,222

 

232,430

 

434,142

 

71,745

 

1,940,011

 

1,500,000

 

(5,653,880)

 

(49,819)

 

 

 

6,517,851

 

The Management notes are an integral part of the financial statements.

6


 
 

 

Braskem S.A.

 

Statement of cash flows

Years ended December 31

All amounts in thousands of reais

 

 

 

 

Consolidated

 

Parent company

 

 

Note

 

2017

 

2016

 

2017

 

2016

 

 

2.4(a)

   

 

Adjusted

   

 

Adjusted

Profit (loss) before income tax and social contribution and

  for the result with discontinued operations

 

 

           5,416,713

 

              (99,250)

 

           4,688,646

 

            (140,053)

 

 

 

 

                     

 

              

 

            

 

               

Adjustments for reconciliation of profit

 

 

               

 

              

 

              

 

               

 

Depreciation, amortization and depletion

 

 

           2,928,855

 

           2,683,100

 

           1,880,065

 

           2,052,972

 

Results from equity investments

12(c)

 

              (39,956)

 

              (30,078)

 

         (2,441,996)

 

            (986,493)

 

Interest and monetary and exchange variations, net

 

 

           3,697,714

 

           3,026,008

 

           2,711,904

 

           2,252,597

 

Gain from divestment in subsidiary

5

 

            (276,816)

 

         

 

            (276,366)

 

                 

 

Leniency agreement

 

 

               

 

           2,853,230

 

             

 

           2,348,510

 

Provision for losses and write-offs of long-lived assets

 

 

              213,184

 

                41,016

 

              184,470

 

                39,718

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

      11,939,694

 

        8,474,026

 

        6,746,723

 

        5,567,251

 

 

 

 

 

 

 

 

 

 

 

Changes in operating working capital

 

 

 

 

 

 

 

 

 

 

Financial investments in time deposit

7(i)

 

                 

 

            (427,688)

 

      

 

            

 

Trade accounts receivable

 

 

         (1,598,392)

 

           1,007,875

 

           1,685,243

 

           2,985,748

 

Inventories

 

 

         (1,557,902)

 

              862,338

 

            (829,586)

 

              914,160

 

Taxes recoverable

 

 

              471,362

 

           1,058,104

 

              205,657

 

              623,932

 

Prepaid expenses

 

 

              (30,521)

 

                64,029

 

              (19,460)

 

                56,416

 

Other receivables

 

 

                25,802

 

              353,981

 

                75,230

 

              341,762

 

Trade payables

 

 

         (1,435,775)

 

         (4,254,575)

 

           3,724,398

 

         (1,318,768)

 

Taxes payable

 

 

            (217,583)

 

            (292,131)

 

              (28,908)

 

            (161,824)

 

Advances from customers

 

 

              (13,512)

 

              216,850

 

              157,033

 

              (16,328)

 

Leniency agreement

 

 

         (1,343,803)

 

              

 

            (942,905)

 

         

 

Sundry provisions

 

 

              194,596

 

              558,231

 

              152,779

 

              544,863

 

Other payables

 

 

                55,541

 

                38,464

 

            (150,659)

 

              (61,546)

 

 

 

 

 

 

 

 

 

 

 

Cash from operations

 

 

        6,489,507

 

        7,659,504

 

      10,775,545

 

        9,475,666

 

 

 

 

 

 

 

 

 

 

 

 

Financial investments

(includes Letras financeiras do tesouro - LFT´s and Letras Financeiras - LF´s)

 

 

            (953,228)

 

            (221,847)

 

         (1,014,032)

 

            (271,049)

 

 

 

 

 

 

 

 

 

 

 

Cash generated from operations and handling of financial investments

 

 

        5,536,279

 

        7,437,657

 

        9,761,513

 

        9,204,617

 

 

 

 

 

 

 

 

 

 

 

 

Interest paid

 

 

         (2,154,053)

 

         (1,826,942)

 

            (827,839)

 

            (478,594)

 

Income tax and social contribution paid

 

 

            (920,606)

 

         (1,152,847)

 

            (363,617)

 

            (204,121)

 

 

 

 

 

 

 

 

 

 

 

Net cash generated by operating activities

 

 

        2,461,620

 

        4,457,868

 

        8,570,057

 

        8,521,902

 

 

 

 

 

 

 

 

 

 

 

Proceeds from the sale of fixed assets

 

 

                39,660

 

                     564

 

                39,245

 

                     122

Proceeds from the sale of investments

5

 

              450,000

 

              

 

              449,550

 

  

Effect in the merger of cash in subsidiaries

 

 

              

 

                 

 

                31,779

 

            

Additions to investments in subsidiaries

1(a.ii)

 

            (608,181)

 

   

 

            (610,000)

 

          

Acquisitions to property, plant and equipment and intangible assets

(i)

 

         (2,273,197)

 

         (2,586,511)

 

         (1,379,547)

 

         (1,340,377)

Premium in the dollar put option

 

 

              (14,683)

 

                (4,856)

 

              (14,683)

 

                (4,856)

Held-for-maturity financial investments

 

 

            

 

                38,353

 

               

 

                38,353

 

 

 

 

 

 

 

 

 

 

 

Net cash used in investing activities

 

 

       (2,406,401)

 

       (2,552,450)

 

       (1,483,656)

 

       (1,306,758)

 

 

 

 

 

 

 

 

 

 

 

Short-term and Long-term debit

 

 

 

 

 

 

 

 

 

 

Obtained

 

 

           8,492,341

 

           4,107,626

 

           2,077,328

 

           4,067,345

 

Payments

 

 

         (8,779,091)

 

         (4,901,593)

 

         (7,241,734)

 

         (5,682,323)

Derivative transactions

 

 

                     

 

           

 

         

 

           

 

Payments

 

 

            (810,279)

 

       

 

            (810,279)

 

              

Braskem Idesa borrowings

 

 

         

 

              

 

 

 

         

 

Obtained

 

 

              187,959

 

              503,921

 

   

 

                 

 

Payments

 

 

         (1,080,502)

 

            (469,282)

 

                

 

               

Related parties

 

 

 

 

 

 

         

 

    

 

Obtained

 

 

             

 

       

 

           3,941,614

 

           2,791,610

 

Payments

 

 

   

 

          

 

         (5,662,812)

 

         (7,248,125)

Dividends paid

 

 

            (998,893)

 

         (1,997,984)

 

            (998,893)

 

         (1,997,984)

 

 

 

 

 

 

 

 

 

 

 

Net cash used in financing activities

 

 

       (2,988,465)

 

       (2,757,312)

 

       (8,694,776)

 

       (8,069,477)

 

 

 

 

 

 

 

 

 

 

 

Exchange variation on cash of foreign subsidiaries

 

 

                  6,475

 

              586,642

 

   

 

       

 

 

 

 

 

 

 

 

 

 

 

Increase (decrease) in cash and cash equivalents

 

 

       (2,926,771)

 

          (265,252)

 

       (1,608,375)

 

          (854,333)

 

 

 

 

 

 

 

 

 

 

 

Represented by

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents at the beginning of the year

 

 

           6,701,864

 

           7,043,262

 

           3,561,431

 

           4,415,764

 

Cash and cash equivalents at the end of the year

 

 

           3,775,093

 

           6,778,010

 

           1,953,056

 

           3,561,431

 

 

 

 

 

 

 

 

 

 

 

Increase (decrease) in cash and cash equivalents

 

 

       (2,926,771)

 

          (265,252)

 

       (1,608,375)

 

          (854,333)

                       

 

(i)   

In the period ended December 31, 2017, the capitalized interest paid that was included in this item (R$288,424 Consolidated, R$69,342 Parent Company) was reclassified to “Interest paid” (Note 2.5(a)).

 

The Management notes are an integral part of the financial statements.

7


 
 

 

Braskem S.A.

 

Statement of value added

Years ended December 31

All amounts in thousands of reais

 

 

 

 

Consolidated

 

 

 

Parent company

 

 

 

2017

 

2016

 

2017

 

2016

 

 

 

 

 

Adjusted

 

 

 

Adjusted

Revenue

 

          58,000,752

 

              52,429,423

 

           45,303,874

 

         39,775,501

 

Sale of goods, products and services

 

             57,958,099

 

                55,930,688

 

              45,351,039

 

           42,711,853

 

Other income (expenses), net

 

                      1,202

 

                 (3,437,060)

 

                   (82,722)

 

            (2,867,482)

 

Allowance for doubtful accounts

 

                    41,451

 

                      (64,205)

 

                     35,557

 

                 (68,870)

Inputs acquired from third parties

 

        (41,147,077)

 

            (39,909,905)

 

         (34,116,843)

 

       (31,662,604)

 

Cost of products, goods and services sold

 

           (38,845,377)

 

               (37,802,247)

 

            (32,523,499)

 

          (30,222,548)

 

Material, energy, outsourced services and others

 

             (2,237,835)

 

                 (2,019,390)

 

              (1,539,920)

 

            (1,353,186)

 

Impairment of assets

 

                  (63,865)

 

                      (88,268)

 

                   (53,424)

 

                 (86,870)

Gross value added

 

          16,853,675

 

              12,519,518

 

           11,187,031

 

           8,112,897

 

 

 

 

 

 

 

 

 

 

Depreciation, amortization and depletion

 

             (2,928,855)

 

                 (2,683,100)

 

              (1,880,065)

 

            (2,052,972)

 

 

 

 

 

 

 

 

 

 

Net value added produced by the Company

 

          13,924,820

 

                9,836,418

 

             9,306,966

 

           6,059,925

 

 

 

 

 

 

 

 

 

 

Value added received in transfer

 

                652,527

 

                   720,407

 

             2,996,197

 

           1,618,945

 

Results from equity investments

 

                    48,832

 

                       30,078

 

                2,450,872

 

                986,493

 

Financial income

 

                  603,630

 

                     690,122

 

                   545,262

 

                632,452

 

Other

 

                           65

 

                            207

 

                            63

 

                          -  

 

 

 

 

 

 

 

 

 

 

Total value added to distribute

 

          14,577,347

 

              10,556,825

 

           12,303,163

 

           7,678,870

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Personnel

 

            1,421,214

 

                1,267,513

 

             1,018,832

 

              765,684

 

Direct compensation

 

               1,147,158

 

                     986,940

 

                   801,083

 

                564,067

 

Benefits

 

                  212,815

 

                     218,110

 

                   154,876

 

                140,879

 

FGTS (Government Severance Pay Fund)

 

                    61,241

 

                       62,463

 

                     62,873

 

                  60,738

 

 

 

 

 

 

 

 

 

 

Taxes, fees and contribuitions

 

            4,232,072

 

                3,018,046

 

             3,511,778

 

           2,246,826

 

Federal

 

               2,214,611

 

                  1,288,179

 

                1,569,651

 

                732,051

 

State

 

               1,995,068

 

                  1,703,249

 

                1,928,530

 

             1,502,420

 

Municipal

 

                    22,393

 

                       26,618

 

                     13,597

 

                  12,355

 

 

 

 

 

 

 

 

 

 

Remuneration on third parties' capital

 

            4,790,740

 

                7,000,463

 

             3,689,563

 

           5,077,832

 

Financial expenses (including exchange variation)

 

               4,545,979

 

                  6,755,962

 

                3,487,287

 

             4,888,738

 

Rentals

 

                  244,761

 

                     244,501

 

                   202,276

 

                189,094

 

 

 

 

 

 

 

 

 

 

Remuneration on own capital

 

            4,133,321

 

                  (729,197)

 

             4,082,990

 

             (411,472)

 

Profit (loss) for the year

 

               3,074,114

 

                    (438,331)

 

                3,074,114

 

               (442,430)

 

Dividends

 

               1,000,000

 

                               

 

                1,000,000

 

                          

 

Non-controlling interest in subsidiaries

 

                    50,331

 

                    (317,725)

 

                           

 

                         

 

Discontinued operations results

 

                      8,876

 

                       26,859

 

                       8,876

 

                  30,958

 

 

 

          

 

               

 

           

 

                 

Value added distributed

 

          14,577,347

 

              10,556,825

 

           12,303,163

 

           7,678,870

                     

 

 

The Management notes are an integral part of the financial statements.

8


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

1                    Operations

 

Braskem S.A. (hereinafter “Parent Company”) is a public company headquartered in the city of Camaçari, Bahia (“BA”), which jointly with its subsidiaries (hereinafter “Braskem” or “Company”), operates 41 industrial units, 29 of which in the Brazilian states of Alagoas (“AL”), Bahia (“BA”), Rio de Janeiro (“RJ”), Rio Grande do Sul (“RS”) and São Paulo (“SP”), six are located in the United States, four in Mexico and two are located in Germany. These units produce thermoplastic resins – polyethylene (“PE”), polypropylene (“PP”) and polyvinyl chloride (“PVC”), as well as basic petrochemicals.

 

Braskem is also engaged in the import and export of chemicals, petrochemicals and fuels, the production, supply and sale of utilities such as steam, water, compressed air, industrial gases, as well as the provision of industrial services and the production, supply and sale of electric energy for its own use and use by other companies. Braskem also invests in other companies, either as a partner or as shareholder.

 

The Company is controlled by Odebrecht S.A. (“Odebrecht”), which directly and indirectly holds interests of 50.11% and 38.32% in its voting and total capital, respectively.

 

(a)               Significant corporate and operating events impacting these financial statements

 

(i)                  In January 2017, Braskem’s new line to produce ultra-high molecular weight polyethylene (UHMWPE), known commercially as UTEC®, started operations. Located in La Porte, Texas, the plant complements the production capacity of the existing line in Brazil at the Camaçari Petrochemical Complex.

 

(ii)               On January 27, 2017, the Board of Directors of the Company authorized the execution of a purchase agreement with Odebrecht Utilities S.A. (“Odebrecht Utilities”), through which Braskem undertook to purchase all shares held by the seller in Cetrel S.A. (“Cetrel”), which represent 63.66% of its voting capital, for the aggregate amount of R$610 million.

 

Cetrel is an environmental services company that launched its operations in 1978, together with the companies that set up operations in the Camaçari Petrochemical Complex. With over 100 clients, or around 70% of the Camaçari Complex, Cetrel is responsible for treating and disposing of industrial wastewater and solid waste, environmental monitoring and supplying water for industrial use to Braskem’s plants in Camaçari.

 

Cetrel plays an important role in managing the environmental processes of the Camaçari Petrochemical Complex, and its acquisition ensures the security and reliability of the complex’s industrial operations.

 

On September 29, 2017, a Shareholders’ Meeting of Braskem approved the consummation of the acquisition and, on October 2, 2017, the acquisition of 1,269,290 shares issued by Cetrel was concluded with payment of the agreed upon amount of R$610 million, on which date control of Cetrel was transferred to Braskem. The Company´s accounting policy choice for acquisition of companies under common control is the predecessor accounting. The impact from the difference between the consideration given and the aggregate book value of the assets and liabilities of the acquired entity, in the amount of R$488,388, was recognized in “Equity”, under “Equity valuation adjustments”.

 

On October 16, 2017, during an extraordinary meeting of the Board of Directors of Cetrel, Braskem elected the new executive board and, on October 25, 2017, the extraordinary shareholders meeting elected the new members of the Board of Directors and Audit Board.

 

9


 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

The net assets at the acquisition date are composed of the following main items:

 

         

September/2017

           

Current and non-current assets

       
 

Cash and cash equivalents

     

1,819

 

Financial investments

     

35,186

 

Trade accounts receivable

     

55,055

 

Inventories

     

8,152

 

Deferred income tax and social contribution

     

106,760

 

Property, plant and equipment

     

287,905

 

Intangible assets

     

52,556

 

Other assets

     

25,852

         

573,285

           

Current and non-current liabilities

       
 

Trade payables

     

16,019

 

Borrowings

     

18,485

 

Debentures

     

317,960

 

Other liabilities

     

29,787

         

382,251

           

Net assets (assets (-) liabilities)

     

191,034

 

The following table summarizes the consideration paid to Odebrecht Utilities on the acquisition date and book value of the net assets acquired:

         

September/2017

           

Consideration

       
 

Acquisition of 1,269,290 shares (63.66% of the capital)

     

610,000

(A) Total consideration transferred

     

610,000

           

% of participation

 

100.00%

 

63.66%

           

(B) Cetrel's shareholders' equity on September 9, 2017

 

191,034

 

121,612

           

Result (A) - (B)

   

(i)

488,388

 

 

(i)   

Difference between the consideration given and the aggregate book value of the assets and liabilities of the acquired entity on September 9, 2017.

 

(iii)             On June 21, 2017, the Board of Directors approved the construction of a new polypropylene production unit in La Porte, Texas, United States. The total investment is up to approximately US$675 million for 450 kta in production capacity. The conclusion of the construction of this project and the start of its operations is expected in 2020.

 

(iv)       On December 1, 2017, the Extraordinary Shareholders' Meeting approved the merger, at carrying cost, of Braskem Petroquímica S.A. (“Braskem Petroquímica”) into the Parent Company, without any change in its capital or issue of new shares.

 

On the merger date, the investment in Braskem Petroquímica was composed as follows:

 

10


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

         

December 1, 2017

Equity amount

     

                     2,104,722

Balances calculated on the acquisition of Braskem Petroquímica in 2010, reclassified to the following accounts:

 
 

Property, plant and equipment - fair value adjustments

     

                        341,650

 

Intangible assets - goodwill for the future profitability

     

                      (252,820)

 

Deferred income tax and social contribution - assets

     

                        102,690

 

Contingencies - possible success

     

                        (49,211)

 

Deferred income tax and social contribution - liabilities

     

                      (113,240)

         

                          29,069

         

                  2,133,791

  

 

(i)   

Future profitability arising from the acquisition of a company registered in the acquired company and written off at Braskem, for business combination purposes.

 

The merger had the following impacts on the balance sheet of the Parent Company:

 

 

 

 

 

 

 

December 1, 2017

       

 Business

   
   

 Braskem

 

 combination

   

Assets

 Petroquímica

 

 balances (2010)

 

 Total

Current assets

         
 

Cash and cash equivalents

                    31,779

   

                          31,779

 

Trade accounts receivable

               1,133,732

   

                     1,133,732

 

Inventories

                  156,948

   

                        156,948

 

Taxes recoverable

                    58,114

   

                          58,114

 

Prepaid expenses

                      2,543

   

                            2,543

 

Related parties

                  193,269

   

                        193,269

 

Other receivables

                      3,371

 

 

 

                            3,371

   

             1,579,756

 

 

 

                  1,579,756

Non-current assets

         
 

Taxes recoverable

                    96,009

 

 

 

                          96,009

 

Deferred income tax and social contribution

 

 

                  102,690

 

                        102,690

 

Other receivables

                    21,666

 

 

 

                          21,666

 

Investments

                    48,973

 

 

 

                          48,973

 

Property, plant and equipment

                  583,729

 

                  341,650

 

                        925,379

 

Intangible assets

                  259,607

 

                 (252,820)

 

                            6,787

   

             1,009,984

 

                191,520

 

                  1,201,504

             

Total assets

             2,589,740

 

                191,520

 

                  2,781,260

             

Liabilities

         

Current liabilities

         
 

Trade payables

                  206,657

   

                        206,657

 

Payroll and related charges

                    19,408

   

                          19,408

 

Taxes payable

                    18,504

   

                          18,504

 

Dividends

                    54,715

   

                          54,715

 

Sundry provisions

                      9,503

   

                            9,503

 

Other payables

                      3,312

 

 

 

                            3,312

   

                312,099

 

 

 

                      312,099

Non-current liabilities

       
 

Trade payables

                    19,501

   

                          19,501

 

Deferred income tax and social contribution

                  123,439

 

                  113,240

 

                        236,679

 

Sundry provisions

                    28,081

 

                    49,211

 

                          77,292

 

Other payables

                      1,898

 

 

 

                            1,898

   

                172,919

 

                162,451

 

                      335,370

             

Total liabilities

                485,018

 

                162,451

 

                      647,469

 

11


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

The line Investments includes 1,154,758 class "A" preferred shares issued by Braskem S.A., in the amount of R$48,892. On the date of the merger, this amount was recorded as treasury shares.

(v)        On January 9, 2017, the Board of Directors approved the sale of the subsidiaries Quantiq Distribuidora Ltda (“Quantiq”) and IAQG Armazéns Gerais Ltda (“IQAG”) in the amount of R$550 million, and on April 3, 2017 the transfer of control to the buyer company was concluded (Note 5).

           

(b)               Net Working Capital

 

On December 31, 2017, in compliance with CPC 26 and its corresponding IAS 1 (Presentation of Financial Statements), the subsidiary Braskem Idesa reclassified to current liabilities its financial obligations whose original maturities were long term, since the Company was not in compliance with certain contractual covenants on the reporting date of these financial statements (Note 16). Consequently, the consolidated net working capital is negative R$1,145,404.

Note that Braskem Idesa has been settling its obligations in accordance with the original maturity schedule and none of its creditors has requested the immediate reimbursement of said obligations and, without the aforementioned reclassification, consolidated net working capital would positive in R$7,762,329.

 

2                    Summary of significant accounting policies

 

The principal accounting policies applied consistently in the preparation of these financial statements are described in the notes of the items on which they have impacts.

 

2.1              Basis of preparation and presentation of the financial statements

 

The financial statements have been prepared under the historical cost convention and were adjusted, when necessary, to reflect the fair value of assets and liabilities.

 

The preparation of financial statements requires the use of certain estimates. It also requires Management to exercise its judgment in the process of applying the Company’s accounting policies. The areas involving a higher degree of judgment or complexity, or areas where assumptions and estimates are significant to the consolidated financial statements are disclosed in Note 3.

 

Issue of these financial statements was authorized by the Executive Board on March 27, 2018, with the Board of Directors having manifested at a meeting held on March 28, 2018, authorizing the convening of the Annual General Meeting.

 

2.1.1        Consolidated financial statements

 

The consolidated financial statements were prepared and presented in accordance with accounting practices adopted in Brazil, including the standards issued by the Brazilian Accounting Pronouncements Committee (“CPC”), and in accordance with the International Financial Reporting Standards (“IFRS”) issued by the International Accounting Standards Board (“IASB”).

 

All relevant information pertaining exclusively to these financial statements is presented herein and corresponds to the information used by the Management of the Company.

 

The individual and consolidated Statement of Value Added (“DVA”) was prepared in accordance with CPC 09 and is required under Brazilian Corporation Law and under the accounting practices adopted in Brazil for public companies. IFRS does not require the presentation of this statement.

 

12


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

(a)               Consolidation

 

The consolidated financial statements comprise the financial statements of the Parent Company and the following entities:

 

       

Total and voting interest - %

     

Headquarters

 

2017

 

2016

Direct and Indirect subsidiaries

             

Braskem America Finance Company ("Braskem America Finance")

   

EUA

 

                    100.00

 

                    100.00

Braskem America, Inc. (“Braskem America”)

   

EUA

 

                    100.00

 

                    100.00

Braskem Argentina S.A. (“Braskem Argentina”)

   

Argentina

 

                    100.00

 

                    100.00

Braskem International GmbH ("Braskem Austria")

 

 (i)

 

Austria

 

                    100.00

 

                    100.00

Braskem Europe GmbH ("Braskem Alemanha")

   

Germany

 

                    100.00

 

                    100.00

Braskem Finance Limited (“Braskem Finance”)

   

Cayman Islands

 

                    100.00

 

                    100.00

Braskem Idesa S.A.P.I. ("Braskem Idesa")

   

Mexico

 

                      75.00

 

                      75.00

Braskem Idesa Servicios S.A. de CV ("Braskem Idesa Serviços")

   

Mexico

 

                      75.00

 

                      75.00

Braskem Incorporated Limited ("Braskem Inc")

   

Cayman Islands

 

                    100.00

 

                    100.00

Braskem Mexico Proyectos S.A. de C.V. SOFOM ("Braskem México Sofom")

   

Mexico

 

                    100.00

 

                    100.00

Braskem Mexico, S. de RL de CV ("Braskem México")

   

Mexico

 

                    100.00

 

                    100.00

Braskem Mexico Servicios S. RL de CV ("Braskem México Serviços")

   

Mexico

 

                    100.00

 

                    100.00

Braskem Netherlands B.V. ("Braskem Holanda")

   

Netherlands

 

                    100.00

 

                    100.00

Braskem Netherlands Finance B.V. (“Braskem Holanda Finance”)

   

Netherlands

 

                    100.00

 

                    100.00

Braskem Netherlands Inc. B.V. (“Braskem Holanda Inc”)

   

Netherlands

 

                    100.00

 

                    100.00

Braskem Petroquímica Chile Ltda. (“Braskem Chile”)

   

Chile

 

                    100.00

 

                    100.00

Braskem Petroquímica

 

 (ii)

 

Brazil

 

 

 

                    100.00

Cetrel

 

 (iii)

 

Brazil

 

                      63.66

 

Distribuidora de Água Camaçari S.A. ("DAC")

 

 (iv)

 

Brazil

 

                      63.66

 

Lantana Trading Co. Inc. (“Lantana”)

   

Bahamas

 

                    100.00

 

                    100.00

           

Specific Purpose Entity ("SPE")

         

Fundo de Investimento Multimercado Crédito Privado Sol (“FIM Sol”)

 

 (v)

 

Brazil

   

                    100.00

Fundo de Investimento Caixa Júpiter Multimercado

 

 

Brazil

 

 

 

 

  

Crédito Privado Longo Prazo ("FIM Júpiter")

       

                    100.00

 

                    100.00

             

 

(i)   

In the process of dissolution.

(ii)

Merged on December 1, 2017.

(iii)

Acquired on October 2, 2017.

(iv)

Wholly-owned subsidiary of Cetrel.

(v)

Contract terminated in 2016.

 

(a.i)      Reconciliation of equity and profit (loss) for the period between parent company and consolidated

 

       

Shareholders' equity

 

Profit (loss) for the year

       

2017

 

2016

 

2017

 

2016

                     

Parent company

   

     6,517,851

 

       2,787,482

 

           4,082,990

 

            (411,472)

 

Shares of Braskem's capital held by subsidiary

(i)

 

 

 

             (48,892)

 

 

 

 

 

Non-controlling interest in subsidiaries

   

         (827,501)

 

        (1,017,880)

 

                  50,331

 

              (317,725)

Consolidated

   

     5,690,350

 

       1,720,710

 

           4,133,321

 

            (729,197)

  

 

(i)   

Considered as treasury shares as of December 1, 2017 with the merger of Braskem Petroquímica (Note 1(a.iv)).

 

2.1.2    Parent company financial statements

The financial statements have been prepared in accordance with accounting practices adopted in Brazil, following the provisions in Federal Law 6,404/76, and subsequent amendments, and the standards issued by CPC, and are disclosed together with the consolidated financial statements.

 

13


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

2.2              Foreign currency translation

 

(a)               Functional and presentation currency

 

The functional and presentation currency of the Company is the real

 

(b)               Functional currency other than the Brazilian real

 

Certain subsidiaries have a different functional currency from that of the Parent Company, as follows:

 

   

Functional currency

     

Subsidiaries

 
 

Braskem Alemanha, Braskem Austria e Braskem Austria Finance

 

Euro

 

Braskem America, Braskem America Finance, Braskem Holanda, Braskem Holanda Finance, 
   Braskem Holanda Inc. and Braskem México Sofom

 

U.S.dollar

 

Braskem Idesa , Braskem Idesa Serviços, Braskem México and Braskem México Serviços

 

Mexican peso

 

The other subsidiaries adopt the Brazilian real as functional currency.

 

(c)               Exchange variation effects

 

The main effects from exchange variation on the Company’s transactions that impacted these financial statements are shown below:

 

 

End of period rate at December 31

 

Average rate

 

2017

 

2016

 

Variation

 

2017

 

2016

 

Variation

U.S. dollar - Brazilizan real

3.3080

 

3.2591

 

1.50%

 

3.1925

 

3.4833

 

-8.35%

U.S. dollar - Mexican peso

19.6890

 

20.6352

 

-4.59%

 

18.9142

 

18.6987

 

1.15%

U.S. dollar - Euro

0.8464

 

0.9479

 

-10.71%

 

0.8871

 

0.9041

 

-1.89%

 

2.3              New or revised pronouncements that are not yet effective

 

Several new standards will be effective for fiscal years beginning after January 1, 2018.  The Company did not early adopt these changes while preparing its financial statements.

 

 

(a)               Estimated impact from the adoption of CPC 48 / IFRS 9 and CPC 47 / IFRS 15

 

The Company is obliged to adopt “CPC 48 / IFRS 9 – Financial Instruments” and “CPC 47 / IFRS 15 – Revenue from Contracts with Customers” starting from January 1, 2018.  The Company has already assessed the estimated impact of the initial application of CPC 48 / IFRS 9 (Note 2.3(a.1)) and CPC 47 / IFRS 15 (Note 2.3(a.2)) on its consolidated financial statements. The estimated impact of adopting these standards on the Company’s equity on January 1, 2018, is based on assessments made until the date of preparation of these financial statements and is summarized below. The actual impacts of adopting the standards on January 1, 2018, may be different due to the following factors:

 

(i)                

the Company did not conclude the testing and appraisal of controls over the new IT systems; and

(ii)               

the new accounting standards are subject to changes until the Company reports its first financial statements that include the date of initial application.

 

The total estimated adjustment (net of taxes) on the opening balance of the shareholders' equity under “Retained earnings” of the Company on January 1, 2018, is a reduction of R$9,388.  The component relating to the estimated adjustment is the change in the methodology for calculating impairment pursuant to CPC 48 / IFRS 9.

 

14


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

 

As presented on December 31, 2017

 

Adjustments estimated at the adoption of CPC 48 / IFRS 9

 

Adjusted opening balance estimated on January 1, 2018

Retained earnings

 

 

                       (9,388)

 

                            (9,388)

Non-controlling

                       (827,501)

 

 

 

                        (827,501)

 

                     (827,501)

 

                      (9,388)

 

                      (836,889)

 

(a.1)     CPC 48 / IFRS 9 – Financial Instruments

 

CPC 48 / IFRS 9 – Financial Instruments sets the requirements for the recognition and measurement of financial assets, financial liabilities and some contracts to buy or sell non-financial items. This standard replaces CPC 38 / IAS 39 – Financial Instruments: Recognition and Measurement.

 

(a.1.i)   Classification – Financial Assets

 

CPC 48 / IFRS 9 has a new approach for the classification and measurement of financial assets, which reflects the business model in which the assets are managed and their cash flow characteristics.

 

CPC 48 / IFRS 9 has three main classification categories for financial assets: measured at amortized cost (“AC”), at fair value through other comprehensive income (“FVTOCI”) and at fair value through profit or loss (“FVTPL”). The standard eliminates the categories existing in IAS 39 of held-to-maturity, loans and receivables and available-for-sale. This standard requires that financial assets have to be classified according to the Company’s business model for managing its financial assets.

 

Pursuant to CPC 48 / IFRS 9, derivatives embedded in contracts where the host is a financial asset under the scope of the standard are never separated. Instead, the hybrid financial instrument as a whole is assessed for classification. 

 

Based on its assessment, the Company does not consider that the new classification requirements will have a significant impact on the accounting of its financial investments. However, as some customer receivables are assigned or derecognized in advance, and as Management is still preparing its Business Model to identify the correct accounting classification of each receivable, the Company did not estimate the impact on accounting and presentation of these financial assets.  Until the reporting of these financial statements, these receivables are classified as Loans and Receivables measured by amortized cost.

 

(a.1.ii)  Impairment – Financial and Contractual Assets

 

CPC 48 / IFRS 9 replaced the “incurred loss” model of CPC 38 / IAS 39 for a prospective model of "expected credit losses." This will require judgment regarding the way in which changes in economic factors affect expected credit losses, which will be determined based on weighted probabilities. 

 

The new expected losses model will apply to financial assets measured at AC or FVTPL, except investments in equity instruments and contractual assets.

 

According to CPC 48 / IFRS 9, provisions for expected losses will be measured at one of the following bases:

 

 

15


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

    ·        

The 12-month expected credit losses (expected credit losses from default events within 12 months after the reporting date for financial assets that risk has not risen significantly since its initial recognition); and

·        

Full lifetime expected credit losses (expected credit losses that result from all possible default events over the life of the financial instrument). The measurement of these losses applies when the credit risk of the financial asset on the date of reporting has increased significantly since initial recognition.

 

The Company’s preliminary assessment indicates that the application of impairment loss requirements of CPC 48 / IFRS 9 on January 1, 2018, would result in a reduction of R$9,388 in its consolidated shareholders’ equity, net of taxes, as follows:

 

Allowance for doubtful accounts

       

 

  

Losses incurred (CPC38/IAS39)        

                          350,025

 

Expected credit losses (CPC48/IFRS9)        

                          359,413

Estimated adjustment

       

                           (9,388)

 

Estimated credit losses were calculated based on the actual experience of credit loss (write offs) over the last five years. This percentage was applied to the account receivable amount.

 

After determining the total loss percentage, the exposure was divided by groups and these groups are segmented as per the note on operating credit risk, graded from 1 to 5, where 1 is the best and 5 is the worst. The risk is defined based the on financial score which, in turn, is based on indicators calculated from the balance sheets and income statements of customers.

 

For significant risk increase is consider renegotiated trade accounts and those needing collections lawsuits. The trade accounts past due more than 90 days represent to the Company a real outlook of default.

 

(a.1.iii)  Hedge Accounting

 

While applying CPC 48 / IFRS 9, the Company can, as an accounting policy, choose to continue applying the hedge accounting requirements of the CPC 38 / IAS 39, instead of the new CPC 48 / IFRS 9 requirements.  The Company chose to apply the new requirements of CPC 48 / IFRS 9.

 

 

CPC 48 / IFRS 9 requires the Company to ensure that hedge accounting relationships are aligned with the Company’s risk management objectives and strategies, and that a more qualitative and prospective approach is applied to assess the effectiveness of the hedge. CPC 48 / IFRS 9 also introduces new requirements for rebalancing the hedge relationship and prohibits the voluntary discontinuation of hedge accounting.  According to the new model, it is possible that more risk management strategies, particularly those of a hedge of a risk component of a non-financial item, may qualify for hedge accounting. Currently, the Company does not hedge such risk components. 

 

Currently, the Company uses foreign exchange options contracts to hedge the cash flows  change resulting from exchange rates fluctuations related to costs in Reais that are non-dollarized (energy, freight, salaries, etc.).

 

While adopting CPC 48 / IFRS 9, the Company elected to book the changes in fair value of the forward points separately, as hedge cost.  As a result, these changes will be recognized in other comprehensive income and accrued in a hedge cost reserve as a separate component within shareholders’ equity and subsequently booked in the same way as accumulated gains or losses in the cash flow hedge reserve.

 

16


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

According to CPC 38 / IAS 39, for all cash flow hedges, the amount that has been accumulated in the cash flow hedge reserve is reclassified to profit or loss in the same period as the hedged cash flows affect profit or loss.

The types of hedge accounting relationships presently designated by the Company meet the requirements of CPC 48 / IFRS 9 and are aligned with the organization's risk management objective and strategy. 

 

The new accounting rules on hedge accounting are aligned with the Company’s risk management practices.  The current coverage ratios will be classified as hedge after the adoption of IFRS 9. Moreover, the Company intends that operations started as from January 1, 2018 be designated as hedge instruments for the total intrinsic value and extrinsic value of the USD call and put options.

 

(a.1.iv) Disclosures

 

CPC 48 / IFRS 9 will require extensive new disclosures, specifically regarding hedge accounting, credit risk and expected credit losses. The Company’s assessment includes an analysis to identify deficiencies related to the information required in the current processes, and the Company is in the process of implementing changes in its systems and controls to meet the new requirements.

 

(a.1.v)  Transition

 

Changes in accounting policies stemming from the adoption of CPC 48 / IFRS 9 will be applied prospectively, including:

 

   ·        

Exemption allowed for not restating comparative information of prior periods resulting from changes in the classification and measurement of financial instruments, including expected credit losses. Differences in the book balances of financial assets and liabilities resulting from the adoption of CPC 48 / IFRS 9 will be recognized in accumulated earnings and reserves on January 1, 2018.

·        

New hedge accounting requirements.

·        

The following assessments must be made based on facts and circumstances existing on the date of first-time adoption:

o  

Determination of business model within which a financial asset is held.

o  

Designation and revocation of previous designations of determined financial assets and liabilities measured at FVTPL.

(a.2)     Estimated impact from the adoption of CPC 47 / IFRS 15

 

CPC 47 / IFRS 15 – Revenue from Contracts with Customers introduces a comprehensive framework to determine if and when revenue must be recognized, and by how much the revenue is measured. CPC 48 / IFRS 15 replaces the current standards in force for revenue recognition, including CPC 30 / IAS 18 – Revenue.

 

(a.2.i) Sales

 

The Company assessed that in its sales may have two distinct performance obligations between the Company and its customers, which are:

 

   ·        

Delivery the sold product - the performance obligation finalize when the control of the product is transferred to the customer. For the Company, there is no difference between CPC 30 / IAS 18 - Revenue and CPC 47 / IFRS 15 related to the revenue recognition date associated with this performance obligation.

·        

Freight contracted to the product deliver - the Company's performance obligation in contract the freight to deliver the product finalize when the service is completed. For this performance obligation, the Company does not expect material effect on its result.

 

17


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

(a.2.ii) Variable compensation (bonus and discounts)

 

The Company, as contractual practice with some customers, grants rebates for the achievement of revenue targets. For customers that the Company expects will meet such targets and, as such, will have a future discount, the Company has as an accounting practice the provisioning of amounts due monthly. This provision, which until December 31, 2017, is recognized as a deduction from sales revenue, will be disclosed from January 1, 2018, as a deductible amount direct over gross sales revenue (Note 27).

 

The Company considers commercial discounts included in customer invoices as part of the fair value of revenue recognized, according to the accounting standard applicable until December 31, 2017 (CPC 30 / IAS 18). As such, the commercial discounts included in customer invoices will not have any change in the timing and measurement of their accounting recognition according to CPC 48 / IFRS 15.

 

(a.2.iii) Disclosures

 

CPC 47 / IFRS 15 will require new disclosures which the Company is identifying deficiencies in relation to the information required in the current processes in order to implement in its systems and controls to meet with the new requirements.

 

(a.2.iv) Transition

 

The Company plans to adopt CPC 47 / IFRS 15 using the cumulative effect method, with initial application of the standard on the initial date (that is January 1, 2018). As a result, the Company will not apply the requirements of CPC 47 / IFRS 15 to the comparative period reported.

 

Apart from the aforementioned reporting changes for bonuses for the achievement of revenue targets, the Company does not expect changes in the timing and measurement of its revenue.

 

 (b)         IFRS 16 – Leases – Adoption on January 1, 2019

 

This pronouncement replaces existing standards, including CPC 06 / IAS 17 – Leases and ICPC 03 (IFRIC 4 / SIC 15 / SIC 27) Complementary Aspects of Leases.

 

This standard introduces a single model for the accounting of leases in the balance sheet of the lessees, whereby a right-of-use asset that represents the right to use the leased asset and a leased liability that represents the obligation to pay the lease are recognized.

 

The standard is effective for annual periods starting on or after January 1, 2019. Early adoption is permitted, but, as of the reporting date of these Financial Statements, the Company is conducting an inventory of contracts that could have an accounting impact from this new standard and is developing processes and controls to meet the new requirements. This accounting impact will depend of the Company’s lease portfolio on that date and the Company’s assessment as to whether the Company will choose to use practical expedients and exemptions for recognition allowed by this pronouncement.

Furthermore, the nature of expenses related to these lease agreements will now change, since IFRS 16 replaces the accounting of expenses on a straight-line basis with the cost of depreciation of right-of-use assets and interest expenses on lease obligations.

 

2.4              Change in accounting policy

 

(a)      The Management of Braskem decided to change, in the statement of cash flows, the presentation of interest paid, which previously was presented under the group referred to as “cash used in investment activities.” These expenses are now recorded under the item “interest paid”. This change enables: (i) the direct identification of the total amount paid as interest; and (ii) greater accuracy in determining the net cash from operations. The amounts reclassified in the period ended December 31, 2017 were R$288,424 and

18


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

R$69,342 in the consolidated and Parent Company cash flows, respectively.

 
(b)    

In 2017, the Company changed the classification of provision for profit sharing to standardize such classification among all companies, whether or not productive, and because it deemed the current classification more appropriate, since this provision does not present recurring elements or, even when recurring, the amounts differ from year to year.

 

In the fiscal year ended December 31, 2017, the consolidated amounts related to this item were reclassified from “costs of goods sold” (R$163,056), “selling and distribution expenses” (R$7,155) and “general and administrative expenses” (R$191,586) to the item “other income (expenses), net” (Note 29).

 

3                    Application of critical estimates and judgments

 

Critical estimates and judgments are those that require the most difficult, subjective or complex judgments by management, usually as a result of the need to make estimates that affect issues that are inherently uncertain. Estimates and judgments are continually reassessed and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Actual results can differ from planned results due to differences in the variables, assumptions or conditions used in making estimates.

 

The Company makes a series of other estimates that are presented in the respective notes, such as allowance for doubtful accounts and provision for repairing environmental damage.

 

In order to provide an understanding of the way the Company forms its judgments on future events, the variables and assumptions used in critical estimates are presented below:

 

3.1               Deferred income tax (“IR”) and social contribution (“CSL”)

 

The recognition and the amount of deferred taxes assets depend on the generation of future taxable income, which requires the use of an estimate related to the Company’s future performance. These estimates are included in the business plan, which is annually prepared by the Executive Board and submitted to the Board of Directors for approval. This plan uses as main variables projections for the price of the products manufactured by the Company, price of inputs, growth of gross domestic product of each country where the Company operates, exchange variation, interest rate, inflation rate and fluctuations in the supply and demand of inputs and finished products. These projections are carried out on the basis of specialized external consultancies and based on the Company.

 

Information on deferred income tax and social contribution is presented in Note 21(c).

 

3.2               Fair value of derivative and non-derivative financial instruments

 

The Company evaluates the derivative financial instruments at their fair value and the main sources of information are the stock exchanges, commodities and futures markets, disclosures of the Central Bank of Brazil and quotation services like Bloomberg and Reuters. Nevertheless, the volatility of the foreign exchange and interest rate markets in Brazil has been causing significant changes in future rates and interest rates over short periods of time, leading to significant changes in the market value of swaps and other financial instruments.

 

 

19


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

The fair values of non-derivative, quoted financial instruments are based on current bid prices. If the market for a financial asset and for unlisted securities is not active, the Company establishes fair value by using valuation techniques. These include the use of recent arm’s length transactions, reference to other instruments that are substantially the same, discounted cash flow analysis, and option pricing models that make maximum use of market inputs and rely as little as possible on information provided by the Company’s Management.

 

Information on derivative and non-derivative financial instruments is presented in Note 19.

 

3.3               Useful life of assets

 

The Company recognizes the depreciation and depletion of its long-lived assets based on their useful life estimated by independent appraisers and approved by the Company’s technicians taking into consideration the experience of these professionals in the management of Braskem’s plants. The useful lives initially established by independent appraisers are normally reviewed at the end of every year by the Company’s technicians in order to check whether they need to be changed. This review may take place during the year in case of possible non-recurring events.

 

The main factors that are taken into consideration in the definition of the useful life of the assets that compose the Company’s industrial plants are the information of manufacturers of machinery and equipment, level of the plants’ operations, quality of preventive and corrective maintenance and the prospects of technological obsolescence of assets.

 

The Company’s management also decided that (i) depreciation should cover all assets value because when the equipment and installations are no longer operational, they are sold by amounts that are immaterial; and (ii) land is not depreciated because it has an indefinite useful life.

 

The useful lives applied to the assets determined the following average (%) depreciation and depletion rates:

 

     

Consolidated

     

2017

 

2016

Buildings and improvements

   

               3.36

 

               3.49

Machinery, equipment and installations

   

               8.34

 

               9.34

Mines and wells

   

               8.84

 

               8.83

Furniture and fixtures

   

             10.13

 

             10.36

IT equipment

   

             20.09

 

             20.53

Lab equipment

   

               9.56

 

               9.65

Security equipment

   

               9.77

 

               9.78

Vehicles

   

             17.51

 

             22.72

Other

   

             18.17

 

             18.97

 

Information on property, plant and equipment is presented in Note 13.

 

20


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

3.4               Impairment test and analysis

 

(a)               Tangible and intangible assets with defined useful lives

 

On the reporting date of each of its financial statements, the Company conducts an analysis to determine the existence of any indication that the book balance of long-lived tangible assets and intangible assets with defined useful lives may not be recoverable. This analysis is conducted to assess the existence of scenarios that could adversely affect its cash flow and, consequently, its ability to recover the investment in such assets. These scenarios arise from issues of a macroeconomic, legal, competitive or technological nature.

 

Some significant and notable aspects considered by the Company in this analysis include: (i) the possibility of an oversupply of products manufactured by the Company or of a significant reduction in demand due to adverse economic factors; (ii) the prospects of material fluctuations in the prices of products and inputs; (iii) the likelihood of the development of new technologies or raw materials that could materially reduce production costs and consequently impact sales prices, ultimately leading to the full or partial obsolescence of the industrial facilities of the Company; and (iv) changes in the general regulatory environment that make the production process of Braskem infeasible or that significantly impact the sale of its products. For this analysis, the Company maintains an in-house team with a more strategic vision of the business and also remains in permanent contact with a team of external consultants. If the aforementioned variables indicate any material risk to cash flows, the Management of Braskem conducts impairment tests in accordance with Note 3.4(b).

 

The Company’s assets are grouped initially under operating Segments, based on product lines and production site location. Within each Segment, assets are grouped into Cash-Generating Units (“CGU”), based solely on the production site location (country and, for Basic Petrochemicals, region in Brazil). Based on these concepts, the assets are grouped as follows:

 

Reportable operating segments:

 

Chemicals:

 

·          

CGU Chemicals Bahia: represented by assets of the chemicals plants located in the state of Bahia;

·          

CGU Chemicals South: represented by assets of the chemicals plants located in the state of Rio Grande do Sul;

·          

CGU Chemicals Southeast: represented by assets of the chemicals plants located in the states of Rio de Janeiro and São Paulo;

 

Polyolefins:

 

·          

CGU Polyethylene: represented by assets of the PE plants located in Brazil;

·          

CGU Polypropylene: represented by assets of the PP plants located in Brazil;

·          

CGU Renewables: represented by the assets of the Green PE plant located in Brazil;

 

Vinyls:

 

·          

CGU Vinyls: represented by assets of PVC and chloride soda plants located in Brazil;

 

United States and Europe:

 

·          

CGU Polypropylene USA: represented by assets of PP plants located in the United States;

·          

CGU Polypropylene Europe: represented by assets of PP plants located in Germany;

 

21


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

Mexico:

 

·          

Represented by the assets of the ethylene and PE plants located in Mexico.

 

(b)               Intangible assets with indefinite useful lives

 

The balances of goodwill from future profitability arising from business combinations are tested for impairment once a year. These tests are based on the projected cash generation for a five-year period, which are extracted from the business plan of the Company and cited in Note 3.1. In addition to the projected cash flow for the period from 2018 to 2022, perpetuity is also calculated based on the long-term vision and excluding real growth. Cash flows and perpetuity are adjusted to present value at a discount rate based on the Weighted Average Cost of Capital (“WACC”).

 

The goodwill allocated to the Polyolefins operating segment (Note 14 (a)) was generated in a business combination that resulted in the simultaneous acquisition of polypropylene and polyethylene plants. The main raw materials of these plants were already supplied by the Parent Company, which allowed for the obtainment of significant synergies in the operation. These synergies were one of the main drivers of that acquisition. Accordingly, the Company’s management tested this goodwill for impairment in the ambit of their operating segment since the benefits of the synergies are associated with all units acquired.

 

The remaining existing goodwill is allocated to the Chemicals Sul CGU and to the Vinyls operating segment (Note 14(a)).

 

Goodwill from future profitability are presented in Note 14. Said note also presents the results of impairment tests.

 

3.5               Contingencies

 

Existing contingent liabilities and provisions are mainly related to discussions in the judicial and administrative spheres arising from primarily labor, pension, civil and tax lawsuits and administrative procedures.

 

The Management of Braskem, based on the opinion of its external legal advisors, classifies these proceedings in terms of probability of loss as follows:

 

Probable loss – these are proceedings for which there is a higher probability of loss than of a favorable outcome, i.e., the probability of loss exceeds 50%. For these proceedings, the Company recognizes a provision that is determined as follows:

 

(i)      

labor claims – the amount of the provision corresponds to the amount to be disbursed as estimated by the Company’s legal counsels;

 

(ii)    

tax claims - the amount of the provision corresponds to the value of the matter plus charges corresponding to the variation in the Selic rate; and

 

(iii)  

other claims – the amount of the provision corresponds to the value of the matter.

 

Possible loss – these are proceedings for which the possibility of loss is greater than remote and less than probable. The loss may occur, however, the elements available are not sufficient or clear to allow for a conclusion on whether the trend is for a loss or a gain. In percentage terms, the probability of loss is between 25% and 50%. For these claims, except for the cases arising from business combinations, the Company does not recognize a provision and mentions the most significant ones in a note (Note 23.2) to the financial statements. In business combination transactions, in accordance with the provision in CPC 15 and IFRS 3, the Company records the fair value of the claims based on the assessment of loss. The amount of the provision corresponds to the value of the matter, plus charges corresponding to the variation in the Selic rate, multiplied by the probability of loss, as determined by our external counsels.

 

22


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

The Company’s management believes that the estimates related to the outcome of the proceedings and the possibility of future disbursement may change in view of the following: (i) higher courts may decide in a similar case involving another company, adopting a final interpretation of the matter and, consequently, advancing the termination of the of a proceeding involving the Company, without any disbursement or without implying the need of any financial settlement of the proceeding; and (ii) programs encouraging the payment of the debts implemented in Brazil at the Federal and State levels, in favorable conditions that may lead to a disbursement that is lower than the one that is recognized in the provision or lower than the value of the matter.

 

The Company’s contingencies are presented in Note 23.

 

3.6              Hedge accounting

 

The Parent Company designated non-derivative financial liabilities in foreign currency to hedge the future cash flows generated by its exports. This decision was based on two important concepts and judgments: (i) the performance of exports according to its business plan (Note 3.2), which are inherent to the market and business where it operates, and (ii) the ability of the Company to refinance its liabilities in U.S. dollar, since the priority financing in U.S. dollar is part of the Company’s guidelines and strategy and the maintenance of a minimum level of net liabilities in U.S. dollar is envisaged in the Financial Policy of the Company.

 

The subsidiary Braskem Idesa designated all of the financing it obtained for the construction of its industrial plant to protect part of its sales to be made in the same currency as said financing, the U.S. dollar. The sales estimate is included in the project that was presented to the banks/lenders, which, due to the consistency of the projection, granted Braskem Idesa a financing line shall be paid exclusively using the cash generated by these sales. All the commercial considerations of the project were based on market studies conducted by expert consulting firms during the feasibility-analysis phase.

 

All hedge transactions conducted by the Company are in compliance with the accounting procedures and practices adopted by Braskem, and effectiveness tests are conducted for each transaction every quarter, which prove the effectiveness of its hedge strategy.

 

The Company determined that hedged items for the Parent Company and the subsidiary Braskem Idesa will be characterized by the first sales in U.S. dollars in each quarter until the amount designated for each period is reached (Note 19). The liabilities designated for hedge will be aligned with the hedging maturity schedule and the Company’s financial strategy.

                                                                                         

According to the Financial Policy, the Company may contract derivatives (swaps, NDFs, options, etc.) to hedge against any undesired fluctuations in currencies and rates. These derivatives may be designated for hedge accounting based on the judgment of Management and when such designation is expected to significantly improve the demonstration of the compensatory effect on the fluctuations in the items protected by the hedge. The Company currently has derivatives designated for cash flow hedge accounting for (i) Libor hedge at Braskem Idesa and (ii) hedge of Braskem dollar put and call options (Note 19.3).

 

4                    Risk management

 

Braskem is exposed to market risks arising from variations in commodity prices, foreign exchange rates and interest rates, credit risks of its counterparties in cash equivalents, financial investments and trade accounts receivable, and liquidity risks to meet its obligations from financial liabilities.

 

 

23


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

Braskem adopts procedures for managing market and credit risks that are in conformity with its Financial Policy approved by the Board of Directors in March, 2017. The purpose of risk management is to protect the Company’s cash flows and reduce the threats to the financing of its operating working capital and investment programs.

 

4.1               Market risks

 

Braskem prepares a sensitivity analysis for foreign exchange rate and interest rate risks to which it is exposed, which is presented in Note 19.6.

 

(a)               Exposure to commodity risks

 

Most of the Braskem’s feedstocks (naphtha, ethane, propane and propylene) and main products (PE, PP and PVC) are commodities quoted on international markets. A series of factors determine the dynamics of these quotes, which directly impacts the result and cash generation of Braskem. Nevertheless, the Company understands that this risk is inherent in the petrochemical business and, therefore, in general does not seek financial instruments to hedge against commodities price fluctuations. 

 

(b)               Exposure to foreign exchange risk

 

Considering the dynamics of the international petrochemicals market, where most of the time prices are linked to international references in denominated dollars, even Braskem's sales in Brazil are strongly correlated to the US currency. Thus, maintaining a portion of the cost in reais (fixed expenses with personnel, freight and energy, among others) tends to generate a passive net exposure to the local currency.

 

Therefore, in order to partially mitigate long-term foreign exchange risk, as from September 2016, the Company began to contract financial derivatives to form a Long-Term Foreign Exchange Hedge Program. The main mitigation of this program is the purchase and sale of US dollar options, protecting the expected flows for a period of up to 24 months, as described in more detail in Note 19.3.

 

In addition to the Hedge Program, to balance the composition between assets and liabilities in US dollars, Braskem's Financial Policy establishes that the Company should always maintain a percentage of at least 70% of the net debt denominated in US dollars. If appropriate, the company may maintain a percentage higher than 70%, provided that it is conditioned to a sensitivity analysis on the main financial indicators and the proof of the existence of no significant risk in the deterioration of these indicators.

 

On December 31, 2017, Braskem prepared a sensitivity analysis for its exposure to fluctuation in the U.S. dollar, as informed in Note 19.6.

 

(c)                Exposure to interest rate risk

 

Braskem is exposed to the risk that a variation in floating interest rates causes an increase in its financial expense due to payments of future interest. Debt denominated in foreign currency subject to floating rates is mainly subject to fluctuations in Libor. Debt denominated in local currency is mainly subject to the variation in the Long-Term Interest Rate (“TJLP”) and in the Interbank Certificate of Deposit (“CDI”) rate.

 

In 2016 and 2017, Braskem held swap contracts (Note 19.3.1) in which it: receives the pre-contractual rate and pays the CDI overnight rate; and receives Libor and pays a fixed rate.

 

On December 31, 2017, Braskem prepared a sensitivity analysis for the exposure to the floating interest rates Libor, CDI and TJLP, as informed in Notes 19.6(c.1) and (c.2).

 

24


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

4.2               Exposure to credit risk

 

The transactions that subject Braskem to the concentration of credit risks are mainly in current accounts with banks, financial investments and trade accounts receivable in which Braskem is exposed to the risk of the financial institution or customer involved. In order to manage this risk, Braskem maintains bank current accounts and financial investments with major financial institutions, weighting concentrations in accordance with the credit rating and the daily prices observed in the Credit Default Swap market for the institutions, as well as netting contracts that minimize the total credit risk arising from the many financial transactions entered into by the parties.

 

On December 31, 2017, approximately 17.4% of the amounts recorded as “Cash and cash equivalents” (Note 6) were allocated to financial institutions that had clearance agreements with the Company. The obligations under these agreements are accounted for under “Borrowings” (Note 16). The effective netting of these amounts is possible only in the event of default by one of the parties.

 

With respect to the credit risk of customers, Braskem protects itself by performing a rigorous analysis before granting credit and obtaining secured and unsecured guarantees when considered necessary, including credit insurance.

 

The maximum exposure to credit risk of non-derivative financial instruments on the reporting date is the sum of their carrying amounts less any provisions for impairment losses. On December 31, 2017, the balance of trade accounts receivable was net of allowance for doubtful accounts (Note 8).

 

4.3               Liquidity risk

 

Braskem has a calculation methodology to determine minimum cash “vision month” (horizon of 30 days) and minimum cash “vision year” (horizon of up to 12 months) for the purpose of, respectively: (i) ensuring the liquidity needed to comply with obligations of the following month; and (ii) ensuring that the Company maintains liquidity during potential crises. The amounts for determination of the minimum cash “vision year” are calculated mainly based on the projected operating cash generation, less short-term debts and working capital needs. The amounts for determination of the minimum cash "vision month" consider the projection of operational cash disbursement, service of debts and contributions in projects, as well as the expected disbursement for derivatives with maturity in the period, among other items. The Company, in a conservative manner, uses as the minimum cash in its financial policy the highest value between these two references.

 

Braskem has two revolving credit lines for the purpose of managing liquidity risks, which may be used without restrictions to improve the Company’s credit quality or in the event of deterioration in the macroeconomic scenario, in the amounts of: (i) US$750 million until December 2019; and (ii) US$500 million until September 2019. These credit facilities enable Braskem to reduce the amount of cash it holds. As of December 31, 2017, none of these credit lines had been used.

 

The table below shows Braskem’s financial liabilities by maturity, including the amounts due under the Leniency Agreement (Note 23.3). These amounts are calculated from undiscounted cash flows and may not be reconciled with the balance sheet. The Braskem Idesa’s borrowings presents the original long-term maturities, excluding the reclassification to current liabilities arising from the breach of contractual obligations (Note 16).

 

25


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

       

 

 

Consolidated

   

Maturity

   
   

Until

 

Between one and

 

Between two and

 

More than

   
   

one year

 

two years

 

five years

 

five years

 

Total

               

Trade payables

 

          5,326,811

 

                        259,737

   

               5,586,548

Borrowings

 

          1,256,574

 

                     3,963,839

 

                     6,708,910

 

         24,520,093

 

             36,449,416

Debentures

 

               28,569

 

                          83,520

 

                        133,206

 

              180,001

 

                  425,296

Braskem Idesa borrowings

 

             820,282

 

                     1,832,863

 

                     2,250,575

 

           7,616,260

 

             12,519,980

Derivatives

 

                 6,875

   

                      6,875

Loan to non-controlling shareholder of Braskem Idesa

   

           1,756,600

 

               1,756,600

Leniency agreement (Note 23.3)

 

             257,347

 

                        325,299

 

                     1,007,348

 

              334,026

 

               1,924,020

At December 31, 2017

 

       7,696,458

 

                   6,465,258

 

                10,100,039

 

      34,406,980

 

          58,668,735

 

4.4               Capital management

 

The ideal capital structure, according to Braskem’s Management, considers the balance between own capital and the sum of all payables less the amount of cash and cash equivalents and financial investments. This composition meets the Company’s objectives of perpetuity and of offering an adequate return to shareholders and other stakeholders. This structure also permits borrowing costs to remain at adequate levels to maximize shareholder remuneration.

 

Due to the impact of the U.S. dollar on the Company’s operations, the Management of Braskem believes that the own capital used for capital management purposes should be measured in this currency and on a historical basis. Moreover, the Company may temporarily maintain a capital structure that is different from this ideal. This occurs, for example, during periods of growth, when the Company may finance a large portion of its projects through borrowings, provided that this option maximizes return for shareholders once the financed projects start operating. In order to adjust and maintain the capital structure, the Management of Braskem may also consider the sale of non-strategic assets, the issue of new shares or even adjustments to dividend payments. 

 

As is also the case of liquidity, capital is not managed at the Parent Company level, but rather at the consolidated balance sheet level.

 

5                    Available-for-sale assets and discontinued operations

 

During the second half of 2016, the Management of the Company approved the sale plan of the subsidiaries Quantiq Distribuidora Ltda. and IQAG Armazens Gerais Ltda. to the company GTM do Brasil Comércio de Produtos Químicos Ltda. On January 9, 2017, the Board of Directors approved the sale of the subsidiaries, in the amount of R$550 million, was signed on the following day, and in January the operation was approved by Brazil’s antitrust agency CADE (Conselho Administrativo de Defesa Econômica).

 

Although the sale agreement was executed in January 2017, the consolidated financial statements of Quantiq and IQAG are presented as held-for-sale assets and discontinued operations in the period of 2016, since Braskem had already received a firm offer by the buying party before December 31, 2016 and both the Company’s Management and its Board of Directors were committed to the sale plan.

 

The operating profits or losses of Quantiq and IQAG were presented in the segment information as operating segment “Chemical distribution”.

 

The results of Quantiq and IQAG for 2016 and 2017 are presented in the line “profit from discontinued operations” on the consolidated statements of operations.

 

The transfer of control to the buyer company was concluded on April 3, 2017. On the same date, Braskem received R$450 million. The remaining R$100 million will be received within 12 months, subject to adjustments typical to operations of this nature. The capital gain from the operation was R$276,816 (Total income of R$550,000 (-) net assets of R$273,184), recorded in the second quarter of 2017.

 

26


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

Assets and liabilities classified as available-for-sale and profit or loss from discontinued operations until the date of transfer of control are shown below:

 

(a)      Balance sheet

 

 

Assets and liabilities classified as held for sale

Mar/2017

 

Dec/2016

Assets

     
 

Cash and cash equivalents

                40,216

 

         76,146

 

Trade accounts receivable

              119,076

 

         65,626

 

Inventories

                82,815

 

         84,296

 

Taxes recoverable

                46,858

 

         45,859

 

Property, plant and equipment

                61,591

 

         61,037

 

Intangible assets

                  6,729

 

           6,665

 

Other assets

                17,932

 

         20,075

Total assets

            375,217

 

     359,704

         

Liabilities

     
 

Trade payables

                75,852

 

         62,692

 

Payroll and related charges

                  7,099

 

         11,170

 

Dividends

                  6,371

 

           6,371

 

Taxes payable

                  9,668

 

           7,064

 

Other payables

                  3,043

 

           8,099

Total liabilities

            102,033

 

       95,396

         

Net assets (Assets (-) Liabilities)

            273,184

 

     264,308

 

(b)     Statement of operations

 

Result with discontinued operations

Mar/2017

 

Dec/2016

Net sales revenue

              212,238

 

       830,754

 

Cost of products sold and services provided

            (176,957)

 

     (674,619)

Gross profit

                35,281

 

       156,135

         

Income (expenses)

     
 

Selling and distribution

              (10,164)

 

       (45,938)

 

General and administrative

              (12,067)

 

       (77,258)

 

Other income (expenses), net

                (1,298)

 

            (608)

Operating profit

                11,752

 

         32,331

Financial results

                  1,747

 

           8,429

Profit before income tax and social contribution

                13,499

 

         40,760

 

Current and deferred income tax and social contribution

                (4,623)

 

       (13,901)

Result with discontinued operations

                8,876

 

       26,859

Profit per share to the discontinued operations at the end of the year (R$)

     

Earnings per share - common

                0.0112

 

         0.0337

Earnings per share - preferred shares class "A"

                0.0112

 

         0.0337

Earnings per share - preferred shares class "B"

                0.0112

 

         0.0337

 

 

 

27


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

(c)      Cash flow

 

             

2016

Profit before income tax and social contribution 

         

                40,760

Adjustments for reconciliation of profit

           
 

Depreciation, amortization and depletion

         

                  5,428

 

Interest and  monetary and exchange variations, net

         

                   (867)

 

Other

         

                       93

             

              45,414

Changes in operating working capital

         

                41,642

Cash from operations

         

              87,056

Acquisitions to property, plant and equipment

         

                (5,491)

Net cash used in investing activities

         

               (5,491)

Short-term and long-term debt

           
 

Payments

         

              (57,543)

Related parties

         

 

 

Obtained

         

                26,469

 

Payments

         

              (35,094)

Dividends paid

         

                (6,029)

Net cash provided (used) by financing activities

         

            (72,197)

Increase in cash and cash equivalents

         

                9,368

Represented by

           
 

Cash and cash equivalents at the beginning for the year

         

                66,778

 

Cash and cash equivalents at the end for the year

         

                76,146

Increase in cash and cash equivalents

         

                9,368

 

6                    Cash and cash equivalents

 

       

 Consolidated

 

 Parent Company

       

2017

 

2016

 

2017

 

2016

                     

Cash and banks

 (i)

           1,428,766

 

           2,178,611

 

                67,424

 

              382,112

Cash equivalents:

 

Domestic market

           1,706,784

 

           2,914,685

 

           1,885,120

 

           3,085,233

 

Foreign market

 (i)

              639,543

 

           1,608,568

 

                     512

 

                94,086

Total

   

        3,775,093

 

        6,701,864

 

        1,953,056

 

        3,561,431

 

(i)   

On December 31, 2017, it includes cash and banks of R$247,285 (R$172,430 on December 31, 2016) and cash equivalents of R$47,400 (R$29,169 on December 31, 2016) of the subsidiary Braskem Idesa, available for use exclusively in its project.

 

This item includes cash, bank deposits and highly liquid financial investments available for redemption within three months. These assets are convertible into a known cash amount and are subject to insignificant risk of change in value.

 

Cash equivalents in Brazil are mainly represented by fixed-income instruments and time deposits held by the FIM Jupiter fund. Cash equivalents abroad mainly comprise fixed–income instruments issued by first-class financial institutions (time deposit) with high market liquidity.

 

 

28


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

7                    Financial investments

 

       

 Consolidated

 

 Parent Company

       

2017

 

2016

 

2017

 

2016

Loans and receivables

                 
 

Time deposit investments

 (i)

              440,616

 

              434,015

 

        

 

              

Held-for-trading

 
 

Time deposit investments

  

                15,764

 

 

 

                15,764

 

 

 

Letras financeiras do tesouro - LFT´s and Letras Financeiras - LF´s

 (ii)

           1,816,889

 

              755,712

 

           1,816,889

 

              740,332

 

Other

 

                39,739

 

                     756

 

                     667

 

                     754

Total

 

        2,313,008

 

        1,190,483

 

        1,833,320

 

            741,086

                   

Current assets

 

           2,302,672

 

           1,190,483

 

           1,833,320

 

              741,086

Non-current assets

 

                10,336

 

 

Total

 

        2,313,008

 

        1,190,483

 

        1,833,320

 

            741,086

 

(i)   

This investment was given as guarantee to cover Braskem’s obligation related to the constitution of a reserve account for the project finance of the subsidiary Braskem Idesa.

(ii)

Government bonds held for trade refer to Brazilian floating-rate government bonds (“LFTs”) issued by the Brazilian federal government and floating-rate bonds (“LFs”) issued by financial institutions. These bonds have maturity above three months, immediate liquidity and expected realization in the short term.

 

8                    Trade accounts receivable

 

The Company’s billing period is generally 30 days; therefore, the amount of the trade accounts receivable corresponds to their fair value. The Company realizes part of its trade accounts receivable through the sale of trade notes to funds and financial institutions that acquire receivables. These operations are not entitled to recourse and with substantial transfer of receivables risks and benefits, for which reason the trade notes are written-off at the moment of the operation.

 

         

 Consolidated

 

 Parent Company

         

2017

 

2016

 

2017

 

2016

Costumers

                   
 

Domestic market

     

           1,459,623

 

                   869,306

 

           1,521,082

 

              969,072

 

Foreign market

     

           2,209,094

 

                1,215,626

 

           1,977,584

 

           3,137,384

Allowance for doubtful accounts

   

            (350,025)

 

                  (380,559)

 

            (337,697)

 

            (358,878)

Total

     

         3,318,692

 

              1,704,373

 

         3,160,969

 

         3,747,578

                       

Current assets

     

           3,281,196

 

                1,634,137

 

           1,824,740

 

              952,689

Non-current assets

     

                37,496

 

                     70,236

 

           1,336,229

 

           2,794,889

Total

     

         3,318,692

 

              1,704,373

 

         3,160,969

 

         3,747,578

 

The breakdown of trade accounts receivable by maturity is as follows:

         

 Consolidated

 

 Parent company

         

2017

 

2016

 

2017

 

2016

                       

Accounts receivables not past due

   

           2,886,546

 

                1,668,063

 

           2,540,524

 

           3,578,195

Past due securities:

     
 Up to 90 days      

              567,590

 

                   173,125

 

              478,677

 

              264,932

 91 to 180 days      

                  3,673

 

                     15,325

 

              278,493

 

                27,575

 As of 180 days      

              210,908

 

                   228,419

 

              200,972

 

              235,754

       

           3,668,717

 

                2,084,932

 

           3,498,666

 

           4,106,456

Allowance for doubtful accounts

   

            (350,025)

 

                  (380,559)

 

            (337,697)

 

            (358,878)

Total customers portfolio

   

         3,318,692

 

              1,704,373

 

         3,160,969

 

         3,747,578

 

 

 

 

29


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

The changes in the allowance for doubtful accounts are presented below:

 

       

 Consolidated

 

 Parent company

       

2017

 

2016

 

2017

 

2016

                     

Balance of provision at the beginning of the year

   

            (380,559)

 

                  (327,974)

 

            (358,878)

 

            (290,010)

 Provision/reversal in the year    

                18,573

 

                  (102,065)

 

                12,679

 

              (98,745)

Write-offs    

                22,878

 

                     38,499

 

                22,878

 

                29,877

 Addition through merger of Cetrel    

              (10,917)

 
 Addition through merger of Braskem Petroquímica      

              (14,376)

 
 Transfers (of) to non-current assets held for sale    

 

 

                     10,981

 

 

 

 

Balance of provision at the end of the year

   

          (350,025)

 

                (380,559)

 

          (337,697)

 

          (358,878)

 

The methodology adopted by the Company for recognizing the provision for impairment is based on the history of losses and considers the sum of (i) 100% of the amount of receivables past due for over 180 days; (ii) 50% of the amount of receivables past due between 90 and 180 days; (iii) 100% of the amount of receivables under judicial collection (iv) all the receivables from the first renegotiation maturing within more than 24 months; and (v) 100% of the receivables arising from a second renegotiation with customers. Receivables from subsidiaries are not considered in this calculation. This methodology is revised on an annual basis by the Management of the Company.

 

9                    Inventories

 

       

 Consolidated

 

 Parent company

       

2017

 

2016

 

2017

 

2016

                     

Finished goods

   

 

           4,255,114

 

                  3,444,898

 

           2,785,182

 

           2,314,755

Raw materials, production inputs and packaging

 

 

           1,715,757

 

                  1,407,399

 

           1,549,001

 

           1,266,323

Maintenance materials

   

 

              365,803

 

                     312,167

 

              165,073

 

              162,568

Advances to suppliers

   

 

              482,043

 

                     103,267

 

              273,401

 

                82,618

Imports in transit and other

 

 

                74,670

 

                       31,816

 

                74,667

 

                31,168

Total

   

         6,893,387

 

               5,299,547

 

         4,847,324

 

         3,857,432

                     

In current assets

   

  

           6,846,923

 

                  5,238,014

 

           4,800,860

 

           3,795,899

In non-current assets

   

 

                46,464

 

                       61,533

 

                46,464

 

                61,533

Total

     

         6,893,387

 

               5,299,547

 

         4,847,324

 

         3,857,432

 

Inventories of finished products are stated at average cost of purchase or production or the estimated price of sale or acquisition, excluding taxes, whichever is lower

 

The value of finished products includes raw materials, ancillary and maintenance materials used, depreciation of industrial facilities, expenses with Company’s and third-party personnel involved in industrial production and maintenance, and logistics expenses with the transfer of these products from the plants to the sale terminals.

 

In the fiscal years ended December 31, 2017 and December 31, 2016, finished goods presented a value below their net realizable value, which means there is no need to accrue a provision. For this estimate, the Company considers the sale price projected for the period during which it expects to sell the product. This period is determined based on the historical data for the turnover of the respective inventory.

 

30


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

10  Related parties

 

(a) Consolidated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated

 

 

 

Balances at December 31, 2017

 

Balances at December 31, 2016

 

 

 

Associated companies, Jointly-controlled investment and Related companies

 

Associated companies, Jointly-controlled investment and Related companies

 

 

 

Odebrecht and
subsidiaries

 

Petrobras and

subsidiaries

 

 

 

 

 

Odebrecht and

subsidiaries

 

Petrobras and

subsidiaries

 

 

 

 

Balance sheet

 

 

 

Other

 

Total

 

 

 

Other

 

Total

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trade accounts receivable

 

7,634

 

45,184

 

60,502

 

113,320

 

5,634

 

33,843

 

28,390

 

67,867

 

Inventories

 

250,904

10(c.i) and (c.ii)

  118

 

 

 

251,022

 

 

5,434

 

 

5,434

 

Dividends and interest on capital

 

 

 

 

10,859

 

10,859

 

 

 

14,986

 

14,986

 

Other

 

 

 

 

 

 

  50

 

 

 

  50

Total assets

 

258,538

 

45,302

 

71,361

 

375,201

 

  5,684

 

39,277

 

43,376

 

88,337

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current

 

 

 

 

 

 

 

 

 

 

 

Trade payables

 

21,530

 

149,058

 

  700

 

171,288

 

77,461

 

904,090

 

1,226

 

982,777

 

Other receivables

 

2,338

 

  562

 

7,591

 

10,491

 

 

 

 

 

 

Total liabilities

 

23,868

 

149,620

 

8,291

 

181,779

 

77,461

 

904,090

 

  1,226

 

982,777

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Twelve-month period ended December 31, 2017

 

Twelve-month period ended December 31, 2016

 

 

 

Associated companies, Jointly-controlled investment and Related companies

 

Associated companies, Jointly-controlled investment and Related companies

 

 

 

Odebrecht and

subsidiaries

 

Petrobras and

subsidiaries

 

 

 

 

 

Odebrecht and

subsidiaries

 

Petrobras and

subsidiaries

 

 

 

 

 

 

 

 

 

Other

 

Total

 

 

 

Other

 

Total

Transactions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales of products

 

27,467

 

  1,810,789

 

629,302

 

  2,467,558

 

49,051

 

  2,023,815

 

562,709

 

  2,635,575

 

Purchases of raw materials, finished goods

   

 

 

 

 

 

 

 

 

 

services and utilities

 

742,161

 

  12,795,819

 

5,664

 

  13,543,644

 

  1,564,103

(i)

  12,291,190

 

56,170

 

  13,911,463

 

Financial income (expenses)

 

2,056

 

(39,433)

 

 

(37,377)

 

  (21)

 

6,452

 

 

6,431

 

General and administrative expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

Post-employment benefits plan ("EPE")

 

 

 

 

 

 

 

 

 

 

 

Odebrecht Previdência Privada ("Odeprev")

   

 

36,725

 

 

 

 

 

 

41,845

 

41,845

 

Acquisiton of subsidiary

 

610,000

1(a.ii)

 

 

 

 

610,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

                                     

(i) 

Includes expenses with the Braskem Idesa project in the amount of R$734,263.

31


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

 

(b)             Parent Company

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances at December 31, 2017

 

 

 

Associated companies, Jointly-controlled investment and associated companies

Related companies

 

 

 

 

EPE

 

 

 

 

 

Braskem

 

Braskem

 

Braskem

 

Braskem

 

Braskem

 

Braskem

 

 

 

Odebrecht and

 

Petrobras and

 

 

 

 

 

 

Balance sheet

 

Inc.

 

Holanda

 

Holanda Inc

 

Petroquímica

 

America

 

Argentina

 

Other

 

subsidiaries

 

subsidiaries

 

Other

 

FIM Júpiter

 

Total

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and equivalents

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

1,613,351

 

1,613,351

 

Financial investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,816,888

 

1,816,888

 

Trade accounts receivable

 

 

 

428

 

 

 

23,833

 

  111,824

 

  104,084

 

3,855

 

45,184

 

  

 

 

  289,208

 

Inventories

 

 

 

-

 

-

 

-

 

-

 

 

 

250,904

 10(c.i) and (c.ii)

  118

 

  

 

 

  251,022

 

Dividends and interest on capital

 

 

 

-

 

-

 

-

 

-

 

 

  10,859

 

 

 

  

 

 

  10,859

 

Related parties

 

 

 

115

 

 

 

20,771

 

 

  9,592

 

 

 

  

 

 

  30,478

 

 

 

 

 

-

 

-

 

-

 

-

 

 

 

-

 

-

 

  

 

 

-

Non-current

 

 

 

-

 

-

 

-

 

-

 

 

 

-

 

-

 

  

 

 

-

 

Trade accounts receivable

 

 

 

1,298,733

 

 

 

 

 

 

 

 

  

 

 

1,298,733

 

Related parties

 

 

 

-

 

-

 

-

 

-

 

 

 

-

 

-

 

  

 

 

-

 

Loan agreements

 

15,172

 

 

 

 

 

 

881

 

 

 

  

 

 

  16,053

Total assets

 

15,172

 

  1,299,276

 

 

 

44,604

 

  111,824

 

125,416

 

254,759

 

45,302

 

 

 

3,430,239

 

  5,326,592

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current

 

 

 

-

 

-

 

-

 

-

 

 

 

-

 

-

 

  

 

 

 

 

Trade payables

 

  25

 

 

 

 

 

 

  13,829

 

12,796

 

149,058

 

  

 

 

  175,708

 

Accounts payable to related parties

 

 

-

 

-

 

-

 

-

 

 

 

-

 

-

 

  

 

 

-

 

Advance to export

 

 

 

-

 

107,574

 

 

675,547

 

 

 

 

 

  

 

 

  783,121

 

Other payables

 

 

 

-

 

-

 

-

 

  60

 

 

 

 

 

  

 

 

60

 

Other

 

 

 

-

 

-

 

-

 

-

 

 

  7,591

 

2,338

 

  562

 

  

 

 

  10,491

 

 

 

 

 

-

 

-

 

-

 

-

 

 

 

-

 

-

 

  

 

 

-

Non-current

 

 

 

-

 

-

 

-

 

-

 

 

 

-

 

-

 

  

 

 

-

 

Trade  Payables

 

 

 

13,585,736

 

 

 

 

 

 

 

 

  

 

 

13,585,736

 

Accounts payable to related parties

 

 

-

 

-

 

-

 

-

 

 

 

-

 

-

 

  

 

 

-

 

Advance to export

 

 

 

-

 

  6,910,306

 

 

274,564

 

 

 

 

 

  

 

 

7,184,870

 

Payable notes

 

12,703

 

 

 

 

 

 

 

 

 

  

 

 

  12,703

Total liabilities

 

  12,728

 

  13,585,736

 

  7,017,880

 

 

950,171

 

 

  21,420

 

15,134

 

149,620

 

  

 

 

  21,752,689

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Twelve-month period ended December 31, 2017

 

 

 

Associated companies, Jointly-controlled investment and associated companies

 

 

 

Related companies

EPE

 

 

 

 

 

Braskem

 

Braskem

 

Braskem

 

Braskem

 

Braskem

 

Braskem

 

 

Odebrecht and

 

Petrobras and

 

 

 

 

 

 

 

 

 

Inc

 

Holanda

 

Holanda Inc

 

Petroquímica

 

America

 

Argentina

Other

 

subsidiaries

 

subsidiaries

 

Other

 

FIM Júpiter

Total

Transactions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales of products

 

-

 

3,774,728

 

 

31,082

 

159,784

 

  326,232

 

  722,800

 

27,467

 

  1,782,154

 

  

 

 

6,824,247

 

Purchases of raw materials, finished products

-

 

-

 

-

 

-

 

-

 

 

 

-

 

-

 

  

 

 

-

 

services and utilities

 

-

 

8,102,867

 

 

  2,983,908

 

 

 

  41,148

 

714,216

 

11,637,035

 

  

 

 

23,479,174

 

Financial income (expenses)

 

25,451

 

  (295,793)

 

(756,179)

 

(3)

 

  (48,919)

 

  1,725

 

(101)

 

2,056

 

(39,433)

 

  

 

  6,445

 

(1,104,751)

 

General and administrative expenses - Odeprev

-

 

-

 

-

 

-

 

-

 

 

 

-

 

-

 

 36,725

 

 

  36,725

 

Acquisiton of subsidiary

 

-

 

-

#

-

#

-

 

-

#

#

#

610,000

 1(a.ii)

-

#

 

#

 

 

  610,000

                                                 

 

 

32


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

   

Balances at December 31, 2016

   

Associated companies, Jointly-controlled investment and associated companies

 

Related companies

 

EPE

 

 

   

Braskem

 

Braskem

 

Braskem

 

Braskem

 

Braskem

 

Braskem

     

Odebrecht and

 

Petrobras and

     

FIM Sol and

   

Balance sheet

Inc.

 

Holanda

 

Holanda Inc

 

Petroquímica

 

America

 

Argentina

 

Other

 

subsidiaries

 

subsidiaries

 

Other

 

FIM Júpiter

 

Total

Assets

                                             

Current

                                             
 

Cash and equivalents

 

1,994,314

 

1,994,314

 

Financial investments

 

674,387

 

674,387

 

Trade accounts receivable

 

 

189

 

 

 

2,223

 

24,212

 

97,060

 

95,583

 

5,634

 

32,152

   

257,053

 

Inventories

 

5,434

   

5,434

 

Dividends and interest on capital

16,435

   

14,986

   

31,421

 

Related parties

 

20

 

 

 

104,471

 

50,802

 

24

 

16,977

 

50

   

172,344

   

Non-current

 

Trade accounts receivable

2,523,072

 

112,330

 

 

 

88,615

   

2,724,017

 

Related parties

  Loan agreements

14,378

 

 

 

 

 

 

 

 

 

 

 

94

 

 

 

 

 

 

 

 

 

14,472

Total assets

2,537,450

 

112,539

 

 

 

211,744

 

75,014

 

97,084

 

127,640

 

5,684

 

37,586

 

 

 

2,668,701

 

5,873,442

                                                 

Liabilities

Current

 

Trade payables

25

   

15

     

34,682

 

886,775

   

921,497

 

Accounts payable to related parties

 

 

       

 

Advance to export  

97,165

   

670,325

       

767,490

Other payables    

189,106

     

13

   

189,119

                 

Non-current

             
 

Trade  Payables

1,527,820

 

6,351,905

   

918,038

         

8,797,763

 

Accounts payable to related parties

             

 

Advance to export  

7,951,033

   

270,505

       

8,221,538

Payable notes

12,515

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12,515

Total liabilities

1,540,360

 

6,351,905

 

8,048,198

 

1,107,144

 

940,845

 

 

 

13

 

34,682

 

886,775

 

 

 

 

 

18,909,922

                                                 
   

Twelve-month period ended December 31, 2016

   

Associated companies, Jointly-controlled investment and associated companies

 

Related companies

 

EPE

 

 

   

Braskem

 

Braskem

 

Braskem

 

Braskem

 

Braskem

 

Braskem

     

Odebrecht and

 

Petrobras and

     

FIM Sol and

   
   

Inc

 

Holanda

 

Holanda Inc

 

Petroquímica

 

America

 

Argentina

 

Other

 

subsidiaries

 

subsidiaries

 

Other

 

FIM Júpiter

 

Total

Transactions

                                             
 

Sales of products

142,978

 

2,876,647

   

2,157,743

 

151,687

 

266,190

 

876,116

 

48,781

 

1,979,837

   

8,499,979

 

Purchases of raw materials, finished products services and utilities

160,378

 

4,724,595

   

3,548,904

   

62,347

 

810,574

 

11,268,019

   

20,574,817

 

Financial income (expenses)

(375,743)

 

394,646

 

1,404,690

 

(13)

 

114,417

 

(28,767)

 

(10,742)

 

(21)

 

6,453

 

 

 

(158,877)

 

1,346,043

 

General and administrative expenses - Odeprev

 

39,213

 

 

 

39,213

 

 

33


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

(c)               New and/or renewed agreements with related companies

 

As provided for in the Company’s bylaws, the Board of Directors has the exclusive power to decide on any contract with related parties but those related to the purchase of raw materials that exceed R$5,000 per operation or R$15,000 altogether per year. This provision encompasses contracts between the Parent Company and its subsidiaries and (i) any of its common shareholders and (ii) directors of the Company, its parent company or subsidiary or its respective related parties.

 

Pursuant to Federal Law 6,404/76, officers and directors are prohibited from: (i) performing any acts of liberality with the use of the Company’s assets and in its detriment; (ii) intervening in any operations in which these officers and directors have a conflict of interest with the Company or in resolutions in which they participate; and (iii) receiving, based on their position, any type of personal advantage from third parties, directly or indirectly, without an authorization under the Bylaws or by the shareholders’ meeting.

 

As part of the control to identify related parties, the officers and directors of Braskem are asked, on an annual basis, if they or their direct family members have any kind of relevant interaction, in an amount equal to or greater than R$5,000 per operation, or in an aggregate amount greater than R$15,000, with companies that transact with Braskem and its subsidiaries, per fiscal year. Such interaction may be in the form of holding an equity interest or participating in the management of the company. For the fiscal years 2017 and 2016, the companies that were informed by the managers are considered in this note if they met the aforementioned criteria.

 

The related parties that have significant relationship with the Company are as follows:

 

Odebrecht and its direct and indirect subsidiaries:

 

·         

Agro Energia Santa Luzia S.A. (“USL”)

·          

Brenco Companhia Brasileira de Energia Renovável. (“Brenco”)

·          

Construtora Norberto Odebrecht S.A. (“CNO”).

·          

Odebrecht Agroindustrial Participações S.A. (“ODB Agro Par”)

·          

Rio Claro Agroindustrial S.A.

·          

Usina Conquista do Pontal S.A. (“UCP”)

·          

Santo Antônio Energia S.A. (“SAESA”)

 

Petrobras and its direct and indirect subsidiaries:

 

·         

Petrobras: shareholder of Braskem.

·          

Petrobras Distribuidora (“BR Distribuidora”).

·          

Refinaria Alberto Pasqualini (“REFAP”).

 

Joint ventures of Braskem:

 

·         

Refinaria de Petróleo Riograndense S.A. (“RPR”).

 

The main transactions with related parties, in the fiscal years ended December 31, 2017 and December 31, 2016, except subsidiaries of the Company, are as follows:

 

·         

Odebrecht and its subsidiaries:

 

 

  

(i)     

In March 2017, the Company entered into an agreement for supply of hydrous ethanol with UCP and USL. Ethanol is the feedstock consumed by Braskem to produce green ethylene. The agreement is guaranteed by ODB Agro Par and Rio Claro. The agreement also provides for a commercial discount and other flexibilities in the process of Braskem’s acquisition of the product. It also includes an advance of R$150,000, to be restated at market rates. The advance is guaranteed by a pledge of the

34


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

  

  

sugarcane crop, its products and subproducts at net market value in an amount greater than the value of the advance, with the pledged asset insured through a policy contracted from a premium insurer and with a provision for subrogation. The agreement is valid through April 30, 2018 and the balance as of December 31, 2017 was R$50,904.

 

In December 2017, the Company entered into an amendment that changed the billing for raw material acquisitions to future delivery, so as to bring forward the billing of the volume of the goods to be delivered between January and March 2018. The amendment determines that the price practiced at time of delivery is the lesser of the ceiling established in the amendment and the reference established in the original contract.

 

(ii)      

In December 2017, an agreement was entered into with USL, UCP, ODB Agro Par and Brenco, with the purpose of ensuring the supply of hydrous ethanol volumes, which included a commercial discount on the supply and established contractual flexibilities for acquisition. The contract includes an advance of R$200,000, which is guaranteed by a pledge of the sugarcane crop, its products and sub-products at a net market value greater than the amount of the advance, with the pledged asset insured by a policy contracted from a premium insurer and with a provision for subrogation, with duration through April 30, 2019.
 

(iii)    

In December 2017, the Company signed an industrial maintenance services agreement with CNO that encompassed boilers and the welding of tubing and static equipment, as well as operational and maintenance services on cargo machinery to be performed at the Braskem Units located in Rio Grande do Sul. The agreement has an estimated maximum amount of R$120,000 and is valid through December 1, 2021.
 

(iv)    

In August 2017, a power purchase agreement was executed with SAESA to supply Braskem’s industrial units. The agreement has an estimated maximum value of R$517,000 and is valid for 13 years as from January 1, 2017.
 

·          

Petrobras and its subsidiaries:
 

(i)       

On December 23, 2016, Braskem and Petrobras entered into an agreement for the annual purchase of 7 million tons of petrochemical naphtha for five years. This agreement includes commercial renegotiation rights for both parties as of the third year, in case of changes in certain market conditions. The established price is 102.1% of ARA international benchmark, which is the average price of inputs in the European ports of Amsterdam, Rotterdam and Antwerp).
 

(ii)      

As from January 2017, Braskem maintains agreements for the sale of gasoline to Petrobras Distribuidora S.A., which is renewed on a monthly basis. Sales in the year amount to R$995,602.
 

(iii)         

In November 2016, the Company entered into an agreement with Petrobras for the purchase of 108,000 tons of polymer-grade propylene through REFAP, with duration of 5 years.

 

 

 

35


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

·          

Braskem joint venture:

(i)       

In 2017, sales of gasoil to RPR amounted to R$44,698. The product is used as feedstock in the diesel production process.

(ii)      

Since January 2017, Braskem has maintained monthly negotiations for the sale of gasoline to RPR. Sales in the period amounted to R$323,949.

 

(d)               Changes in accounts payable to related parties

 

     

 

 

 

 

 

 

 

 

 

 

 

 

Parent company

     

Balance at

         

Interest, changes

         

Balance at

     

December 31,

         

monetary and

     

Incorporations

 

December 31,

     

2016

 

Obtained

 

Payments

 

foreign exchange, net

 

Transferences

 

effects

 

2017

                               

Current

                           
 

Export prepayment

 

               767,490

 

 

 

    (5,600,660)

 

                          607,467

 

            5,008,823

 

 

 

               783,120

 

Credit notes

 

               189,119

 

       167,672

 

         (62,152)

 

 

 

 

 

           (294,578)

 

                        61

 

Total

 

             956,609

 

     167,672

 

  (5,662,812)

 

                        607,467

 

         5,008,823

 

         (294,578)

 

             783,181

                               

Non-current

                           
 

Export prepayment

 

            8,220,091

 

    3,773,942

 

 

 

                          198,213

 

          (5,008,823)

 

 

 

            7,183,423

 

Credit notes

 

                 13,962

 

 

 

 

 

                                 188

 

 

 

 

 

                 14,150

 

Total

 

         8,234,053

 

  3,773,942

 

 

 

                        198,401

 

        (5,008,823)

 

 

 

         7,197,573

                               
 

Total

 

         9,190,662

 

  3,941,614

 

  (5,662,812)

 

                        805,868

 

                       

 

         (294,578)

 

         7,980,754

 

(e)               Key management personnel

 

      

Parent company and consolidated

Income statement transactions

 

2017

 

2016

Remuneration

       

Short-term benefits

 

                     60,303

 

                      44,277

Post-employment benefit

 

                          664

 

                           515

Total

 

                   60,967

 

                    44,792

 

 

 

36


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

11                Taxes recoverable

 

       

 Consolidated

 

 Parent Company

       

2017

 

2016

 

2017

 

2016

                     

Parent Company and subsidiaries in Brazil

               
 

IPI

 

                18,226

 

                38,909

 

                18,226

 

                37,859

 

Value-added tax on sales and services (ICMS) - normal operations

 (a)

 

              499,984

 

              495,339

 

              499,979

 

              420,625

 

ICMS - credits from PP&E

 

              140,904

 

              125,145

 

              140,904

 

              118,984

 

Social integration program (PIS) and social contribution on revenue
   (COFINS) - normal operations

 

                22,389

 

                32,823

 

                21,904

 

                28,386

 

PIS and COFINS - credits from PP&E

 

              223,297

 

              253,503

 

              222,964

 

              242,475

 

Income tax and social contribution (IR and CSL)

 (b)

 

              691,697

 

              584,157

 

              684,570

 

              487,079

 

REINTEGRA program

 (c)

 

              102,166

 

                53,129

 

              102,166

 

                51,414

 

Federal supervenience

 (d)

 

              160,198

 

              155,533

 

              160,198

 

              151,798

 

Other

 

                  4,322

 

                  1,046

 

                  2,486

 

                  2,694

     

Foreign subsidiaries

 
 

Value-added tax ("IVA")

 

                90,050

 

              132,152

 
 

Income tax (IR)

 

              415,443

 

              569,684

 
 

Other

 

                  4,021

 

                  2,628

     

 

 Total  

        2,372,697

 

        2,444,048

 

        1,853,397

 

        1,541,314

                   

Current assets

 

           1,349,064

 

           1,355,695

 

              830,152

 

              543,275

Non-current assets

 

           1,023,633

 

           1,088,353

 

           1,023,245

 

              998,039

Total

 

        2,372,697

 

        2,444,048

 

        1,853,397

 

        1,541,314

 

(a)               ICMS – normal operations

 

Accumulated ICMS credits over the past few years arises mainly from domestic sales subject to deferred taxation and export sales.

 

The Management of the Company has been prioritizing a series of actions to maximize the use of these credits and currently does not expect losses on the realization of cumulative balances.

 

(b)               IR and CSL

 

Accumulated IR and CSL arises from prepayments of these taxes and retentions on income from financial investments over the past few years.

The realization of these credits occurs in two ways: (i) offset of overdue or falling due liabilities related to taxes levied by the Federal Revenue Service; or (ii) cash reimbursement.

 

Diverse tax refund claims were already filed with Brazil’s Federal Revenue Service.

 

(c)                REINTEGRA Program

 

The REINTEGRA program aims to refund to exporters the federal taxes levied on the production chain for goods sold abroad. The amount to be refunded is equivalent to the following percentages of all export revenue, in accordance with Federal Law 13,043/14 and Executive Order 8,543/15:

 

(i)   

3%, between October 1, 2014 and February 28, 2016;

(ii)  

1%, between March 1, 2016 and November 30, 2016;

(iii) 

0.1% between December 1, 2016 and December 31, 2017;

(iv) 

2% between January 1, 2017 and December 31, 2017; and

(v)  

2% between January 1, 2018 and December 31, 2018.

 

37


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

Such credits may be realized in two ways: (i) by offsetting own debits overdue or undue related to taxes levied by the Federal Revenue Service; or (ii) by a cash reimbursement.

 

In the fiscal year ended December 31, 2017, the Company recognized credits in the amount of R$178,716 (R$8,694 in 2016) and offset the amount of R$138,531 (R$230,220 in 2016). In the Statement of Operations, credits were recognized in the item “Cost of Products Sold.”

 

(d)          Federal supervenience

 

This item includes credits arising from legal discussions regarding the legality and constitutionality of various taxes and contributions in which the Company has already obtained a favorable ruling or has unquestionable precedents in its favor.

 

These amounts will be realized after the use of other credits described above in this Note.

 

12                Investments

 

(a)                Information on investments

 

     

Parent company

     

Interest in total and

 

Adjusted net profit (loss)

 

Adjusted

     

voting capital (%) - 2017

 

for the year

 

equity

     

Direct and indirect

 

2017

 

2016

 

2017

 

2016

                       

Subsidiaries

                   
 

Braskem Alemanha

                                     100.00

 

        1,069,616

 

        1,404,696

 

        4,069,847

 

        2,883,238

 

Braskem America

                                     100.00

 

           993,681

 

        1,147,107

 

        3,665,456

 

        2,582,061

 

Braskem America Finance

                                     100.00

 

                  981

 

               1,099

 

              (5,667)

 

              (6,573)

 

Braskem Argentina

                                     100.00

 

             10,844

 

               7,945

 

             34,934

 

             24,090

 

Braskem Austria

                                     100.00

 

                 (322)

 

                    15

 

               4,459

 

               4,170

 

Braskem Chile

                                     100.00

 

               4,382

 

               6,977

 

             19,067

 

             14,685

 

Braskem Holanda

                                     100.00

 

        2,291,436

 

        1,264,789

 

        4,006,132

 

        1,320,056

 

Braskem Holanda Finance

                                     100.00

 

              (8,569)

 

                   (16)

 

              (8,658)

 

                   (25)

 

Braskem Holanda Inc

                                     100.00

 

               1,661

 

               2,367

 

               3,909

 

               2,150

 

Braskem Finance

                                     100.00

 

              (9,529)

 

             44,647

 

          (101,894)

 

            (92,365)

 

Braskem Idesa

                                       75.00

 

           202,657

 

       (1,270,899)

 

       (3,586,358)

 

       (4,071,517)

 

Braskem Idesa Serviços

                                       75.00

 

               6,674

 

               4,350

 

             15,450

 

               9,241

 

Braskem Inc.

                                     100.00

 

            (40,349)

 

          (559,670)

 

           243,560

 

           283,909

 

Braskem México

                                     100.00

 

              (1,292)

 

             32,994

 

           183,595

 

           173,590

 

Braskem México Sofom

                                     100.00

 

               3,971

 

               3,691

 

             15,397

 

               8,667

 

Braskem México Serviços

                                     100.00

 

                  552

 

                 (265)

 

               2,812

 

               1,952

 

Braskem Petroquímica

                                     100.00

 

             61,170

 

             57,669

 

 

 

        2,081,901

 

Cetrel

                                       63.66

 

                 (916)

   

           505,066

 
 

DAC

                                       63.66

 

               4,875

   

             76,971

 
 

Lantana

                                     100.00

 

                   (13)

 

                  173

 

                 (888)

 

                 (874)

   

 

 

Jointly-controlled investment

 

 
 

RPR

                                       33.20

 

           106,109

 

             86,682

 

           201,038

 

           175,896

 

Odebrecht Comercializadora de Energia S.A. ("OCE")

                                       20.00

 

                 (543)

 

              (5,720)

 

               5,178

 

               5,721

   

Associates

#

 

Borealis

#

                                       20.00

 

             17,752

 

             10,538

 

           166,630

 

           162,629

 

 

 

38


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

(b)               Changes in investments – Parent Company

 

 

 

           

Goodwill on the acquisition of investment with common control

                                   
               

Capital increase (decrease)

 

Dividends and interest on equity

 

Equity in results of investees

     

Provision for losses/ other

 

Equity valuation adjustments

 

Currency translation adjustments

   
 

Balance at 2016

 

Incorporations effects

 

Acquisition of shares

       

Effect of results

 

Adjustment of profit in inventories

 

Goodwill amortization

       

Balance at 2017

                         

Subsidiaries and jointly-controlled investment

                                                 
                                                   
                                                   

Domestic subsidiaries

                                                 

Cetrel

 

610,000

 

(488,388)

   

(583)

   

121,029

Braskem Petroquímica

2,131,629

 

(2,133,791)

   

(38,280)

 

61,169

 

5,061

 

(25,788)

 

RPR

58,405

   

(30,960)

 

35,230

   

4,078

 

 

 

66,753

OCE

1,145

 

 

 

 

 

 

 

 

 

 

 

(109)

 

 

 

 

 

 

 

 

 

 

 

1,036

 

2,191,179

 

(2,133,791)

 

610,000

 

(488,388)

 

 

 

(69,240)

 

95,707

 

5,061

 

(25,788)

 

 

 

4,078

 

 

 

188,818

                                                   

Foreign subsidiaries

                                                 

Braskem Alemanha

162,901

   

60,545

 

302

   

(210)

 

6,832

 

230,370

Braskem Argentina

21,385

   

10,844

 

(3,755)

     

28,474

Braskem Austria

4,169

   

(322)

       

612

 

4,459

Braskem Chile

14,685

   

4,382

       

 

 

19,067

Braskem Holanda

1,248,185

   

2,291,436

 

49,600

   

361,935

 

32,704

 

3,983,860

Braskem Inc.

283,909

   

(40,349)

       

243,560

Braskem México

173,589

   

(1,291)

     

 

 

11,297

 

183,595

 

1,908,823

 

 

 

 

 

 

 

 

 

 

 

  2,325,245

 

46,147

 

 

 

 

 

361,725

 

51,445

 

  4,693,385

                                                   
 

4,100,002

 

(2,133,791)

 

610,000

 

(488,388)

 

 

 

(69,240)

 

  2,420,952

 

51,208

 

(25,788)

 

 

 

365,803

 

51,445

 

4,882,203

                                                   

Associates

32,527

 

81

   

511

 

(3,793)

 

4,591

   

(511)

   

33,406

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   

Total

4,132,529

 

(2,133,710)

 

610,000

 

(488,388)

 

511

 

(73,033)

 

2,425,543

 

51,208

 

(25,788)

 

(511)

 

365,803

 

51,445

 

4,915,609

 

 
 

39


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

(c)               Equity accounting results

 

   

 

 

Consolidated

 

 

 

Parent company

   

2017

 

2016

 

2017

 

2016

                 

Equity in results of subsidiaries, associate and jointly-controlled

 

                39,779

 

                29,738

 

           2,476,751

 

              972,322

Result with discontinued operations

   

 

 

              (30,958)

Amortization of fair value adjustment

   

              (25,788)

 

              (30,816)

Provision for losses on investments

   

                (9,144)

 

                44,647

Dividends received

 

                     177

 

                     340

 

                     177

 

                     340

   

              39,956

 

              30,078

 

         2,441,996

 

            955,535

 

 

 

 

40


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

(d)               Impact on the consolidation of Braskem Idesa

 

In compliance with IFRS 12 and CPC 45, the Company is presenting the financial statements of the subsidiary in which the non-controlling shareholder holds interest, with material effects on the Company’s consolidated statements.

 

 Balance sheet

 

 Consolidated Braskem

           
     

 without the effect of
Braskem Idesa consolidated

 

 Braskem Idesa consolidated  (i)

 

 Eliminations

 

 Consolidated

     

2017

 

2016

 

2017

 

2016

 

2017

 

2016

 

2017

2016

Assets

   

 

 

 

     

 

   

Curent

                 
 

Cash and cash equivalents

 

         3,480,407

         6,500,265

          294,686

             201,600

       3,775,093

       6,701,865

 

Financial investments

 

         2,302,672

         1,190,483

       2,302,672

       1,190,483

 

Trade accounts receivable

 

         2,809,034

         1,455,893

          620,531

             247,465

       (148,369)

         (69,221)

       3,281,196

       1,634,137

 

Inventories

 

         6,500,198

         4,862,571

          346,725

             375,443

       6,846,923

       5,238,014

 

Taxes recoverable

 

         1,286,035

         1,240,662

            63,029

             115,033

       1,349,064

       1,355,695

 

Other receivables

 

            392,750

            278,865

            44,630

               27,169

 

 

          437,380

          306,034

     

    16,771,096

    15,528,739

    1,369,601

           966,710

     (148,369)

       (69,221)

  17,992,328

  16,426,228

Non-current assets held for sale

 

 

            359,704

 

 

 

 

 

          359,704

     

    16,771,096

    15,888,443

    1,369,601

           966,710

     (148,369)

       (69,221)

  17,992,328

  16,785,932

                     

Non-current

                 
 

Taxes recoverable

 

         1,023,581

         1,088,304

                   52

                      49

       1,023,633

       1,088,353

 

Deferred tax

 

            129,469

            189,613

       1,036,257

          1,463,502

       1,165,726

       1,653,115

 

Related parties

 

         5,051,706

         4,690,672

(ii)

    (5,051,706)

    (4,690,672)

 

Other receivables

 

            637,549

            648,511

            33,207

               29,823

 

          670,756

          678,334

 

Property, plant and equipment

 

       19,180,263

       18,814,175

     11,228,346

        11,171,400

(iii)

       (646,999)

       (648,865)

     29,761,610

     29,336,710

 

Intangible

 

         2,575,567

         2,667,708

          151,930

             141,379

 

 

       2,727,497

       2,809,087

     

    28,598,135

    28,098,983

  12,449,792

      12,806,153

  (5,698,705)

  (5,339,537)

  35,349,222

  35,565,599

Total assets

 

    45,369,231

    43,987,426

  13,819,393

      13,772,863

  (5,847,074)

  (5,408,758)

  53,341,550

  52,351,531

                     

Liabilities and shareholders' equity

                 

Current

                 
 

Trade payables

 

         5,254,167

         6,335,452

          159,872

             278,905

       (148,369)

         (69,221)

       5,265,670

       6,545,136

 

Borrowings

 

         1,184,781

         2,594,463

       1,184,781

       2,594,463

 

Debentures

 

              27,183

            27,183

 

 

Braskem Idesa Borrowings

 

       9,691,450

        10,437,791

       9,691,450

     10,437,791

 

Payroll and related charges

 

            609,883

            540,405

            20,634

               22,050

          630,517

          562,455

 

Taxes payable

 

         1,248,137

         1,140,911

            13,067

               12,849

       1,261,204

       1,153,760

 

Other payables

 

         1,019,346

         2,053,031

            57,581

             125,955

 

 

       1,076,927

       2,178,986

     

      9,343,497

    12,664,262

    9,942,604

      10,877,550

     (148,369)

       (69,221)

  19,137,732

  23,472,591

Non-current liabilities held for sale

 

 

              95,396

 

 

 

 

 

            95,396

     

      9,343,497

    12,759,658

    9,942,604

      10,877,550

     (148,369)

       (69,221)

  19,137,732

  23,567,987

     
     

Non-current

 
 

Loan agreements

 

       22,176,640

       20,736,604

     22,176,640

     20,736,604

 

Braskem Idesa Borrowings

 

            286,141

          286,141

 

 

Accounts payable to related parties

 

       5,065,971

          4,698,881

(ii)

    (5,065,971)

    (4,698,881)

 

Non-controlling loan in Braskem Idesa

 

(v)

       1,756,600

          1,620,519

 

 

 

       1,756,600

       1,620,519

 

Provision for losses on subsidiaries

 

         2,689,769

         3,053,637

 

 

(iv)

    (2,689,769)

    (3,053,637)

 

 

 

Other payables

 

         4,286,245

         4,698,937

              7,842

                 6,774

 

 

 

       4,294,087

       4,705,711

     

    29,438,795

    28,489,178

    6,830,413

        6,326,174

  (7,755,740)

  (7,752,518)

  28,513,468

  27,062,834

Shareholders' equity

                 
 

Attributable to the  Company's shareholders

         6,517,850

         2,738,590

     (2,953,624)

         (3,430,861)

      2,953,625

      3,430,861

       6,517,851

       2,738,590

 

Non-controlling interest in Braskem Idesa

 

              69,089

 

 

 

       (896,590)

    (1,017,880)

        (827,501)

     (1,017,880)

     

      6,586,939

      2,738,590

   (2,953,624)

      (3,430,861)

   2,057,035

   2,412,981

    5,690,350

    1,720,710

Total liabilities and shareholders' equity

   

    45,369,231

 

    43,987,426

 

  13,819,393

 

      13,772,863

 

  (5,847,074)

 

  (5,408,758)

 

  53,341,550

 

  52,351,531

 
(i)   

Consolidation of Braskem Idesa with its direct subsidiary Braskem Idesa Serviços.

(ii)

Loan from Braskem Holanda as part of shareholders’ contribution to the Braskem Idesa project.

(iii)

Adjustment corresponding to the capitalization of a portion of financial charges of the abovementioned loan.

(iv)

Provision recorded in the subsidiary Braskem Holanda for the negative shareholders' equity of Braskem Idesa.

(v)

Loan owed to the non-controlling shareholder as part of shareholders’ contribution to the project.

41


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

 

Statement of operations

                               
     

 Consolidated Braskem

           
     

 Ex consolidated  Braskem Idesa

 

 Braskem Idesa consolidated

 

 Eliminations

 

 Consolidated

     

2017

 

2016

 

2017

 

2016

 

2017

 

2016

 

2017

 

2016

         

Adjusted

     

Adjusted

             

Adjusted

Net sales revenue

 

      46,207,109

 

  46,343,171

 

    3,656,801

 

    1,495,018

 

  (603,316)

 

  (174,201)

 

  49,260,594

 

  47,663,988

 

Cost of products sold

 

       (34,898,834)

 

   (34,040,770)

 

     (2,125,031)

 

     (1,109,020)

 

     623,117

 

     164,221

 

   (36,400,748)

 

   (34,985,569)

                                   
     

      11,308,275

 

  12,302,401

 

    1,531,770

 

        385,998

 

      19,801

 

      (9,980)

 

  12,859,846

 

  12,678,419

                                   

Income (expenses)

                               
 

Selling and distribution

 

         (1,287,817)

 

     (1,286,558)

 

        (171,791)

 

        (117,115)

 

                

 

                

 

     (1,459,608)

 

     (1,403,673)

 

General and administrative

 

         (1,336,072)

 

     (1,201,489)

 

        (122,043)

 

        (123,855)

 

       23,843

 

       39,731

 

     (1,434,272)

 

     (1,285,613)

 

Research and development

 

            (167,456)

 

        (162,010)

 

                    

 

                    

 

                

 

                

 

        (167,456)

 

        (162,010)

 

Results from equity investments

 

              191,949

 

        (923,096)

 

                    

 

                    

 

    (151,993)

 

     953,174

 

            39,956

 

            30,078

 

Other income (expenses), net

 

            (511,709)

 

     (3,913,567)

 

            32,305

 

              7,613

 

                

 

                

 

        (479,404)

 

     (3,905,954)

                                   
     

         8,197,170

 

    4,815,681

 

    1,270,241

 

        152,641

 

  (108,349)

 

   982,925

 

    9,359,062

 

    5,951,247

                                   

Financial results

                               
 

Financial expenses

 

         (3,044,668)

 

     (3,054,334)

 

        (973,952)

 

        (688,868)

 

     271,403

 

     172,240

 

     (3,747,217)

 

     (3,570,962)

 

Financial income

 

              850,367

 

          955,423

 

            24,666

 

              3,193

 

    (271,403)

 

    (268,494)

 

          603,630

 

          690,122

 

Exchange rate variations, net

 

            (936,804)

 

     (2,115,993)

 

          132,186

 

     (1,094,424)

 

         5,856

 

                

 

        (798,762)

 

     (3,210,417)

                                   
     

       (3,131,105)

 

   (4,214,904)

 

      (817,100)

 

   (1,780,099)

 

        5,856

 

    (96,254)

 

   (3,942,349)

 

   (6,091,257)

                                   

Profit (loss) before income tax

                               

    and social contribution

 

         5,066,065

 

        600,777

 

        453,141

 

   (1,627,458)

 

  (102,493)

 

   886,671

 

    5,416,713

 

      (140,010)

                                   
 

IR and CSL - current and deferred

 

            (992,285)

 

     (1,039,107)

 

        (299,983)

 

          423,061

 

                

 

                

 

     (1,292,268)

 

        (616,046)

     

          (992,285)

 

   (1,039,107)

 

      (299,983)

 

        423,061

 

                

 

                

 

   (1,292,268)

 

      (616,046)

                                   

Profit (loss) for the year of continued operations

 

         4,073,780

 

      (438,330)

 

        153,158

 

   (1,204,397)

 

  (102,493)

 

   886,671

 

    4,124,445

 

      (756,056)

                                   

Discontinued operations results

                               
 

Profit (loss) from discontinued operations

 

                13,499

 

            40,760

 

                    

 

                    

 

                

 

                

 

            13,499

 

            40,760

 

IR and CSL - current and deferred

 

                (4,623)

 

          (13,901)

 

                    

 

                    

 

                

 

                

 

            (4,623)

 

          (13,901)

     

                  8,876

 

            26,859

 

                    

 

                    

 

                

 

                

 

              8,876

 

            26,859

                                   

Profit (loss) for the year

 

         4,082,656

 

      (411,471)

 

        153,158

 

   (1,204,397)

 

  (102,493)

 

   886,671

 

    4,133,321

 

      (729,197)

 

 

42

 


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

 Statement of cash flows

 

 Consolidated Braskem

                       
     

 Ex consolidated  Braskem Idesa

 

 Braskem Idesa consolidated

 

 Eliminations

 

 Consolidated

     

2017

 

2016

 

2017

 

2016

 

2017

 

2016

 

2017

 

2016

                                 

Restated

Profit (loss) before income tax and social contribution and
  for the result with discontinued operations

 

       5,066,065

 

              641,537

 

         453,141

 

    (1,627,458)

 

    (102,493)

 

     886,671

 

       5,416,713

 

         (99,250)

     

Adjustments for reconciliation of profit (loss)

 
 

Depreciation, amortization and depletion

 

       2,230,466

 

           2,381,160

 

         742,033

 

         331,691

 

      (43,644)

 

      (29,751)

 

       2,928,855

 

      2,683,100

 

Results from equity investments

 

        (191,949)

 

              923,096

   

     151,993

 

    (953,174)

 

          (39,956)

 

         (30,078)

 

Interest and  monetary and exchange variations, net

 

       2,900,745

 

           1,851,033

 

         802,825

 

      1,229,219

 

        (5,856)

 

      (54,244)

 

       3,697,714

 

      3,026,008

 

Gain on sale of investment in subsidiary

 

        (276,816)

   

        (276,816)

 

 

 

Leniency agreement

 

 

 

           2,853,230

   

      2,853,230

 

Provision for losses and write-offs of long-lived assets

 

          212,759

 

                40,530

 

                425

 

                486

 

 

 

 

 

          213,184

 

           41,016

     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     

    9,941,270

 

        8,690,586

 

   1,998,424

 

       (66,062)

 

 

 

  (150,498)

 

  11,939,694

 

   8,474,026

                                   

Changes in operating working capital

 
 

Financial investments in time deposit

 

 

 

            (427,688)

   

       (427,688)

 

Trade accounts receivable

 

     (1,304,474)

 

           1,083,117

 

       (373,066)

 

       (126,617)

 

       79,148

 

       51,375

 

     (1,598,392)

 

      1,007,875

 

Inventories

 

     (1,594,570)

 

              966,974

 

           36,668

 

       (104,636)

   

     (1,557,902)

 

         862,338

 

Taxes recoverable

 

          417,992

 

              976,770

 

           53,370

 

           81,334

   

          471,362

 

      1,058,104

 

Prepaid expenses

 

          (21,732)

 

                64,029

 

           (8,789)

 

 

   

          (30,521)

 

           64,029

 

Other receivables

 

            34,500

 

              332,673

 

           (8,698)

 

           21,308

   

            25,802

 

         353,981

 

Trade payables

 

     (1,237,594)

 

         (4,052,705)

 

       (119,033)

 

       (150,495)

 

      (79,148)

 

      (51,375)

 

     (1,435,775)

 

    (4,254,575)

 

Taxes payable

 

        (134,766)

 

            (674,466)

 

         (82,817)

 

         382,335

   

        (217,583)

 

       (292,131)

 

Advances from customers

 

            (3,089)

 

              207,020

 

         (10,423)

 

             9,830

   

          (13,512)

 

         216,850

 

Leniency agreement

 

     (1,343,803)

   

     (1,343,803)

 

 

 

Other payables

 

          124,050

 

              430,714

 

         126,087

 

         165,981

 

 

 

 

 

          250,137

 

         596,695

     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash from operations

 

    4,877,784

 

        7,597,024

 

   1,611,723

 

       212,978

 

 

 

  (150,498)

 

    6,489,507

 

   7,659,504

                                   
 

Financial investments
(includes Letras financeiras do tesouro - LFT´s
and Letras Financeiras - LF´s)

 

        (953,228)

 

            (221,847)

 

 

 

 

 

 

 

 

 

        (953,228)

 

       (221,847)

                                   
 

Cash generated from operations and
    handling of financial investments

 

    3,924,556

 

        7,375,177

 

   1,611,723

 

       212,978

 

 

 

  (150,498)

 

    5,536,279

 

   7,437,657

                                   
 

Interest paid

 

     (1,648,971)

 

         (1,611,718)

 

       (505,082)

 

       (215,224)

   

     (2,154,053)

 

    (1,826,942)

 

Income tax and social contribution paid

 

        (919,236)

 

         (1,152,847)

 

           (1,370)

 

 

 

 

 

 

 

        (920,606)

 

    (1,152,847)

                                   

Net cash generated by operating activities

 

    1,356,349

 

        4,610,612

 

   1,105,271

 

          (2,246)

 

 

 

  (150,498)

 

    2,461,620

 

   4,457,868

                                   

Proceeds from the sale of fixed assets

 

          450,000

   

          450,000

 

Acquisitions to property, plant and equipment

 

        (608,181)

   

        (608,181)

 

Acquisitions of intangible assets

 

     (2,185,567)

 

         (1,844,510)

 

         (87,630)

 

       (892,499)

 

 

 

     150,498

 

     (2,273,197)

 

    (2,586,511)

Other

 

            24,977

 

                34,061

 

 

 

 

 

 

 

 

 

            24,977

 

           34,061

     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net cash used in investing activities

 

   (2,318,771)

 

       (1,810,449)

 

       (87,630)

 

     (892,499)

 

 

 

   150,498

 

   (2,406,401)

 

  (2,552,450)

                                   

Short-term and long-term debt

                 
 

Obtained

 

       8,492,341

 

           4,107,626

   

       8,492,341

 

      4,107,626

 

Payments

 

     (8,779,091)

 

         (4,901,593)

   

     (8,779,091)

 

    (4,901,593)

Derivative transactions - payments

 

        (810,279)

   

        (810,279)

 

 

Braskem Idesa borrowings

           
 

Obtained

   

         187,959

 

         503,921

   

          187,959

 

         503,921

 

Payments

   

    (1,080,502)

 

       (469,282)

   

     (1,080,502)

 

       (469,282)

Related parties

                   
 

Obtained loans (payment of loans )

 

            20,637

 

            (882,158)

 

         (20,637)

 

         882,158

   

Dividends paid

 

        (998,893)

 

         (1,997,984)

 

 

 

 

 

 

 

 

 

        (998,893)

 

    (1,997,984)

     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net provided (used) in financing activities

 

   (2,075,285)

 

       (3,674,109)

 

     (913,180)

 

       916,797

 

 

 

 

 

   (2,988,465)

 

  (2,757,312)

                                   

Exchange variation on cash of foreign subsidiaries

 

            17,849

 

              541,734

 

         (11,374)

 

           44,908

 

 

 

 

 

              6,475

 

         586,642

     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Increase (decrease) in cash and cash equivalents

 

   (3,019,858)

 

          (332,212)

 

         93,087

 

         66,960

 

 

 

 

 

   (2,926,771)

 

     (265,252)

                                   

Represented by

                               
 

Cash and cash equivalents at the beginning for the year

 

       6,500,265

 

           6,908,623

 

         201,599

 

         134,639

   

       6,701,864

 

      7,043,262

 

Cash and cash equivalents at the end for the year

 

       3,480,407

 

           6,576,411

 

         294,686

 

         201,599

 

 

 

 

 

       3,775,093

 

      6,778,010

     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Increase (decrease) in cash and cash equivalents

 

   (3,019,858)

 

          (332,212)

 

         93,087

 

         66,960

 

 

 

 

 

   (2,926,771)

 

     (265,252)

 

43


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

13                Property, plant and equipment

 

(a)               Change

 

     

 Consolidated

     

 Land

 

 Buildings and Improvements

 

 Machinery, Equipment and Facilities

 

 Projects and Stoppage in Progress (i)

 

 Other

 

 Total

                         

 

 Cost  

  471,655

 

           5,530,714

 

         36,804,409

 

           3,495,965

 

           1,404,759

 

         47,707,502

 

 Accumulated depreciation/depletion  

 

 

(1,111,642)

 

(16,595,497)

 

 

 

(663,653)

 

(18,370,792)

Balance as of December 31, 2016

 

  471,655

 

           4,419,072

 

         20,208,912

 

           3,495,965

 

              741,106

 

         29,336,710

                         

Acquisitions

 

 

 

 

 

              149,018

 

           2,090,157

 

                  6,066

 

           2,245,241

Additions for acquisition of subsidiary

 

    14,937

 

              122,846

 

                63,081

 

                46,833

 

                92,052

 

              339,749

Capitalized financial charges

 

 

 

 

 

 

 

              130,272

 

 

 

              130,272

Foreign currency translation adjustment

 

      5,600

 

              168,554

 

              387,757

 

                56,425

 

                  4,877

 

              623,213

Transfers by concluded projects

 

(ii)

    29,703

 

              145,622

 

           2,216,704

 

(2,539,041)

 

              147,012

 

 

Other, net of depreciation/depletion

 

(21,249)

 

(5,149)

 

(166,585)

 

(5,946)

 

(12,342)

 

(211,271)

Depreciation / depletion

 

 

 

(280,448)

 

(2,275,788)

 

 

 

(146,068)

 

(2,702,304)

Net book value

 

  500,646

 

           4,570,497

 

         20,583,099

 

           3,274,665

 

              832,703

 

         29,761,610

 

 Cost  

  500,646

 

           6,058,259

 

         39,211,042

 

           3,274,665

 

           1,755,092

 

         50,799,704

 

 Accumulated depreciation/depletion  

 

 

(1,487,762)

 

(18,627,943)

 

 

 

(922,389)

 

(21,038,094)

Balance as of December 31, 2017

 

  500,646

 

           4,570,497

 

         20,583,099

 

           3,274,665

 

              832,703

 

         29,761,610

 

(i)   

On December 31, 2017, the main amounts recorded under this item corresponded to expenses with scheduled maintenance shutdowns in Brazil and at overseas plants that are either in the preparation phase or ongoing (R$578,920), capitalized financial charges (R$174,333), inventories of spare parts (R$441,262), strategic projects in Brazil (R$436,460), which include the processing of ethane at UNIB BA and the strategic projects of Braskem America (R$552,727), such as the construction of the new unit of polypropylene production in the United States (Note 1(a.iii)). The remainder corresponds mainly to various projects for maintaining the production capacity of plants.

(ii)

Related mainly to expenses incurred by the Parent Company, which were transferred to “Machinery, equipment and facilities” (R$1,592,844).

 
   

 Parent Company

   

 Land

 

 Buildings and Improvements

 

 Machinery, Equipment and Facilities

 

 Projects and Stoppage in Progress

 

 Other

 

 Total

                         

 

Cost  

              292,509

 

           1,734,953

 

         26,981,068

 

           2,822,457

 

              993,980

 

         32,824,967

 

Accumulated depreciation/depletion  

 

 

(936,866)

 

(15,323,570)

 

 

 

(601,404)

 

(16,861,840)

Balance as of December 31, 2016

 

              292,509

 

              798,087

 

         11,657,498

 

           2,822,457

 

              392,576

 

         15,963,127

                         

Acquisitions

 

 

 

 

 

              141,029

 

           1,216,852

 

(3,484)

 

           1,354,397

Additions through merger of Braskem Petroquímica

 

                77,680

 

              108,310

 

              638,750

 

                67,351

 

                33,288

 

              925,379

Capitalized financial charges

   

 

 

 

 

                99,017

 

 

 

                99,017

Transfers by concluded projects

   

                  6,097

 

           1,592,844

 

(1,687,530)

 

                88,589

 

 

Other, net of depreciation/depletion

 

(18,048)

 

 

 

(157,056)

 

(2,152)

 

(3,886)

 

(181,142)

Depreciation / depletion

 

 

 

(56,172)

 

(1,669,905)

 

 

 

(108,485)

 

(1,834,562)

Net book value

 

              352,141

 

              856,322

 

         12,203,160

 

           2,515,995

 

              398,598

 

         16,326,216

 

Cost  

              352,141

 

           1,926,834

 

         29,887,613

 

           2,515,995

 

           1,158,743

 

         35,841,326

 

Accumulated depreciation/depletion  

 

 

(1,070,512)

 

(17,684,453)

 

 

 

(760,145)

 

(19,515,110)

Balance as of December 31, 2017

 

              352,141

 

              856,322

 

         12,203,160

 

           2,515,995

 

              398,598

 

         16,326,216

 

The machinery, equipment and facilities of the Company require inspections, replacement of components and maintenance in regular intervals. The Company makes shutdowns in regular intervals that vary from two to six years to perform these activities. These shutdowns can involve the plant as a whole, a part of it, or even relevant pieces of equipment, such as industrial boilers, turbines and tanks. Shutdowns that take place every six years, for example, are usually made for the maintenance of industrial plants as a whole. Expenses with each scheduled shutdown are included in property, plant and equipment items that were the subject matter of the stoppage and are fully depreciated until the beginning of the following related stoppage. The expenditures with personnel, the consumption of small materials, maintenance and the related services from third parties are recorded, when incurred, as production costs. Property, plant and equipment items are depreciated on a straight-line basis. Projects in progress are not depreciated. Depreciation begins when the assets are available for use.

44


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

 

Based on the analysis cited in Note 3.4(a), the Management of Braskem believes that the plants will operate at their full capacity, or close to it, within the projected period, therefore impairment tests of these assets were not necessary. The prices of products manufactured by the Company are quoted in international markets, in the short or medium term, and adjust to the prices of raw materials to preserve the historical margins of the business.

 

The financial charges are capitalized on the balance of the projects in progress using (i) an average rate of all borrowings; and (ii) the portion of the foreign exchange variation that corresponds to a possible difference between the average rate of financing in the internal market and the rate mentioned in item (i) above.

 

In 2017, charges amounting to R$130,272 (R$367,780 in 2016) were capitalized. The average rate of these charges in the year was 7.78% p.a. (8.120% p.a. in 2016).

 

(b)               Property, plant and equipment by country

 

 

 2017

 

 2016

       

Brazil

             16,665,988

 

             16,939,745

Mexico

             10,581,347

 

             10,522,536

United States of America

               2,275,987

 

               1,668,399

Germany

                  229,328

 

                  205,650

Other

                      8,960

 

                         380

 

           29,761,610

 

           29,336,710

 

14                Intangible assets

 

                       

Parent

   

 Consolidated

 

Company

   

 Goodwill

                   
   

 based on

         

 Customers

       
   

 expected future

 

 Brands

 

 Software 

 

and Suppliers

       
   

 profitability

 

 and Patents

 

 licenses

 

 Agreements

 

 Total

 

 Total

  Cost

 

3,187,722

 

339,512

 

566,673

 

772,888

 

4,866,795

 

4,179,855

  Accumulated amortization

(1,128,848)

 

(110,880)

 

(364,336)

 

(453,644)

 

(2,057,708)

 

(1,658,612)

Balance as of December 31, 2016

2,058,874

 

228,632

 

202,337

 

319,244

 

2,809,087

 

2,521,243

                       

Acquisitions

 

                  340

 

                  27,319

 

                    297

 

       27,956

 

                  25,150

Additions through merger of Braskem Petroquímica

   

6,787

Additions through acquisition on subsidiary

 

                    1,316

 

                    402

 

         1,718

 

Foreign currency translation adjustment

 

8,357

 

4,759

 

(932)

 

12,184

 

Other, net of amortization

 

               1,107

 

(124)

 

 

 

            983

 

(2,818)

Amortization

 

 

(8,349)

 

(43,467)

 

(72,615)

 

(124,431)

 

(48,859)

Net book value

            2,058,874

 

           230,087

 

                192,140

 

             246,396

 

  2,727,497

 

             2,501,503

  Cost

            3,187,722

 

           349,316

 

                607,528

 

             772,253

 

  4,916,819

 

             4,333,979

  Accumulated amortization

(1,128,848)

 

(119,229)

 

(415,388)

 

(525,857)

 

(2,189,322)

 

(1,832,476)

Balance as of December 31, 2017

            2,058,874

 

           230,087

 

                192,140

 

             246,396

 

  2,727,497

 

             2,501,503

                       

Average annual rates of amortization

   

5.89%

 

11.91%

 

6.00%

       

 

 

 

45


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

The Company adopts the following accounting practice for each class of intangible assets:

 

(a)               Goodwill based on future profitability

 

The existing goodwill was determined in accordance with the criteria established by the accounting practices adopted in Brazil before the adoption of the CPC and IASB pronouncements and represent the excess of the amount paid over the amount of equity of the acquired companies. Such goodwill was systematically amortized until December 2008. As from 2009, it has been subject to annual impairment tests. In October 2017, Braskem conducted an impairment test of the goodwill using the value in use method (discounted cash flow) and did not identify any loss, as shown in the table below:

 

                 
   

 

 

 

 

 

 

 Consolidated

           

 Book value

   
   

 Allocated

 

 Cash flow

 

 (with goodwill

   
   

 goodwill

 

 (CF)

 

 and work capital)

 

 CF/Book value

CGU and operating segments

               

CGU - UNIB - South

 

                       926,854

 

                  11,970,190

 

                    2,912,030

 

                               4.1

Operating segment - Polyolefins

 

                       939,667

 

                  26,654,836

 

                    7,766,269

 

                               3.4

Operating segment - Vinyls

 

                       192,353

 

                    5,091,859

 

                    2,895,428

 

                               1.8

 

(i)   

The carrying amount includes, in addition to goodwill, long-lived assets and working capital from each operating segment.

 

The assumptions adopted to determine the discounted cash flow are described in Note 3.4(b). The WACC used was 12.33% p.a. The inflation rate considered for perpetuity was 4.1%.

 

Given the potential impact on cash flows of the “discount rate” and “perpetuity”, Braskem conducted a sensitivity analysis based on changes in these variables, with cash flows shown in the table below:

 

           

 

 

 Consolidated

           

+0.5% on

 

-0.5% on

           

 discount rate

 

perpetuity

CGU and operating segments

               

CGU - UNIB - South

         

                  11,327,443

 

                  11,485,194

Operating segment - Polyolefins

         

                  25,042,032

 

                  25,405,611

Operating segment - Vinyls

         

                    4,808,622

 

                    4,877,875

 

The main assumptions used for projecting cash flows are related to the projection of macroeconomic indicators, international prices, global and local demand in the countries where Braskem has operational production plants.

 

Macroeconomic indicators are provided by a widely recognized consulting firm and include items such as: exchange, inflation and interest rates, among others.

 

Prices for key petrochemical products are obtained from projections made by an international consulting firm. However, final prices take into consideration meetings of specific internal committees and the knowledge of the Company’s experts in preparing the benchmarks for each market. In most cases, for the projected period, the internally projected prices were more conservative than those originally projected by the international consulting firm.

46


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

Similar to for prices, global demand also is contracted from a specific consulting firm and, in the markets where the Company operates more directly, they consider additional variables for the composition of local demand.

 

In the Vinyls segment, whose main product is PVC, the projected cash flow exceeded the book value of assets by 76%.  The main variables impacting this business are related to fluctuations in the exchange rate, international spreads (especially those related to the prices of naphtha, PVC and Caustic Soda) and Brazilian demand. Effective deviations of these important variables from the Company’s projections could lead to cash flows being lower than the value of the assets.

 

(b)               Intangible assets with defined useful lives

 

(b.1)    Trademarks and patents

 

The technologies acquired from third parties, including those acquired through business combination, are recorded at the cost of acquisition and/or fair value and other directly attributed costs, net of accumulated amortization and provision for impairment, when applicable. Technologies that have defined useful lives and are amortized using the straight-line method based on the term of the purchase agreement (between 10 and 20 years). Expenditures with research and development are accounted for in profit or loss as they are incurred.

 

(b.2)    Contractual customer and supplier relationships

Contractual customer and supplier relationships arising from a business combination were recognized at fair value at the respective acquisition dates. These contractual customer and supplier relationships have a finite useful life and are amortized using the straight-line method over the term of the respective purchase or sale agreement (between 14 and 28 years).

 

(b.3)    Software

All software booked has defined useful life estimated between 3 and 10 years and is amortized using the straight-line method. Costs associated with maintaining computer software programs are recognized in profit or loss as incurred.

 

(c)                Intangible assets by country

 

     

 2017

 

 2016

           

Brazil

   

2,502,231

 

2,526,371

Mexico

   

151,930

 

141,379

United States of America

   

47,357

 

115,355

Germany

   

25,948

 

25,956

Other

   

31

 

26

     

2,727,497

 

2,809,087

 

 

 

47


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

15                Borrowings

 

(a)               Borrowings

 

         

 

 

 Consolidated

     

Annual financial charges

 

2017

 

2016

Foreign currency

           
 

Bonds

 

Exchange variation + interest between 3.50 and 7.38

 

         20,082,588

 

         14,216,539

 

Advances on exchange contracts

 

US dollar exchange variation + 3.52%

 

 

 

              362,779

 

Export prepayment

 

Note 15 (d)

 

              781,573

 

              777,801

 

BNDES

 

Exchange variation + interest between 6.82 and 6.98

 

 

 

              201,147

 

Export credit notes

 

Exchange variation + interest between 7.30 and 7.87

 

              679,895

 

           1,173,127

 

Working capital

 

US dollar exchange variation + 1.88% above Libor

 

              883,181

 

           1,644,487

 

Transactions costs

     

            (285,657)

 

            (199,570)

         

      22,141,580

 

      18,176,310

               
 

Current liabilities

     

              985,639

 

           1,128,524

 

Non-current liabilities

     

         21,155,941

 

         17,047,786

 

Total

     

      22,141,580

 

      18,176,310

               

Local currency

           
 

Export credit notes

 

8.00

 

 

 

              381,632

 

Export credit notes

 

105.00 and 108.00 of CDI

(i)

              508,146

 

           1,717,262

 

BNDES

 

TJLP + interest between 0.00 and 2.62

 

                31,347

 

           1,527,765

 

BNDES

 

SELIC + 2.32

 

                22,039

 

              602,648

 

BNDES

 

Interest between 3.50 and 7.00

 

              132,020

 

              288,486

 

BNB/ FINEP/ FUNDES/FINISA/FINAME

 

6.17%

 

              486,227

 

              580,647

 

FINAME

 

TJLP + interest between 1.90 and 6.00

 

                  2,293

 

                  1,850

 

Fundo de Desenvolvimento do Nordeste (FDNE)

 

6.5%

 

                42,045

 

                46,991

 

Other

 

CDI + 0.04%

 

                     655

 

                19,321

 

Transactions costs

     

                (4,931)

 

              (11,845)

         

        1,219,841

 

        5,154,757

               
 

Current liabilities

     

              199,142

 

           1,465,939

 

Non-current liabilities

     

           1,020,699

 

           3,688,818

 

Total

     

        1,219,841

 

        5,154,757

               

Foreign currency and local currency

           
 

Current liabilities

     

           1,184,781

 

           2,594,463

 

Non-current liabilities

     

         22,176,640

 

         20,736,604

 

Total

     

      23,361,421

 

      23,331,067

               
         

 

 

 

         

2017

 

2016

Foreign currency

           
 

Current liabilities

     

              189,600

 

              651,471

 

Non-current liabilities

     

           1,813,113

 

           2,774,213

         

        2,002,713

 

        3,425,684

Local currency

           
 

Current liabilities

     

              192,704

 

           1,465,938

 

Non-current liabilities

     

           1,010,579

 

           3,688,819

         

        1,203,283

 

        5,154,757

               

Foreign currency and local currency

           

Current liabilities

     

              382,304

 

           2,117,409

Non-current liabilities

     

           2,823,692

 

           6,463,032

Total

     

        3,205,996

 

        8,580,441

 
(i)   

The Company enters into swap transactions to offset the variation in the Interbank Certificate of Deposit (CDI) rate (Note 19.3.1 (a.ii)).

48


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

(b)               Bonds

 

     

Issue amount

     

Interest

       

Issue date

 

 

US$

 

Maturity

 

(% per year)

 

2017

 

2016

September-2006

 

                        275,000

 

January-2017

 

                      8.00

 

 

 

          188,325

June-2008

 

                        500,000

 

June-2018

 

                      7.25

 

          440,274

 

          433,766

May-2010

 

                        400,000

 

May-2020

 

                      7.00

 

          159,341

 

          156,985

May-2010

 

                        350,000

 

May-2020

 

                      7.00

 

       1,169,732

 

       1,152,440

October-2010

 

                        450,000

 

no maturity date

 

                      7.38

 

       1,514,826

 

       1,492,434

April-2011

 

                        750,000

 

April-2021

 

                      5.75

 

       2,502,351

 

       2,465,361

July-2011

 

                        500,000

 

July-2041

 

                      7.13

 

       1,705,722

 

       1,680,507

February-2012

 

                        250,000

 

April-2021

 

                      5.75

 

          836,907

 

          824,535

February-2012

 

                        250,000

 

no maturity date

 

                      7.38

 

          841,570

 

          829,130

May-2012

 

                        500,000

 

May-2022

 

                      5.38

 

       1,668,323

 

       1,643,662

July-2012

 

                        250,000

 

July-2041

 

                      7.13

 

          852,861

 

          840,254

February-2014

 

(i)

                        500,000

 

February-2024

 

                      6.45

 

       1,697,859

 

       1,672,760

May-2014

 

(ii)

                        250,000

 

February-2024

 

                      6.45

 

          848,929

 

          836,380

October-2017

 

(iii)

                        500,000

 

January-2023

 

                      3.50

 

       1,667,025

   

October-2017

 

(iv)

                     1,250,000

 

January-2028

 

                      4.50

 

       4,176,868

   

Total

   

                   6,975,000

         

   20,082,588

 

   14,216,539

 

(i)   

Effective interest rate including transaction costs is 7.78% p.a.

(ii)

Effective interest rate including transaction costs is 7.31% p.a.

(iii)

Effective interest rate including transaction costs is 3.64% p.a.

(iv)

Effective interest rate including transaction costs is 4.65% p.a.

 

On October 4, 2017, Braskem issued US$1,750 million in Bonds (R$5,480 million), comprising US$500 million (R$1,566 million) due in January 2023 with interest of 3.5% p.a. and US$1,250 million (R$3,914 million) due in January 2028 with interest of 4.5% p.a. The issue due in 2023 was priced at 99.058% of face value, which represents a yield of 3.7% p.a., and the issue due in 2028 was priced at 98.995% of face value, which represents a yield of 4.625% p.a.

 

The transaction costs associated with the issuance of the Bonds in the amount of US$26 million (R$86 million) were initially recorded as a reduction of liabilities so that the debt amortization during the term of the contract is by its effective interest rate.

 

The proceeds from the issues were used to prepay other liabilities, to fund investments and for general purposes of the Company.

 

49


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

(c)                Prepayment of borrowings

 

With the proceeds from the issues of October 4, 2017, informed in item (b) above, Braskem prepaid borrowings, as follows:

 

Borrowings

 

     

Annual financial charges (%)

 

 Prepayments

Foreign currency

       
 

Advances on exchange contracts

 

US dollar exchange variation + 3.52%

 

                638,193

 

Export prepayment

 

Note 15 (e)

 

                215,145

 

Export credit notes

 

US dollar exchange variation + interest between 7.30 and 8.10

 

                507,866

 

Working capital

 

US dollar exchange variation + 1.74% above Libor

 

                516,101

         

           1,877,305

           
 

Current liabilities

     

              1,170,061

 

Non-current liabilities

     

                707,244

 

Total

     

           1,877,305

           

Local currency

       
 

Export credit notes

 

8.00

 

 

 

Export credit notes

 

105.00 e 112.50 of CDI

 

              1,028,333

 

BNDES

 

TJLP + interest between 0.00 and 3.58

 

              1,735,186

 

Other

 

CDI + 0.04

 

                  11,305

         

           2,774,824

           
 

Current liabilities

     

                139,796

 

Non-current liabilities

     

              2,635,028

 

Total

     

           2,774,824

           

Foreign currency and local currency

       
 

Current liabilities

     

              1,309,858

 

Non-current liabilities

     

              3,342,271

 

Total

     

           4,652,129

 

(d)               Export pre-payment

 

   

Initial amount

               
   

of the transaction

         

 Consolidated

Issue date

 

(US$ thousand)

 

Maturity

 

Charges (% per year)

 

2017

 

2016

January-2013

 

200,000

 

November-2022

 

US dollar exchange variation + semiannual Libor + 1.10

 

         331,701

 

         391,923

May-2016

 

50,000

 

May-2017

 

US dollar exchange variation + quarterly Libor + 3.25

   

         163,564

December-2016

 

68,000

 

November-2019

 

US dollar exchange variation + quarterly Libor + 2.60

   

         222,314

September-2017

 

135,000

 

March-2017

 

US dollar exchange variation + quarterly Libor + 1.61

 

         449,872

 

 

Total

 

453,000

         

       781,573

 

       777,801

 

 

50


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

(e)               Payment schedule

 

The maturity profile of the long-term amounts is as follows:

 

       

 

 

 Consolidated

       

2017

 

2016

             

2018

     

 

 

          2,379,757

2019

     

              1,245,895

 

          3,310,384

2020

     

              2,199,869

 

          2,442,493

2021

     

              3,655,465

 

          3,667,632

2022

     

              1,801,844

 

          1,745,936

2023

     

              1,709,587

 

               13,772

2024

     

              2,539,216

 

          2,461,086

2025

     

                   45,994

 

                 3,839

2026

     

                   44,239

 

                 1,391

2027

     

                   17,586

 

 

2028 and thereafter

     

              8,916,945

 

          4,710,314

Total

     

         22,176,640

 

     20,736,604

 

(f)                Guarantees

 

Braskem gave collateral for part of its borrowings as follows:

 

       

Total

 

Total

   

Loans

 

Maturity

 

debt 2017

 

guaranteed

 

Guarantees

                 

BNB

 

December-2022

 

             113,759

 

                113,759

 

 Mortgage of plants, pledge of machinery and equipment

BNB

 

August-2024

 

             187,794

 

                187,794

 

 Bank surety

BNDES

 

December-2021

 

             185,406

 

                185,406

 

 Mortgage of plants, land and property, pledge of machinery and equipment

FUNDES

 

June-2020

 

               79,882

 

                  79,882

 

 Mortgage of plants, land and property, pledge of machinery and equipment

FINEP

 

July-2024

 

               89,614

 

                  89,614

 

 Bank surety

FINEP

 

December-2019

 

                 6,806

 

                    6,806

 

 Bank surety, pledge of equipment and current account lockout (restricted fund).

FINAME

 

February-2022

 

                 4,175

 

                    4,175

 

 Pledge of equipment

FINISA

 

December-2023

 

                 6,490

 

                    6,490

 

 Bank surety

OTHER

 

July-2021

 

                    654

 

                       654

 

 Pledge of equipment

Total

     

           674,580

 

              674,580

   

 

 

 

51


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

16                Braskem Idesa Financing

 

   

Initial value

               
   

of operation

         

 

 

 Consolidated

Identification

 

US$

 

Maturity

 

Charges (% per year)

 

2017

 

2016

                     

Project finance

   

(i)

             

Project finance I

 

                700,000

 

February-2027

 

Us dollar exchange variation + quarterly Libor + 3.25

 

      2,179,981

 

      2,274,754

Project finance II

 

                189,996

 

February-2027

 

Us dollar exchange variation + 6.17

 

         621,140

 

         663,856

Project finance III

 

                600,000

 

February-2029

 

Us dollar exchange variation + 4.33

 

      1,827,811

 

      1,911,857

Project finance IV

 

                680,004

 

February-2029

 

Us dollar exchange variation + quarterly Libor + 3.88

 

      2,032,093

 

      2,111,234

Project finance V

 

                400,000

 

February-2029

 

Us dollar exchange variation + quarterly Libor + 4.65

 

      1,221,997

 

      1,276,449

Project finance VI

 

                  89,994

 

February-2029

 

Us dollar exchange variation + quarterly Libor + 2.73

 

         273,887

 

         286,480

Project finance VII

 

                533,095

 

February-2029

 

Us dollar exchange variation + quarterly Libor + 4.64

 

      1,627,479

 

      1,701,229

Transactions costs

 

 

         

         (92,938)

 

       (104,157)

Total

 

          3,193,089

         

    9,691,450

 

 10,121,702

                     
                     

Other borrowings

                   

VAT borrowings

   

(ii)

November-2029

 

2.00% above TIIE (*)

 

 

 

           13,500

Borrowings for working capital

(iii)

December-2017

 

Us dollar exchange variation + quarterly Libor + 2.30

 

 

 

         302,589

               

 

 

       316,089

                     
               

    9,691,450

 

 10,437,791

                     

Current liabilities

             

      9,691,450

 

    10,437,791

Total

             

    9,691,450

 

 10,437,791

 

(*)

TIIE – “Tasa de Interés Interbancaria de Equilibrio” – basic interest rate in Mexico, similar to the CDI overnight rate in Brazil.

   

(i)

Financing facility without recourse and with recourse limited to shareholders.

(ii)

Financing obtained in Mexican peso and paid exclusively through the refund of IVA, settled in January 2017.

 

In line with the Company’s Financial Policy, the investment in the construction of  the plant in Braskem Idesa is being financed under the Project finance mode, whereby the construction loan must be paid exclusively with the cash generated by the Braskem Idesa itself and shareholders must provide limited guarantees. Thus, this financing has the usual guarantees of this type of operation such as assets, receivables, cash generation and other rights from the Braskem Idesa.

 

Project Finance includes restrictive contractual clauses (covenants), customary in contracts of this nature.

 

At the reporting date as December 31, 2017, the company was in unremedied breach with regard to part of non-pecuniary obligations provided for in the contracts. As a result, the entire balance of non-current liabilities, in the amount of R$8,907,733, was reclassified to current liabilities, in accordance with CPC 26 and its corresponding accounting standard IAS 1 (Presentation of Financial Statements).

 

In accordance with the aforementioned accounting standards, reclassification is required in situations in which the breach of certain contractual obligations entitles creditors to request to Braskem Idesa the prepayment of obligations in the short term. In this context, note that none of the creditors requested said prepayment of obligations and that Braskem Idesa has been settling its debt service obligations in accordance with their original maturity schedule.

 

Furthermore, Braskem Idesa has been negotiating approval of such breaches with its creditors in order to reclassify the entire amount reclassified from current liabilities back to non-current liabilities.

 

52


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

The following amortization schedule presents the original long-term maturities, excluding the reclassification to current liabilities arising from the aforementioned breach of contractual obligations.

 

   

 Consolidated

   

2017

 

2016

         

2018

 

 

 

                     709,793

2019

 

                     748,071

 

                     736,885

2020

 

                     877,450

 

                     864,149

2021

 

                  1,002,270

 

                     986,914

2022

 

                     835,009

 

                     822,235

2023

 

                  1,105,295

 

                  1,088,155

2024

 

                  1,195,682

 

                  1,177,017

2025

 

                  1,195,096

 

                  1,176,346

2026

 

                  1,052,156

 

                  1,035,586

2027

 

                     474,438

 

                     466,270

2028 and thereafter

 

                     422,266

 

                     428,336

Total

 

               8,907,733

 

               9,491,686

 

17                Debentures

 

The balances of debentures come from the acquisition of Cetrel (Note 1(a.ii)).

 

Issue date

 

Series

 

Maturity

 

Annual financial charges (%)

 

2017

 

2016

March-2013

 

Single

 

March-2025

 

IPCA + 6%

 

                              216,968

   

September-2013

 

Single

 

September-2025

 

126,5% of CDI

 

                                96,356

   
               

                            313,324

 

 

                     

Current liabilities

             

                                27,183

   

Non-current liabilities

             

                              286,141

   

Total

             

                            313,324

 

 

 

(a)               Payment schedule

 

       

 

 

 Consolidated

       

2017

 

2016

             

2019

     

                   26,629

   

2020

     

                   43,674

   

2021

     

                   49,326

   

2022

     

                   49,326

   

2023

     

                   49,326

   

2024

     

                   49,326

   

2025

     

                   18,534

   

Total

     

               286,141

 

  

 

(b)               Guarantees

 

The Company entered into agreements for the fiduciary assignment of receivables, with the maintenance of restricted accounts, in accordance with the assignment agreements.

53


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

18                Changes in borrowings, debentures and Braskem Idesa borrowings

 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated

   

Balance at

 

Addition by

             

Interest, changes

 

Conversion of

     

Balance at

   

December 31,

 

acquisition of

     

Payments

 

monetary and

 

debts of subsidiaries

     

December 31,

   

2016

 

subsidiary

 

Obtained

 

Principal

 

Interest paid

 

foreign exchange, net

 

abroad

 

Transferences

 

2017

                                     

Borrowings

                                   

Current

 

            2,594,463

 

               6,749

 

    2,077,350

 

    (8,767,003)

 

    (1,648,971)

 

                       1,459,513

 

                              8,834

 

          5,453,846

 

            1,184,781

Non-current

 

          20,736,604

 

             11,736

 

    6,414,991

 

 

 

 

 

                          258,501

 

                          208,654

 

        (5,453,846)

 

          22,176,640

Total

 

       23,331,067

 

           18,485

 

  8,492,341

 

  (8,767,003)

 

  (1,648,971)

 

                     1,718,014

 

                        217,488

 

 

 

       23,361,421

                                     

Debentures

                                   

Current

 

 

 

             27,017

 

 

 

         (12,088)

 

 

 

                              5,307

 

 

 

                 6,947

 

                 27,183

Non-current

 

 

 

           290,943

 

 

 

 

 

 

 

                              2,145

 

 

 

               (6,947)

 

               286,141

Total

 

 

 

         317,960

 

 

 

       (12,088)

 

 

 

                             7,452

 

 

 

 

 

             313,324

                                     

 Total borrowings and debentures

                                   

Current

 

            2,594,463

 

             33,766

 

    2,077,350

 

    (8,779,091)

 

    (1,648,971)

 

                       1,464,820

 

                              8,834

 

          5,460,793

 

            1,211,964

Non-current

 

          20,736,604

 

           302,679

 

    6,414,991

 

 

 

 

 

                          260,646

 

                          208,654

 

        (5,460,793)

 

          22,462,781

Total

 

       23,331,067

 

         336,445

 

  8,492,341

 

  (8,779,091)

 

  (1,648,971)

 

                     1,725,466

 

                        217,488

 

 

 

       23,674,745

                                     

Braskem Idesa financing

                                   

Current

 

          10,437,791

 

 

 

       187,959

 

    (1,080,502)

 

       (505,082)

 

                            17,882

 

                          633,402

 

 

 

            9,691,450

Total

 

       10,437,791

 

 

 

     187,959

 

  (1,080,502)

 

     (505,082)

 

                          17,882

 

                        633,402

 

 

 

         9,691,450

                                     

Total geral

                                   

Current

 

          13,032,254

 

             33,766

 

    2,265,309

 

    (9,859,593)

 

    (2,154,053)

 

                       1,482,702

 

                          642,236

 

          5,460,793

 

          10,903,414

Non-current

 

          20,736,604

 

           302,679

 

    6,414,991

 

 

 

 

 

                          260,646

 

                          208,654

 

        (5,460,793)

 

          22,462,781

Total

 

       33,768,858

 

         336,445

 

  8,680,300

 

  (9,859,593)

 

  (2,154,053)

 

                     1,743,348

 

                        850,890

 

 

 

       33,366,195

 

19                Financial instruments

 

19.1          Fair Value

 

(a)               Fair value calculation

 

The fair value of financial assets and liabilities is estimated as the amount for which a financial instrument could be exchanged in an arm’s length transaction and not in a forced sale or settlement. The following methods and assumptions were used to estimate the fair value:

 

(i)

Held-for-trading and available-for-sale financial assets are measured in accordance with the fair value hierarchy (Level 1 and Level 2), with inputs used in the measurement processes obtained from sources that reflect the most recent observable market prices.

 

(ii)

Trade accounts receivable and trade payables correspond mostly to their respective carrying amounts due to the short-term maturity of these instruments. When purchase or sale prices include material financial charges, deferred is calculated.

 

(iii) 

The fair value of borrowings is estimated by discounting future contractual cash flows at the market interest rate, which is available to Braskem in similar financial instruments.

 

(iv)  

The fair value of bonds is based on prices negotiated in financial markets, plus the respective carrying amount of interests.

 

The fair values of the remaining assets and liabilities correspond to their carrying amount.

 

54


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

(b)               Fair value hierarchy

 

The Company adopts CPC 40 and IFRS 7 to measure the fair value of financial instruments recorded in the balance sheet; this requires disclosure in accordance with the following fair value measurement hierarchy:

Level 1 – fair value obtained through prices quoted (without adjustments) in active markets for identical assets or liabilities, such as the stock exchange; and

 

Level 2 – fair value obtained from financial models using directly observable market data, such as discounted cash flow, when the instrument is a forward purchase/sale or a swap contract, or such as the Black-Scholes model, when the instrument has the characteristics of an option.  To measure the credit risk of the parties involved in derivative instruments, Braskem uses CVA (Credit Valuation Adjustment) or DVA (Debt Valuation Adjustment) models, applied flow by flow on the mark-to-market value of each instrument. The Company adopts the ratings of the other parties for positive flows and its own rating for negative flows, both available in the market and disclosed by renowned rating agencies, as a necessary assumption to define the probability of default.

 

19.2          Non-derivative financial instruments and leniency agreement (Note 23.3) - consolidated

 

 

 

         

Fair value

 

Book value

 

Fair value

   

Note

 

Classification by category

 

hierarchy

 

2017

 

2016

 

2017

 

2016

                           

Cash and cash equivalents

 

6

                       
    Cash and banks            

      1,428,766

 

      2,178,611

 

      1,428,766

 

      2,178,611

 Financial investments in Brazil    

Loans and receivables

     

      1,706,784

 

      2,914,685

 

      1,706,784

 

      2,914,685

 Financial investments abroad    

Held-for-trading

 

Level 2

 

         639,543

 

      1,608,568

 

         639,543

 

      1,608,568

             

    3,775,093

 

    6,701,864

 

    3,775,093

 

    6,701,864

                           

Financial investments

 

7

                       
 Letras financeiras do tesouro - LFT    

Held-for-trading

 

Level 2

 

      1,816,889

 

         755,712

 

      1,816,889

 

         755,712

 Time deposit investments    

Loans and receivables

 

Level 2

 

         440,616

 

         434,015

 

         440,616

 

         434,015

 Other    

Held-for-trading

 

Level 2

 

           39,739

 

                756

 

           39,739

 

                756

             

    2,297,244

 

    1,190,483

 

    2,297,244

 

    1,190,483

   

 

                       

Trade accounts receivable

 

8

 

Loans and receivables

     

    3,318,692

 

    1,704,373

 

    3,318,692

 

    1,704,373

                           

Trade payables

   

Financial liabilities not
    measured at fair value

     

    5,525,407

 

    6,746,822

 

    5,525,407

 

    6,746,822

                           

Borrowings

 

15

 

Financial liabilities not
    measured at fair value

                   
 Foreign currency - Bond        

Level 1

 

    20,082,588

 

    14,216,539

 

    21,230,567

 

    12,509,981

 Foreign currency - other borrowings        

Level 2

 

      2,344,649

 

      4,159,341

 

      2,228,608

 

      4,020,769

 Local currency        

Level 2

 

      1,224,772

 

      5,166,602

 

      1,039,873

 

      3,991,892

             

23,652,009

 

23,542,482

 

24,499,048

 

20,522,642

                           

Braskem Idesa borrowings

 

16

 

Financial liabilities not
    measured at fair value

 

Level 2

 

    9,784,388

 

 10,541,948

 

    8,675,711

 

    9,322,409

   

 

                       

Debentures

 

17

 

Financial liabilities not
    measured at fair value

 

Level 2

 

       313,324

 

 

 

       313,324

 

 

                           

Loan ton non-controlling
shareholder of Braskem Idesa

   

Financial liabilities not
    measured at fair value

     

    1,756,600

 

    1,620,519

 

    1,756,600

 

    1,620,519

                           

Leniency agreement

 

23.3

         

    1,629,114

 

    2,853,230

 

    1,629,114

 

    2,853,230

                           

Other payables (BNDESPAR)

   

Financial liabilities not
    measured at fair value

     

 

 

       176,846

 

 

 

       176,846

 

 

 

55


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

19.3          Derivative financial instruments designated for hedge accounting

 

19.3.1    Changes 

 

                       

Net

         

Net

           

Operation characteristics

     

(Asset)/

         

(Asset)/

       

Fair value

 

Principal exposure

     

Accumulated

 

Liability

 

Change in

 

Financial

 

Liability

Identification

 

Note

 

hierarchy

   

Derivatives

 

OCI (equity)

 

2016

 

fair value

 

settlement

 

2017

                                     

Hedge accounting transactions

 

0

                               

Dollar put and call options

 

19.3.1 (a.i)

 

Level 2

 

Real

 

Dollar

   

         (4,184)

 

              391

 

 

 

         (3,793)

Exchange swap

 

19.3.1 (a.ii)

 

Level 2

 

CDI

 

Dollar+Interests

   

       857,099

 

       (46,820)

 

     (810,279)

 

 

Interest rate swaps

 

0

 

Level 2

 

Libor

 

Fixed rates

 

         281,496

 

            (266)

 

           3,394

 

       (28,919)

 

       (25,791)

                   

         281,496

 

       852,649

 

       (43,035)

 

     (839,198)

 

       (29,584)

                                     

Derivatives operations

                                   

Current assets

                     

         (8,387)

         

         (3,793)

Non-current assets

                     

       (29,308)

         

       (32,666)

Current liabilities

                     

         29,042

         

           6,875

Non-current liabilities

                     

       861,302

         

                

                       

       852,649

         

       (29,584)

 

The counterparties in these contracts are constantly monitored based on the analysis of their respective ratings and Credit Default Swaps – CDS. Braskem has many bilateral risk mitigators in its derivative contracts, such as the possibility of depositing or requesting deposits of a guarantee margin from the counterparties it deems convenient.

 

Derivative financial instruments designated for hedge accounting are presented in the balance sheet at their fair value in an asset or liability account depending on whether the fair value represents a positive or a negative balance to Braskem, respectively, and are necessarily classified as "held-for-trading".

 

All hedge financial instruments held at December 31, 2017 were contracted on Over the Counter - OTC markets with large financial counterparties under global derivative contracts in Brazil or abroad and their fair values are classified as Level 2.

 

Braskem’s Financial Policy provides for the active management and continued protection against undesired fluctuations in currencies and rates arising from its operations and financial items, with the possibility of contracting derivative instruments (swaps, NDFs, options, etc.). The other market risks are addressed on a case-by-case basis for each transaction. In general, Braskem assesses the need for hedging in the analysis of prospective transactions and seeks to customize the hedge and keeps it in place for the same period of the hedged transaction.

 

Braskem may elect derivatives for the application of hedge accounting in accordance with CPCs 38, 39, 40 and IAS 39-32 and IFRS 7. The hedge designation is not mandatory. In general, Braskem will elect to designate financial instruments as hedges when the application is expected to provide a significant improvement in the presentation of the offsetting effect on the changes in the hedged items.

 

The effective portion of the changes in the fair value of hedge derivatives and of the exchange variation of financial liabilities designated and qualified as sales flow hedge is recognized in equity, under “Other comprehensive income”. These amounts are transferred to profit or loss for the periods in which the hedged item affects the financial results. The ineffective portion is recognized immediately in profit or loss as “Financial result.”

 

56


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

 

When a hedge instrument matures or is sold or when it no longer meets the criteria for hedge accounting, it is prospectively discontinued and any cumulative gain or loss in equity remains in equity and is recognized in financial result when the hedged item or transaction affects profit or loss. If the hedged item or transaction is settled in advance, discontinued or is not expected to occur, the cumulative gain or loss in equity is immediately transferred to financial result.

 

(a)               Hedge accounting transactions

 

(a.i)      Dollar put and call option

 

In September 2016, Braskem launched a recurring currency hedge program to mitigate the exposure of its cash flows to liabilities denominated in Brazilian real and not pegged to the U.S. dollar (e.g., electricity, payroll, etc.).

 

With the sole purpose of protecting its cash flow, the program adopts two strategies using derivative instruments: (i) purchase of put options (“puts”) and (ii) purchase of put options associated with the sale of call options (“collars”).

 

Both alternatives protect Braskem in the event of appreciation in the local currency, with the difference being that the collar strategy can also result in losses for the Company if the USD/BRL exchange rate surpasses the strike price of the call options. However, any losses always are offset by gains in competitiveness from the reduction in costs denominated in BRL when translated into USD.

 

On December 31, 2017, Braskem held a total notional amount of put options of US$1.4 billion, with an average strike price of 2.96 R$/US$. Simultaneously, the Company also held a total notional amount of call options of US$926 million, with an average strike price of R$/US$4.32. The operations have a maximum term of 18 months.

 

Such operations were designed for the hedge accounting of cash flows as from January 1, 2017.

 

Dollar put options were recognized initially at fair value and measured subsequently at their fair value at the end of each period. Any gain or loss related to the effective portion of dollar options (intrinsic value) is recognized as other comprehensive income or loss under shareholders' equity. Any gain or loss related to the ineffective portion and the extrinsic value of the option are immediately recognized in the financial result.

 

(a.ii)    Exchange rate swap linked to NCEs

 

Identification

         

Maturity

   
     

Hedge

   

Fair value

 

Nominal value

 

Financial charges for year

   

2017

 

2016

Swap NCE I to III

 

                   400,000

 

Exchange variation + 6,15%

 

August-2019

 

 

 

              438,201

Swap NCE IV to VII

 

                   450,000

 

Exchange variation + 4,93% to 7,90%

 

April-2019

 

 

 

              418,898

Total

 

                 850,000

         

 

 

            857,099

                     

Derivatives operations

                   

Current assets

             

 

 

                (4,203)

Non-Current liabilities

             

 

 

              861,302

Total

         

 

 

            857,099

 

Swap operations to offset fluctuations in the CDI overnight rate, which are designated for hedge accounting. The balance was prepaid using proceeds from the issue of Bonds (Note 15(c)), in the amount of R$810,279.

 

57


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

The discontinued amount, which was recorded under Shareholders' Equity as "Other comprehensive income" ("OCI") was taken to the financial result in the amount of R$475,872.

 

19.4          Non-derivative financial liabilities designated to hedge accounting

 

(a.i)      Future exports in U.S. dollars

 

On May 1, 2013, Braskem S.A. designated non-derivative financial instrument liabilities, denominated in U.S. dollars, as hedge for the flow of its highly probable future exports. Thus, the impact of exchange rates on future cash flows in dollars derived from these exports is offset by the foreign exchange variation on the designated liabilities, partly eliminating the volatility of results. The exchange rate on the date of the designation was
US$ 1: R$2.0017. In addition to this hedge accounting, on October 10, 2017, Braskem S.A. designated new financial instruments for the hedging of future sales, which mature in 2028. The hedged exchange rate was US$1 : R$3.1688.

 

Therefore, on December 31, 2017, exports that were designated not yet realized and not discontinued are shown below:

 

 

 

 

 

 

 

Total nominal value

         

 

US$

 

 

 

 

 

 

 

2019

 

 

 

 

 

                     733,980

2020

 

 

 

 

 

                     724,000

2021

 

 

 

 

 

                     716,000

2022

 

 

 

 

 

                     719,000

2023

 

 

 

 

 

                     718,371

2024

 

 

 

 

 

                     688,854

2028

 

 

 

 

 

 1,250,000

 

 

 

 

 

 

 5,550,205

 

The Company considers these exports in the selected period (2018/2028) as highly probable, based on the following factors:

 

    ·         

In recent years, Braskem S.A. exported an average US$3.6 billion per year, which represents around 3 to 4 times the annual exports of the hedged exports.

·         

Hedged exports represent between 20% and 30% of the export flows planned by the Company.

 

The exports of the Company are not sporadic or occasional, but constitute an integral part of its strategy and of the petrochemical business, in which competition is global.

 

The following table shows the changes in financial instruments designated for this hedge in the period: 

 

   

 

 

 

 

 

 

US$

       

Hedge

       
   

2016

 

discontinued

 

Designations

 

2017

                 

Designated balance

 

5,301,099

 

1,000,894

 

 1,250,000

 

 5,550,205

 

 

58


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

On December 31, 2017, the maturities of financial liabilities designated, within the scope of the consolidated balance sheet, were as follows:

 

 

 

 

 

 

 

Total nominal value

         

 

US$

 

 

 

 

 

 

 

2019

 

 

 

 

 

                     733,980

2020

 

 

 

 

 

                     724,000

2021

 

 

 

 

 

                     716,000

2022

 

 

 

 

 

                     719,000

2023

 

 

 

 

 

                     718,372

2024

 

 

 

 

 

                     688,853

2028

 

 

 

 

 

 1,250,000

 

 

 

 

 

 

 5,550,205

 

In order to maintain consistency between the parent company’s results and the consolidated results, the Company selected the hedge instruments with subsidiaries abroad observing the existence of guarantees arising from their operations with third parties. As a result, non-derivative financial liabilities in which the foreign subsidiary acted as an intermediary of the Parent Company in the operations were selected, which effectively maintained the essence of the transactions. Trade payables, especially naphtha, were also considered in the transaction.

 

To ensure the continuity of the hedging relationship, the Company plans to refinance and/or substitute these hedge instruments to adjust them to the schedule and value of the hedged exports. The rollover or replacement of the hedge instrument are provided for in IAS 39 and CPC 38. This explains the fact that liabilities designated for hedge are not necessarily equivalent to the exports designated in the year.

 

Considering the cash generation in recent quarters, the Management of the Company believed it was appropriate to advance the payment of dollar-denominated obligations, including liabilities designated for this hedge. As a result of the decision, the amount of US$787,893 was discontinued prospectively. Exchange variation on the discontinued amount, which is recorded under Shareholders' Equity as “Other comprehensive income” will be taken to net financial income (expenses) as of January 2018, as the hedged exports are realized.

 

       

Conversion rate

       
   

Total nominal

 

at Inception

 

Closing rate

 

Gross nominal

   

value US$

 

R$/US$

 

R$/US$

 

value

                 

Hedge descontinued - First quarter 2018

 

189,325

 

2.0017

 

3.3082

 

247,353

Hedge descontinued - Second quarter 2018

 

208,405

 

2.0017

 

3.2769

 

265,758

Hedge descontinued - Third quarter 2018

 

193,190

 

2.0017

 

3.3080

 

252,364

Hedge descontinued - Fourth quarter 2018

 

196,973

 

2.0017

 

3.3080

 

257,306

   

787,893

         

1,022,781

 

The following table provides the balances of exchange variation recognized in the Company’s net financial income (expenses) due to the realization of exports designated for this hedge in the 12-month period ended December 31, 2017:

 

 

59


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

       

Conversion rate

       
   

Total nominal

 

at Inception

 

Closing rate

 

Gross nominal

   

value US$

 

R$/US$

 

R$/US$

 

value

                 

First quarter

 

201,277

 

2.0017

 

3.2400

 

249,241

Second quarter

 

208,135

 

2.0017

 

3.2015

 

249,721

Third quarter

 

207,273

 

2.0017

 

3.3302

 

275,362

Fourth quarter

 

213,000

 

2.0017

 

3.1684

 

248,506

   

829,685

         

1,022,830

 

The changes in foreign exchange variation and Income Tax and Social Contribution under “Other comprehensive income” of this hedge are as follows:

 

 

 Exchange

     

Net

 

 variation

 

IR and CSL

 

effect

           

At December 31, 2016

           (7,439,927)

 

             2,529,575

 

           (4,910,352)

           

 

 Exchange variation recorded in the period on OCI / IR and CSL

                 (397,045)

 

                  134,995

 

                 (262,050)

           

 

 Exchange variation transferred to profit or loss / IR and CSL

               1,022,830

 

                 (347,762)

 

                  675,068

           

At December 31, 2017

           (6,814,142)

 

             2,316,808

 

           (4,497,334)

 

The realizations expected for 2018 will occur through the payments of financial instruments in conformity with exports made, and the exchange variation recorded in “Other comprehensive income” will be written off to the financial results. For all quarters of the year, realizations will be realized at the discounted cash flow rates. The quarterly schedule of hedged exports in 2018 follows:

 

 

 

 

 

 

 

Total nominal

 

 

 

 

 

 

value US$

 

 

 

 

 

 

 

First quarter

 

 

 

 

 

                     189,325

Second quarter

 

 

 

 

 

                     208,405

Third quarter

 

 

 

 

 

                     193,190

Fourth quarter

 

 

 

 

 

                     196,973

 

 

 

 

 

 

                     787,893

 

(a.ii)     Liabilities related to the Project Finance of future sales in U.S. dollar

 

On October 1, 2014, the subsidiary Braskem Idesa designated its liabilities in the amount of R$2,878,936 related to Project Finance, denominated in U.S. dollar, as hedge instruments to protect highly probably future sales flows. Due to the disbursements by the project's financiers in 2015, Braskem Idesa designated new amounts in April and September 2015, of US$290,545 and US$23,608, respectively, for hedge accounting. Therefore, the impact of exchange variation on future flows of sales in U.S. dollar derived from these sales in dollar will be offset by the exchange variation on the designated liabilities, partially eliminating the volatility in the results of the subsidiary.

 

The Management of Braskem Idesa believes these future sales are highly probable, based on the following:

 

    ·         

In Mexico, domestic sales can be made in U.S. dollar. In 2016, the company began to operate and sell products, including sales in U.S. dollar in the domestic and international markets.

·         

The hedged flow corresponds to less than 18% of the planned revenue flow of the project over the designated period. The current amount of sales already meets the volume of designated hedge, which confirms the highly probably nature of the designated cash flow.

·         

The financing was obtained through a Project Finance structure and will be repaid exclusively through the cash generation of the project (Note 16). Therefore, the existence of the debit is directly associated with the highly probable nature of the future sales in U.S. dollar.

 

 

           

60


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

As of December 31, 2017, designated and unrealized sales were as follows:

           

 

 

 

 

 

 

Nominal value

 

 

 

 

 

 

US$

 

 

 

 

 

 

 

2018

 

 

 

 

 

                     221,790

2019

 

 

 

 

 

                     229,270

2020

 

 

 

 

 

                     266,690

2021

 

 

 

 

 

                     303,392

2022

 

 

 

 

 

                     253,204

2023

 

 

 

 

 

                     333,093

2024

 

 

 

 

 

                     359,559

2025

 

 

 

 

 

                     357,903

2026

 

 

 

 

 

                     309,240

2027

 

 

 

 

 

                     152,103

2028

 

 

 

 

 

                     124,654

2029

 

 

 

 

 

                       31,164

 

 

 

 

 

 

                  2,942,062

 

The following table shows the changes in financial instruments designated for this hedge in the period:

 

   

 

 

 

 

 

 

US$

       

Sales in

 

Hedge

   
   

2016

 

the year

 

discontinued

 

2017

                 

Designated balance

 

3,113,173

 

                          (183,252)

 

                                       325

 

2,930,246

 

 

 

61


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

In 2017, the maturities of designated financial liabilities were distributed as follows:

 

 

 

 

 

 

 

Nominal value

         

 

US$

 

 

 

 

 

 

 

2018

 

 

 

 

 

                     221,390

2019

 

 

 

 

 

                     228,850

2020

 

 

 

 

 

                     266,187

2021

 

 

 

 

 

                     302,816

2022

 

 

 

 

 

                     252,723

2023

 

 

 

 

 

                     332,458

2024

 

 

 

 

 

                     358,873

2025

 

 

 

 

 

                     357,221

2026

 

 

 

 

 

                     308,650

2027

 

 

 

 

 

                     150,419

2028

 

 

 

 

 

                     124,347

2029

 

 

 

 

 

                       26,312

 

 

 

 

 

 

                  2,930,246

 

The following table provides the balance of exchange variation of the discontinued amount net of realization already occurred in the period ended December 31, 2017 (US$325), which is recorded in Braskem Idesa’s shareholders’ equity under “Other comprehensive income” and will be transferred to financial income (expenses) according to the schedule of future hedged sales as they occur:           

 

       

Conversion rate

           
   

Total nominal

 

at Inception

 

Closing rate

 

Total nominal

 

Gross nominal

   

value US$

 

MXN/US$

 

MXN/US$

 

value MXN

 

value

                     

Hedge descontinued

 

11,816

 

13.4541

 

17.9915

 

53,614

 

9,013

               

53,614

 

9,013

 

The following table provides the balances of exchange variation recognized in Braskem Idesa’s financial income (expenses) due to the realization of sales designated for this hedge in the 12-month period ended December 31, 2017:

 

       

Conversion rate

           
   

Total nominal

 

at Inception

 

Closing rate

 

Total nominal

 

Gross nominal

   

value US$

 

MXN/US$

 

MXN/US$

 

value MXN

 

value

                     

First quarter

 

29,174

 

13.6649

 

20.6059

 

202,497

 

30,917

Second quarter

 

47,896

 

13.6560

 

18.8998

 

251,157

 

42,992

Third quarter

 

52,293

 

13.6536

 

17.8492

 

219,401

 

38,919

Fourth quarter

 

53,889

 

13.6537

 

19.1186

 

294,498

 

50,868

   

183,252

         

967,553

 

163,696

 

The changes in foreign exchange variation and Income Tax and Social Contribution under “Other comprehensive income” are as follows:

 

62


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

 

 Exchange

     

Net

 

 variation

 

IR

 

effect

           

At December 31, 2016

           (4,182,052)

 

             1,255,350

 

           (2,926,702)

           

 

 Exchange variation recorded in the period on OCI / IR

                  472,717

 

                 (141,815)

 

                  330,902

           

 

 Exchange variation transferred to profit or loss / IR

                  163,696

 

                   (49,109)

 

                  114,587

           

At December 31, 2017

           (3,545,639)

 

             1,064,426

 

           (2,481,213)

 

The tests of effectiveness of the operations were carried out as provided for in CPC 48 / IFRS 9 and all operations were effective to reduce the dispersion of revenue coming with the designated hedge exports, when assessed in Reais..

 

The realizations expected for 2018 will occur in accordance with the payments under the project finance, and the exchange variation recorded in “Other comprehensive income” will be written off to the financial results. Below is the quarterly schedule of hedged sales in U.S. dollars in 2018:

 

 

 

 

 

 

 

Nominal value

 

 

 

 

 

 

US$

 

 

 

 

 

 

 

First quarter

 

 

 

 

 

                       53,889

Second quarter

 

 

 

 

 

                       55,137

Third quarter

 

 

 

 

 

                       56,382

Fourth quarter

 

 

 

 

 

                       56,382

 

 

 

 

 

 

                     221,790

 

19.5          Credit quality of financial assets

 

(a)               Trade accounts receivable

 

Virtually none of Braskem’s clients have risk ratings assigned by credit rating agencies. For this reason, Braskem developed its own credit rating system for all accounts receivable from clients in Brazil and abroad.

 

On December 31, 2017, the credit ratings for the domestic market were as follows:

 

 

 

 

 

 

(%)

 

 

 

2017

 

2016

1

Minimum risk

 

18.84

 

8.92

2

Low risk

 

50.84

 

39.98

3

Moderate risk

 

13.33

 

30.51

4

High risk

 

13.40

 

16.48

5

Very high risk

(i)

3.59

 

4.11

 

(v) 

Most clients in this group are inactive and the respective accounts are in the process of collection actions in the courts. Clients in this group that are still active buy from Braskem and pay in advance.

 

63


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

Default indicators:

 

 

Last 12 months

 

Domestic market

 

Export market

 

 

December 31, 2017

0.08%

 

0.19%

December 31, 2016

0.18%

 

0.04%

December 31, 2015

0.39%

 

0.70%

 

This calculation considers the amount of trade payables overdue more than 5 days for the domestic market and 30 days for the international market, divided by consolidated gross revenue in the last 12 months.

 

(b)               Other financial assets

 

In order to determine the credit ratings of counterparties of financial assets classified under cash and cash equivalents, held for trading and borrowings and receivables, Braskem uses the risk rating of agencies Standard & Poor’s, Moody’s and Fitch Ratings, within the limits established in its financial policy approved by the Board of Directors.

 

       

2017

 

2016

Financial assets with risk assessment

       

 

AAA

   

      3,569,392

 

      3,871,105

AA+

   

           27,094

 

         241,359

AA

   

             8,047

 

             5,370

AA-

   

         209,389

 

         654,232

A+

   

      1,465,107

 

      2,426,078

A

   

         349,823

 

         364,198

A-

   

 

 

         209,175

BBB+

   

         453,367

 

         116,987

     

      6,082,219

 

      7,888,504

Financial assets without risk assessment

         

Other financial assets with no risk assessment

 

 (i)

             5,882

 

             3,843

     

             5,882

 

             3,843

           

Total

   

    6,088,101

 

    7,892,347

 

(i)   

Investments approved by the Management of the Company, in accordance with the financial policy.

 

19.6          Sensitivity analysis

 

Financial instruments, including derivatives, may be subject to changes in their fair value as a result of the variation in commodity prices, foreign exchange rates, interest rates, shares and share indexes, price indexes and other variables. The sensitivity of the derivative and non-derivative financial instruments to these variables are presented below:

 

(a)               Selection of risks

 

On December 31, 2017, the main risks that can affect the value of Braskem’s financial instruments are:

 

 

 

64


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

·      

Brazilian real/U.S. dollar exchange rate;

·      

Mexican peso/Brazilian real exchange rate;

·      

U.S. dollar/Euro exchange rate;

·      

Libor floating interest rate;

·      

Selic interest rate;

·      

CDI interest rate; and

·      

TJLP interest rate.

 

For the purposes of the risk sensitivity analysis, Braskem presents the exposures to currencies as if they were independent, that is, without reflecting in the exposure to a foreign exchange rate the risks of the variation in other foreign exchange rates that could be directly influenced by it.

 

(b)               Value at risk

 

The value at risk of the derivatives held by Braskem which is defined as the loss that could result in one month as from December 31, 2017, with a probability of 5%, and under normal market conditions, was estimated by the Company at US$9,800 for put options and call options (Note 19.3.1 (a.i)) and US$10,464 for the swap of Libor related to Braskem Idesa project.

 

(c)                Selection of scenarios

 

(c.1)     Probable scenario

 

The Focus Market Readout published by the Central Bank of Brazil on was used to create the probable scenario for the U.S. dollar/Brazilian real exchange rate, the Selic interest rate and the CDI interest rate, based on December 29, 2017. According to the Market Readout, at the end of 2017, the U.S. dollar will appreciate by 0.97% against the year-end PTAX exchange rate on December 29, 2017, while the Selic rate will reach 6.75% p.a. The Selic rate is used as benchmark for sensitivity analysis of the CDI rate.

 

The probable scenario for the TJLP is a decrease of 0.25% from the current rate of 6.75%, i.e., considering the same pace of decrease in the Selic basic interest rate.  The Market Readout does not publish forecasts for the Libor interest rate. Therefore, to determine the probable scenario, Braskem considered a 25% and 50% increase on current market levels.

 

65


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

(c.2)     Possible and extreme adverse scenario

 

The sensitivity values in the table below are the changes in the value of the financial instruments in each scenario.

 

   

Gain (losses)

       

Possible adverse

 

Extreme adverse

Instrument / Sensitivity

 

Probable

(25%)

 

(50%)

             

Brazilian real/U.S. dollar exchange rate

           

Bonds

 

                        (191,889)

 

                     (4,959,133)

 

                     (9,918,266)

Working capital / other

 

                          (12,358)

 

                        (319,367)

 

                        (638,734)

Export credit notes

 

                            (6,577)

 

                        (169,974)

 

                        (339,948)

Braskem Idesa borrowings

 

                          (93,750)

 

                     (2,422,863)

 

                     (4,845,725)

Export prepayments

 

                            (3,209)

 

                          (82,925)

 

                        (165,850)

Dollar put and call options

 

                            (4,117)

 

                        (176,990)

 

                        (844,927)

Financial investments abroad

 

                           18,405

 

                         475,644

 

                         951,287

   

Selic interest rate

 

BNDES

 

                                277

 

                            (1,999)

 

                            (4,101)

   

Libor floating interest rate

 

Working capital / structured operations

 

                            (3,265)

 

                          (16,325)

 

                          (32,650)

Export prepayments

 

                            (1,643)

 

                            (8,216)

 

                          (16,433)

Swaps

 

                           12,615

 

                           38,103

 

                           96,667

Braskem Idesa borrowings

 

                          (76,187)

 

                        (380,933)

 

                        (761,865)

   

CDI interest rate

 

Swaps NCE

 

                           12,208

 

                          (27,340)

 

                          (61,117)

Debentures

 

                           25,657

 

                               (277)

 

                          (15,308)

Financial investments in local currency

 

                            (9,138)

 

                           63,988

 

                         128,016

 

 

IPCA interest rate

 

Debentures

 

                          (33,625)

 

                          (20,015)

 

                          (40,873)

     

 

 

 

 

TJLP interest rate

           

Other government agents

 

                                  14

 

                                 (95)

 

                               (192)

BNDES

 

                                210

 

                            (1,443)

 

                            (2,929)

 

 

Brazilian real/Euro exchange rate

 

Working capital / other

 

                             2,126

 

                          (13,896)

 

                          (27,792)

 

 

66


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

20                Taxes payable

 

         

 

 

 Consolidated

 

 

 

Parent company

         

2017

 

2016

 

2017

 

2016

                       

Brazil

                   
 

IPI

     

                60,917

 

                59,323

 

                60,134

 

                57,191

 

IR and CSL

     

              405,567

 

              159,047

 

              400,544

 

              119,573

 

ICMS

     

              257,720

 

              182,034

 

              254,935

 

              173,915

 

PIS and COFINS

     

                82,140

 

                59,105

 

                80,591

 

                58,252

 

Other

     

                52,926

 

                62,743

 

                29,002

 

                38,987

                       

Other countries

                   
 

IR

     

              434,563

 

              639,983

 

 

 

 

 

Value-added tax

     

                20,173

 

                15,622

 

 

 

 

Total

     

         1,314,006

 

         1,177,857

 

            825,206

 

            447,918

                       

Current liabilities

     

           1,261,204

 

           1,153,760

 

              774,391

 

              424,088

Non-current liabilities

     

                52,802

 

                24,097

 

                50,815

 

                23,830

Total

     

         1,314,006

 

         1,177,857

 

            825,206

 

            447,918

 

(a)               Special Tax Compliance Program (“PERT”)

 

In October 2017, Braskem and its subsidiary Braskem Petroquímica adhered to PERT, a federal government tax installment/amnesty program implemented through Decree MP 783, of May 31, 2017, indicating the payment of tax and social security liabilities in the aggregate amount of R$111,735. The amount was reduced by R$12,895 due to discounts granted under the program. This amount were settled by (i) R$67,953 to be offset using tax credits from income tax losses and social contribution tax loss carryforwards, (ii) R$21,854 paid in cash in October 2017, and (iii) R$9,033 were paid in cash in January 2018.

 

67


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

21                Income tax (“IR”) and social contribution (“CSL”)

 

21.1     Reconciliation of the effects of income tax and social contribution on profit or loss

 

     

Consolidated

 

Parent company

     

2017

 

2016

 

2017

 

2016

                   

Income (loss) before IR and CSL and after discontinued operations

   

         5,416,713

 

          (140,010)

 

         4,688,646

 

          (171,011)

                   

IR and CSL at the rate of 34%

   

         (1,841,682)

 

                47,603

 

         (1,594,140)

 

                58,144

     

Permanent adjustments to the IR and CSL calculation basis

   
 IR and CSL on equity in results of investees    

                  2,201

 

                10,227

 

              845,248

 

              324,883

 IR and CSL accrued in previous years    

 

 

              (46,460)

 

 

 

              (21,275)

 Deferred tax losses and negative base    

                39,092

   
 Tax benefits (Sudene and PAT)    

                87,186

   

                87,186

 
 Difference of rate applicable to each country    (i)

              250,130

 

                81,638

 
 Fine in leniency agreement    

 

 

            (692,299)

 

 

 

            (529,354)

   Other permanent adjustments  

 

              170,805

 

              (16,755)

 

                47,174

 

            (103,817)

                   

Effect of IR and CSL on results of operations

   

       (1,292,268)

 

          (616,046)

 

          (614,532)

 

          (271,419)

                   

Breakdown of IR and CSL:

                 
                   

Current IR and CSL

   

            (869,493)

 

            (898,845)

 

            (385,208)

 

              (89,862)

Deferred IR and CSL

   

            (422,775)

 

              282,799

 

            (229,324)

 

            (181,557)

Total

   

       (1,292,268)

 

          (616,046)

 

          (614,532)

 

          (271,419)

 

(i)   

Includes the impact from the difference between IR/CSL tax rate in Brazil (34%) used for the preparation of this note and the tax rates in countries where the subsidiaries abroad are located, as follows:

 
       

Official rate - %

         

Headquarters

   
       

(Country)

 

2017

             

 

 Braskem Alemanha    

Germany

 

             31.18

 

 Braskem America e Braskem America Finance

(i)

 

USA

 

             35.00

 

 Braskem Argentina    

Argentina

 

             35.00

 

 Braskem Austria e Braskem Austria Finance    

Austria

 

             25.00

 

 Braskem Petroquímica Chile    

Chile

 

             25.50

 

 Braskem Holanda, Braskem Holanda Finance and Braskem Holanda Inc    

Netherlands

 

             25.00

 

 Braskem Idesa, Braskem Idesa Serviços, Braskem México        

 

 

   Braskem México Serviços and Braskem México Proyectos    

Mexico

 

             30.00

 

(i)   

In 2018 the rate will change from 35% to 21%.

 

On a consolidated basis, the effective rate is 23.9% (440.0% in 2016), and at the Parent Company the effective rate is 13.1% (158.7% in 2016). 

 

The effective rate shown above for the year ended December 31, 2016 is related to the provision established to pay the leniency agreement and consequent adjustments to the IR and CSL bases. Disregarding this calculation provision, the effective rate would be 36.90% in the Consolidated and 25.08% in the Parent Company in 2016.

 

68


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

21.2           Breakdown of deferred IR and CSL

 

The income tax (“IR”) and social contribution (“CSL”) recorded in the year are determined on the current and deferred tax basis. These taxes are calculated on the basis of the tax laws enacted at the balance sheet date in the countries where the Company operates and are recognized in the statement of operations, except to the extent they relate to items directly recorded in equity.

 

 (a)       According to tax collection records

 

   

 

 

 

 

 

 

 

 

Consolidated

Assets

 

As of December 31, 2016

 

Impact on the P&L

 

Impact on the equity

 

Cetrel consolidated

 

As of December 31, 2017

                     

 

 Tax losses (IR) and negative base (CSL)  

2,420,376

 

(590,037)

   

48,470

 

1,878,809

 

 Goodwill amortized  

4,624

 

(708)

   

55,419

 

59,335

 

 Exchange variations  

464,947

 

(76,654)

   

 

 

388,293

 

 Temporary adjustments  

717,868

 

(498,825)

 

(7,946)

 

9,857

 

220,954

 

 Business combination  

191,250

 

(7,465)

 

0

 

 

 

183,785

   

3,799,065

 

(1,173,689)

 

(7,946)

 

113,746

 

2,731,176

                   

Liabilities

               

 

 Amortization of goodwill based on future profitability  

767,277

 

(54,404)

     

712,873

 

 Tax depreciation  

867,922

 

92,280

     

960,202

 

 Temporary adjustments  

316,991

 

(85,169)

     

231,822

 

 Business combination  

198,381

 

(197,079)

   

8,362

 

9,664

 

 Additional indexation PP&E  

118,202

 

(51,130)

     

67,072

 

 Hedge accounting  

 

 

(606,877)

 

606,877

   

 

 Deferred on health plans  

 

 

15,269

 

(15,269)

   

 

 Amortization of fair value adjustments on the assets from the acquisiton of Quattor  

263,808

 

255,815

 

 

   

519,623

 

 Other  

123,892

 

(119,619)

 

 

 

 

 

4,273

   

2,656,473

 

(750,914)

 

591,608

 

8,362

 

2,505,529

                     

Net

 

1,142,592

 

(422,775)

 

(599,554)

 

105,384

 

225,647

                     

Presentation in the balance sheet:

                   

 

 Non-current assets  

1,653,115

             

1,165,726

 

 (-) Non-current liabilities  

510,523

             

940,079

 

   

 

 

 

 

 

 

 

 

 

 

Parent Company

Assets

 

As of December 31, 2016

 

Impact on the P&L

 

Impact on the equity

 

Deferred charges on discontinued operations

 

Deferred rectification previous periods

 

As of December 31, 2017

                         

 

 Tax losses (IR) and negative base (CSL)  

215,413

 

(169,188)

   

12,196

 

58,421

 

 Goodwill amortized  

4,623

 

(707)

   

3,916

 

 Exchange variations  

456,816

 

(68,523)

   

388,293

 

 Temporary adjustments  

1,339,681

 

(405,994)

 

(8,247)

 

(3,018)

 

 

 

922,422

 

 Business combination  

89,770

 

170,290

 

 

 

 

 

(76,275)

 

183,785

   

2,106,303

 

(474,122)

 

(8,247)

 

(3,018)

 

(64,079)

 

1,556,837

             

Liabilities

           

 

 Amortization of goodwill based on future profitability  

680,111

 

32,762

 

712,873

 

 Tax depreciation  

792,869

 

167,333

 

960,202

 

 Temporary adjustments  

11,701

 

(3,514)

 

8,187

 

 Business combination  

76,959

 

(116,189)

   

40,532

 

1,302

 

 Additional indexation PP&E  

96,700

 

(30,976)

   

1,348

 

67,072

 

 Other  

139,500

 

(135,984)

   

3,516

 

 Deferred on health plans  

 

 

(15,269)

 

15,269

     

 

 Amortization of fair value adjustments on the assets from the acquisiton of Quattor  

266,004

 

253,619

 

 

   

519,623

 

 Hedge accounting  

 

 

(396,580)

 

396,580

 

 

 

 

 

 

   

2,063,844

 

(244,798)

 

411,849

 

 

 

41,880

 

2,272,775

                         

Net

 

42,459

 

(229,324)

 

(420,096)

 

(3,018)

 

(105,959)

 

(715,938)

 

 

69


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

(b)       Offset for the purpose of presentation in the balance sheet (consolidated)

 

   

 

 

2017

      

Headquarters

 

 

 

IR and CSL

 

 

   

(Country)

 

Tax calculation

 

Compesation

 

Balance

                 

Assets

             

Braskem S.A.

 

Brazil

 

          1,556,837

 

         (1,556,837)

 

Braskem Argentina

 

Argentina

 

                 3,398

   

               3,398

Braskem Alemanha

 

Germany

 

               19,353

   

             19,353

Braskem Chile

 

Chile

 

                    251

 

                   (251)

 

 

Braskem Idesa

 

Mexico

 

          1,036,257

   

        1,036,257

Braskem México Serviços

 

Mexico

 

                 1,334

   

               1,334

Cetrel

 

Brazil

 

               29,268

 

                (7,454)

 

             21,814

DAC

 

Brazil

 

               84,478

 

                   (908)

 

             83,570

       

        2,731,176

 

       (1,565,450)

 

      1,165,726

                 

Liabilities

               

Braskem S.A

 

Brazil

 

          2,272,775

 

         (1,556,837)

 

           715,938

Braskem America

 

USA

 

             223,635

 

 

 

           223,635

Braskem Petroquímica Chile

 

Chile

 

                    757

 

                   (251)

 

                  506

Cetrel

 

Brazil

 

                 7,454

 

                (7,454)

 

 

DAC

 

Brazil

 

                    908

 

                   (908)

 

 

       

2,505,529

 

(1,565,450)

 

940,079

                 
                 
   

 

 

2016

   

Headquarters

 

 

 

IR and CSL

 

 

   

(Country)

 

Tax calculation

 

Compesation

 

Balance

                 

Assets

               

Braskem S.A.

 

Brazil

 

          2,106,303

 

         (2,063,844)

 

             42,459

Braskem Argentina

 

Argentina

 

                 6,745

   

               6,745

Braskem Alemanha

 

Germany

 

               36,932

   

             36,932

Braskem Chile

 

Chile

 

                    135

 

                   (135)

 

 

Braskem Idesa

 

Mexico

 

          1,463,502

   

        1,463,502

Braskem México Serviços

 

Mexico

 

                 1,994

   

               1,994

Braskem Petroquímica

 

Brazil

 

               81,971

 

              (81,971)

 

 

Braskem Petroquímica and Braskem Qpar - business combination effects

 

Brazil

 

             101,483

 

 

 

           101,483

       

        3,799,065

 

       (2,145,950)

 

      1,653,115

                 

Liabilities

               

Braskem S.A

 

Brazil

 

          2,063,844

 

         (2,063,844)

 

 

Braskem America

 

USA

 

             305,289

 

 

 

           305,289

Braskem Chile

 

Chile

 

                 1,404

 

                   (135)

 

               1,269

Braskem Petroquímica

 

Brazil

 

             162,241

 

              (81,971)

 

             80,270

Braskem Petroquímica - efeitos da combinação de negócios

 

Brazil

 

             123,695

 

 

 

           123,695

       

        2,656,473

 

       (2,145,950)

 

         510,523

 

 

70


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

(c)                Realization of deferred income tax and social contribution

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated

 

 

 

 

Balance at

 

Realization

       

December 31,

                     

2023

Assets

 

Note

 

2017

 

2018

 

2019

 

2020

 

2021

 

2022

 

thereafter

                                 
   Tax losses (IR) and negative base (CSL)  

(i)

 

1,878,809

 

18,357

 

95,276

 

115,361

 

287,416

 

471,379

 

891,020

 Goodwill amortized  

 

 

59,335

 

20,053

 

17,604

 

15,156

 

4,062

 

364

 

2,096

 Exchange variations  

(ii)

 

388,293

 

32,663

 

 

 

19,598

 

 

 

 

 

336,032

 Temporary adjustments  

(iii)

 

220,954

 

80,548

 

24,017

 

29,931

 

12,294

 

11,762

 

62,402

 Business combination  

(iv)

 

183,785

 

38,775

 

38,775

 

38,775

 

33,731

 

33,729

 

 

Total assets

     

2,731,176

 

190,396

 

175,672

 

218,821

 

337,503

 

517,234

 

1,291,550

                                 

Liabilities

                               
   Amortization of goodwill based on future profitability  

(v)

 

712,873

   

712,873

 Tax depreciation  

(vi)

 

960,202

   

960,202

 Temporary differences  

(vii)

 

231,822

 

78,653

 

23,452

 

29,227

 

12,005

 

11,485

 

77,000

 Business combination  

(viii)

 

9,664

 

34

 

34

 

34

 

34

 

34

 

9,494

 Additional indexation PP&E  

(ix)

 

67,072

 

5,366

 

5,366

 

5,366

 

5,366

 

5,366

 

40,242

 Amortization of fair value adjustments on 
    the assets from the acquisiton of Quattor
     

519,623

 

41,570

 

41,570

 

41,570

 

41,570

 

41,570

 

311,773

 Other      

4,273

 

 

 

 

 

 

 

 

 

 

 

4,273

Total liabilities

     

2,505,529

 

125,623

 

70,422

 

76,197

 

58,975

 

58,455

 

2,115,857

                                 

Net

     

225,647

 

64,773

 

105,250

 

142,624

 

278,528

 

458,779

 

(824,307)

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Parent company

 

 

 

 

Balance at

 

Realization

       

December 31,

                     

2023

Assets

 

Note

 

2017

 

2018

 

2019

 

2020

 

2021

 

2022

 

thereafter

                                 
   Tax losses (IR) and negative base (CSL)  

(i)

 

58,421

 

 

 

58,421

 
 Goodwill amortized  

0.00

 

3,916

 

364

 

364

 

364

 

364

 

364

 

2,096

 Exchange variations  

(ii)

 

388,293

 

32,663

 

 

 

19,598

   

336,032

 Temporary adjustments  

(iii)

 

922,422

 

252,146

 

75,181

 

93,694

 

38,486

 

36,819

 

426,096

 Business combination  

(iv)

 

183,785

 

38,775

 

38,775

 

38,775

 

33,731

 

33,729

 

 

Total assets

     

1,556,837

 

323,948

 

172,741

 

152,431

 

72,581

 

70,912

 

764,224

                                 

Liabilities

                               
 Amortization of goodwill based on future profitability  

(v)

 

712,873

   

712,873

 Tax depreciation  

(vi)

 

960,202

   

960,202

 Temporary differences  

(vii)

 

8,187

 

2,238

 

667

 

832

 

342

 

327

 

3,781

 Business combination  

(viii)

 

1,302

 

34

 

34

 

34

 

34

 

34

 

1,132

 Additional indexation PP&E  

(ix)

 

67,072

 

5,366

 

5,366

 

5,366

 

5,366

 

5,366

 

40,242

 Amortization of fair value adjustments on the assets from the acquisiton of Quattor      

519,623

 

41,570

 

41,570

 

41,570

 

41,570

 

41,570

 

311,773

 Other      

3,516

 

 

 

 

 

 

 

 

 

 

 

3,516

Total liabilities

     

2,272,775

 

49,208

 

47,637

 

47,802

 

47,312

 

47,297

 

2,033,519

                                 

Net

     

(715,938)

 

274,740

 

125,104

 

104,629

 

25,269

 

23,615

 

(1,269,295)

 

Basis for constitution and realization:

(i)       

In Brazil and Germany, the use of tax losses has limits in relation to the amount of taxable income for the year. In Brazil, this limit is 30%, whereas in Germany is 60%.

(ii)     

In Brazil, the Company opted to tax exchange variation of assets and liabilities denominated in foreign currency under the cash method. Thus, this variation will be realized as assets and liabilities are received/paid. For accounting purposes, exchange variation is recognized under the accrual basis, which results in deferred IR and CSL.

(iii)   

Accounting expenses not yet deductible for calculating income tax and social contribution, whose recognition for tax purposes occurs in subsequent periods.

(iv)     

Refers to: tax-related goodwill, and contingencies recognized from business combinations. Tax realization of goodwill will occur upon the merger of the investments and contingencies arising from write-offs due to the settlement or reversal of the processes involved.

(v)       

Goodwill for the future profitability of the merged companies not amortized since the adoption of Law 11,638/07. Tax realization is associated with the write-off of goodwill due to impairment or any other reason.

 

 

 

71


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

(vi)     

For calculation of IR and CSL, assets are depreciated at rates higher than those used for accounting purposes. As tax depreciation is exhausted, these deferred IR and CSL start to be realized.

(vii)   

Revenues whose taxation will occur in subsequent periods.

(viii) 

Fair value adjustments on property, plant and equipment and intangible assets identified in business combinations, whose tax realization is based on the depreciation and amortization of these assets.

(ix)     

Additional adjustment of property, plant and equipment, whose tax realization is based on the depreciation of assets.

 

Considering the limitations to the use of tax losses in Brazil and Germany and the known impacts on the position of deferred taxes, the Company estimates that it will be necessary to generate taxable income of around R$665,076 in the following years to realize its deferred tax assets registered on December 31, 2017.

 

Annually, the Company revises its projection of taxable income based on its Business Plan (Note 3.1). If this projection indicates that the taxable income will not be sufficient to absorb the deferred taxes, the amount corresponding to portion of the asset that will not be recovered is written off.

 

22                Sundry provisions 

 

 

 Consolidated

 

 Parent company

 

2017

 

2016

 

2017

 

2016

   Provision for customers rebates

                87,913

 

                41,475

 

                34,367

 

                24,167

 Provision for recovery of environmental damages

              300,249

 

              254,040

 

              300,249

 

              228,618

 Other

                25,510

 

                23,621

 

                  3,832

 

                  3,798

Total

            413,672

 

            319,136

 

            338,448

 

            256,583

               
 Current liabilities

              178,676

 

              112,891

 

              125,130

 

                87,084

 Non-current liabilities

              234,996

 

              206,245

 

              213,318

 

              169,499

Total

            413,672

 

            319,136

 

            338,448

 

            256,583

 

(a)               Client discounts, rebates

 

Some sales agreements of Braskem provide for a rebate, in products, should some sales volumes be achieved within the year, six-month period or three-month period, depending on the agreement. The bonus is recognized monthly in a provision, assuming that the minimum contractual amount will be achieved. As it is recognized based on contracts, the provision is not subject to significant uncertainties with respect to their amount or settlement.  

 

(b)               Recovery of environmental damages

 

Braskem has a provision for future expenses for the recovery of environmental damages in some of its industrial plants. The amount provisioned corresponds to the best and most conservative estimate of the expenses required to repair the damages.

 

72


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

(c)                Changes in provisions          

 

 

 

 

 

 

 

 

Consolidated

     

Recovery of

       
     

environmental

       
 

Bonus

 

damage

 

Other

 

Total

               

December 31, 2016

              41,475

 

             254,040

 

            23,621

 

        319,136

               

Additions, inflation adjustments and exchange variation, net

              116,085

 

               102,480

 

               5,744

 

          224,309

Write-offs through usage and payments

              (69,647)

 

               (56,271)

 

              (3,855)

 

         (129,773)

               

December 31, 2017

              87,913

 

             300,249

 

            25,510

 

        413,672

 

 

 

 

 

 

 

Parent company

     

Recovery of

       
     

environmental

       
 

Bonus

 

damage

 

Other

 

Total

               

December 31, 2016

              24,167

 

             228,618

 

              3,798

 

        256,583

               

Additions, inflation adjustments and exchange variation, net

                34,181

 

                 96,203

 

               4,194

 

          134,578

Addition by incorporation

   

                 27,947

     

            27,947

Write-offs through usage and payments

              (23,981)

 

               (52,519)

 

              (4,160)

 

           (80,660)

             

 

December 31, 2017

              34,367

 

             300,249

 

              3,832

 

        338,448

 

23                Contingencies

 

Braskem is a defendant in lawsuits and administrative proceedings arising from the normal course of its business. These claims are of a tax, labor and social security, civil and corporate nature. Proceedings assessed as having a probable chance of loss are provisioned for, as described in Note 3.5. Proceedings assessed as having a possible chance of loss are not provisioned for, except in relevant cases involving business combinations. Any changes in the court’s understanding of the position could cause future impacts on the financial statements of the Company due to such proceedings.

 

 

73


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

23.1          Claims with probable chance of loss and arising from business combinations

 

     

 Consolidated

 

 Parent company

     

2017

 

2016

 

2017

 

2016

Labor claims

(a)

 

              255,938

 

              207,827

 

              247,821

 

              197,452

                   

Tax claims

(b)

               
   Normal operations                  
    IR and CSL    

                17,313

 

                11,462

 

                17,313

 

                11,462

   PIS and COFINS

(ii)

 

              155,681

 

              204,516

 

              155,681

 

              204,333

   ICMS

(iv)

 

                76,342

 

                39,604

 

                76,342

 

                39,604

   Other tax claims    

                  8,985

 

                19,586

 

                  8,985

 

                17,382

     

            258,321

 

            275,168

 

            258,321

 

            272,781

                   

   Business Combination

                 
   IR and CSL    

                50,051

 

                45,656

 

                50,051

 

 

   PIS and COFINS

(iii)

 

                56,135

 

                51,052

 

                56,135

 

                51,052

   ICMS - interstate purchases

(i)

 

              263,538

 

              239,450

 

              263,538

 

              239,450

     

            369,724

 

            336,158

 

            369,724

 

            290,502

                   

Corporate claims

(c)

 

              135,779

 

              105,175

 

              135,779

 

              105,175

     

Civil claims and other

   

                72,883

 

                60,909

 

                72,883

 

                60,909

                   
     

         1,092,645

 

            985,237

 

         1,084,528

 

            926,819

 

(a)        Labor claims

 

The provision on December 31, 2017 is related to 599 labor claims, including occupational health and security cases (632 in 2016). The Company’s legal advisors estimate that the term for the termination of these types of claims in Brazil exceeds five years. The estimates related to the outcome of proceedings and the possibility of future disbursement may change in view of new decisions in higher courts.

 

(b)        Tax claims

 

On December 31, 2017, the main claims are the following:

 

(i)                 ICMS - interstate purchases

 

In 2009, the merged company Braskem Qpar was assessed by the Finance Department of the State of São Paulo for the payment, at the administrative level, of ICMS in view of allegedly committing the following violations:

 

 

 

 

74


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

·               

Undue use of ICMS tax credits (i) in the amount of R$53,478, in the periods from February 2004 to August 2005, November 2005 to February 2006, and September 2006 to January 2008, due to the recording of credits indicated on the invoices for the sale of “acrylonitrile,” issued by Acrinor  Acrilonitrila do Nordeste S/A; (ii) in the amount of R$1,581, in the period from December 2004 to August 2005, arising from the undue recording of credits on invoices for the sale of methyl acrylate, issued by Proquigel Química S/A; and (iii) in the amount of R$3,105, in the period from August 2004 to November 2005, arising from the undue recording of credits in invoices for the sale of methyl methacrylate, issued by Proquigel Química S/A, since the products were to be exported, and therefore were exempt from payment of ICMS tax;

 

·               

The fine for the abovementioned tax offense corresponds to 100% of the principal value recorded, as per Article 527, item II, sub-item “j” jointly with paragraphs 1 and 10 of RICMS/SP; 

 

·               

Fine of 30% on the amount of R$480,389, which corresponds to the sum of the amounts declared in the tax documents for which the shipping of goods was not confirmed by tax authorities, based on the provisions of Article 527, item IV, sub-item “b” jointly with paragraphs 1 and 10 of RICMS/SP; and

·               

Fine due to lack of presentation of tax documents requested, as per Article 527, item IV, sub-item “j” jointly with paragraphs 8 and 10 of RICMS/SP.

 

Discussions in the administrative sphere were ended in 2016, with the Company proposing lawsuits. Due to the favorable injunctions granted to the Company, (i) in one of the claims, the São Paulo Treasury Department rectified the amount of the debt to apply interest for late payment and inflation adjustment limited to the SELIC basic interest rate, which resulted in the debit being reduced by 20%, and (ii) in the other claim, the tax liability was suspended.

 

On December 31, 2017, the balance of these provisions was R$263,538.

 

The Company’s external advisors have assessed that the disputes related to the highlighted matters have a probable likelihood of loss and estimate the conclusion of administrative proceedings in 2020.

 

A performance bond was offered as a guarantee for these claims.

 

(ii)               Non-cumulative PIS and COFINS taxes

 

The Company is charged amounts arising from the compensation of Non-Cumulative PIS and COFINS tax credits that were not approved by the Federal Revenue Service in Offsetting Statements (“DCOMPs”), with credits in amounts that exceeded those declared in the respective Statement of Calculation of Social Contributions (“DACONs”).

 

In October 2017, through the federal tax amnesty program (PERT), the items related to non-acceptance of the credits were settled, due to the following reasons: (i) differences between the amounts reported in the DACONs and those in the electronic files of tax invoices; (ii) amounts not recorded in the interim balance sheets, acquisitions not taxed for contributions, recording of a credit on a portion of IPI, failure to submit tax documents; and (iii) nonpayment of amounts stated as due in tax documents. Said amounts were provisioned for.

 

On December 31, 2017, the balance of this provision was R$153,639.

 

The Company’s external legal advisors, after considering the precedents on the matters at the Administrative Council of Tax Appeals (“CARF”), assessed that the disputes related to such matters have a probable likelihood of loss and estimated the conclusion of administrative procedures in 2020.

 

There are no deposits or any other type of guarantee for these procedures, since they are still being discussed at the administrative level.

 

75


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

(iii)             PIS and COFINS taxes

 

The Company is assessed for the payment of these taxes in many claims, such as:

 

·               

Insufficient payment of COFINS for the period from March 1999 to December 2000, from February 2001 to March 2002, from May to July 2002 and September 2002 due to alleged calculation errors, and non-compliance with the widening the tax calculation base and increasing the contribution rate envisaged in Law 9,718/98;

 

·               

Offset of the COFINS dues relating to September and October 1999 using the credit resulting from the addition of 1% to the COFINS rate;

 

·               

Rejection of the offset of PIS and COFINS dues relating to the period from February to April 2002 using the PIS credits under Decree-Laws 2,445 and 2,449, calculated between June 1990 and October 1995, under the argument that the time period for using said credits had expired; and

 

·               

Alleged non-taxation of revenue from foreign exchange variations, determined as a result of successive reductions in the capital of the associated company.

 

On December 31, 2017, the balance of this provision was R$56,135.

 

The Company’s external advisors assessed that the disputes related to the highlighted matters have a probable likelihood of loss and estimated the conclusion of administrative proceedings in 2020.

 

Guarantees were offered for these claims in the form of bank guarantee and finished products, which, together, cover the amount of court claims. The Company’s management estimates that these cases should be terminated by 2020.

 

(iv)             ICMS – Decree 38,394/2000

 

In 2017, the Company received a tax deficiency notice from the Tax Authority of the State of Alagoas, for the administrative collection of ICMS tax that allegedly was paid below the amount due, in the period from August 2012 to April 2016, in accordance with Article 9 of Decree 38.394/2000.

 

On December 31, 2017, the balance of this provision was R$43,774.

 

The Company’s external legal advisors, considering the behavior of the administrative bodies judging the case,  assessed that the disputes related to the highlighted matters have a probable likelihood of loss and estimated the conclusion of administrative proceedings in 2021.

 

There are no deposits or any other type of guarantee for these procedures, since they are still being discussed at the administrative level.

 

(c)        Corporate claims

 

On December 31, 2017, the main claim is related to an ordinary collection claim combined with a request for damages for losses, requesting the payment of dividends and a share bonus arising from the class "A" preferred shares of the dissolved company Salgema Indústrias Químicas S.A.

 

76


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

Once the claim was granted, the amount effectively owed by Braskem began to be calculated. During this phase, the judge recognized that dividends and bonus related to fiscal years prior to 1987 had become time-barred and were no longer owed by Braskem.

However, the Alagoas State Court of Appeals reviewed the decision and considered that amounts prior to such period also were owed. Against the decision, Braskem filed a Special Appeal with the Superior Court of Justice (“STJ”), which was partially granted, so that the possibility that the statute of limitation will be recognized in a procedure of liquidation of the award will be submitted to the STJ.

 

During fiscal year 2017, Braskem recognized a provision of R$56,171 and there is no guarantee related to this claim.

 

(d)               Changes of claims with probable chance of loss

 

 

Consolidated

         

Corporate

 

Civil claism

   
 

Labor claims

 

Tax claims

 

claims

 

and other

 

Total

                   

December 31, 2016

            207,827

 

             611,326

 

    105,175

 

            60,909

 

       985,237

                   

Additions, inflation adjustments and exchange variation, net

              164,962

 

               177,314

 

      169,683

 

             20,257

 

         532,216

Write-offs through usage and payments

            (115,497)

 

             (130,596)

 

     (170,432)

 

              (8,283)

 

       (424,808)

                   

December 31, 2017

            257,292

 

             658,044

 

    104,426

 

            72,883

 

    1,092,645

   

 

 

 

 

 

 

 

 

 

Parent company

         

Corporate

 

Civil claism

   
 

Labor claims

 

Tax claims

 

claims

 

and other

 

Total

                   

December 31, 2016

            197,452

 

             563,283

 

    105,175

 

            60,909

 

       926,819

                   

Additions, inflation adjustments and exchange variation, net

              156,469

 

               175,010

 

      169,683

 

             20,257

 

         521,419

Addition by incorporation

                  7,351

 

                 51,497

   

           58,848

Write-offs through usage and payments

            (113,451)

 

             (130,392)

 

     (170,432)

 

              (8,283)

 

       (422,558)

                 

 

December 31, 2017

            247,821

 

             659,398

 

    104,426

 

            72,883

 

    1,084,528

 

23.2          Claims with possible chance of loss

 

The balance of contingent liabilities as of December 31, 2017 and 2016 is as follows:

 

 

     

 

 

Consolidated

     

2017

 

2016

           

Tax claims

   

        6,997,301

 

        6,307,214

Labor claims

   

           933,484

 

           580,623

Civil claims

   

           714,963

 

           494,965

Social security tax claims

   

           423,350

 

           122,941

Other lawsuits

   

           248,195

 

             43,356

Total

   

     9,317,293

 

     7,549,099

 

 

77


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

(a)               Civil

 

(i)                 Excess weight

 

Public-Interest Civil Action filed by the Federal Prosecution Office in Brasilia, with the objective of holding the company liable for damages caused to federal roads by trucks carrying excess weight. The action claims damages to the country for material damages and collective pain and suffering, in the amount of R$61 million, on December 31, 2017. The action was denied in the lower court. The case was classified as having a possible chance of loss, in light of the precedents in the Regional Federal Appellate Court of the 1st Region denying the claim by the Federal Prosecution Office.

 

(ii)               Caustic soda transportation

 

The Company is the defendant in civil lawsuits filed by the owner of a former distributor of caustic soda and by the shipping company that provided services to this former distributor, which, at December 31, 2017, totaled R$184 million. The claimants seek indemnity for damages related to the alleged non-performance of the distribution agreement by the Company.

 

Management's evaluation, supported by the opinion of its external legal advisors who are responsible for the cases, is that the lawsuits will possibly be dismissed within a period of 8 years.

 

No judicial deposit or other form of guarantee was accrued for these lawsuits.

 

(iii)             Resale of solvents

 

In January 2017, the Company became defendant in a civil lawsuit filed by former reseller of solvents, claiming alleged breach of a tacit distribution agreement. On December 31, 2017, the damages claimed in the lawsuit amounted to R$164 million.

 

Based on the opinion of external legal counsel accompanying the case, the Management believes that the lawsuit has a possible risk of loss within an eight-year period.

 

No judicial deposit or other form of security was made for these suits.

 

(b)               Tax

 

(i)                 PIS, COFINS, IR and CSL: taxation of tax losses and reductions in debits in connection with the installment payment program under MP 470/09

 

The Company was assessed for not recording as taxable the amounts of the credits from tax losses and social contribution tax loss carryforwards used to settle tax debits paid in installments under Provisional Presidential Decree 470/09. In the specific case of PIS and COFINS taxes, the assessment also includes the reductions applied to fines and interest arising from the adoption of the installment payment plan. Said tax credits and reductions of debits were not taxed, given the understanding of the Company that they did not represent taxable income.

 

On December 31, 2017, the inflation-adjusted amount of taxes recorded and tax effects of disallowances of income tax losses and social contribution tax loss carryforwards through said tax deficiency notices is R$1.6 billion. 

 

78


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

The Company’s external legal advisors estimate that the administrative proceeding should be concluded for the coming year.

 

There are no deposits or any other type of guarantee for these procedures, since they are still being discussed at the administrative level.

 

(ii)               IR and CSL – Charges with goodwill amortization

 

The Company was served by the Federal Revenue Service for deducting amortization charges, from 2007 to 2013, relating to goodwill originated from acquisitions of shareholding interests in 2002. In that year, several business groups divested their petrochemical assets, which were consolidated to enable the consequent foundation of Braskem. 

 

On December 31, 2017, the restated value of the taxes recorded in said tax deficiency notices amounted to R$1.4 billion.

 

The assessment of loss in these claims is based on the following: (i) the equity interests were acquired with effective payment, business purpose and the participation of independent parties; and (ii) the real economic nature of the transactions that resulted in the recording of interest and exchange variation expenses.

 

The Company’s external legal advisors estimate that the administrative proceeding should be concluded by 2022.

There are no deposits or any other type of guarantee for these procedures, since they are still being discussed.

 

(iii)             Non-cumulative PIS and COFINS taxes

 

The Company received a deficiency notice from the Brazilian Federal Revenue Service due to the use of non-cumulative PIS and COFINS tax credits in the acquisition of certain goods and services consumed in its production process. The matters whose chance of loss is deemed as possible are mainly related to the following: (i) effluent treatment services; (ii) charges on transmission of electricity; (iii) freight for storage of finished products; and (iv) extemporaneous credits from acquisitions of property, plant and equipment. These matters have already been contested at the administrative level and comprise the period from 2006 to 2011.

 

On December 31, 2017, the restated value of these notices was R$984 million.

 

The Company’s external legal advisors estimate that: (i) the administrative proceedings should be concluded by 2022; and (ii) in the event of an adverse ruling for the Company, which is not expected, these contingencies could be settled for up to 50% of the amounts in dispute. These estimates are based on the probability of loss of the Company's defense thesis, based on previous administrative and court precedents.

 

There are no deposits or any other type of guarantee for these procedures, since they are still being discussed at the administrative level.

 

(iv)             Income Tax (IR) and Social Contribution (CSL) – Unlimited offsetting

 

The Company received a tax deficiency notice claiming, in December, 2009, December, 2013 and in March, 2017 by the methodology used to offset tax losses and tax loss carryforwards that failed to observe the limit of 30% of the Taxable Profit and Social Contribution calculation base when offsetting such liabilities with Income Tax and Social Contribution liabilities in merger operations, respectively, in November, 2007, September 2008 and August 2013.

 

79


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

On December 31, 2017, the restated value of the taxes recorded amounted to R$734 million.

 

The Company’s external legal advisors estimate that the administrative proceedings should be concluded by 2020 and for the year 2027 for the only one that is in judicial discussion.

 

There are no deposits or any other type of guarantee for these procedures, since they are still being discussed at the administrative level and the only one being disputed in court has had its payment suspended by a preliminary injunction.

 

(v)               ICMS

 

The Company is involved in many ICMS collection claims drawn up in the States of São Paulo, Rio de Janeiro, Rio Grande do Sul, Bahia and Alagoas.

 

On December 31, 2017, the adjusted amounts of these claims total R$470 million and the claims include the following matters:

 

·          

ICMS credit on the acquisition of assets that are considered by the Revenue Services as being of use and consumption. The Revenue Service understands that the asset has to be a physically integral part of the final product to give rise to a credit. Most of the inputs questioned do not physically compose the final product. However, the Judicial branch has a precedent that says that the input must be an integral part of the product or be consumed in the production process.

 

·          

ICMS credit arising from the acquisition of assets to be used in property, plant and equipment, which is considered by the Revenue Services as not being related to the production activity, such as laboratory equipment, material for the construction of warehouses, security equipment, etc.

 

·          

internal transfer of finished products for an amount lower than the production cost;

 

·          

omission of the entry or shipment of goods based on physical count of inventories;

 

·          

lack of evidence that the Company exported goods so that the shipment of the goods is presumably taxed for the domestic market;

 

·          

non-payment of ICMS on the sale of products subject to tax substitution and credit from acquisitions of products subject to tax substitution;

 

·          

fines for the failure to register invoices; and

 

·          

nonpayment of ICMS tax on charges related to the use of the electricity transmission system in operations conducted in the Free Market (ACL) of the Electric Power Trading Chamber (CCEE).

 

The Company’s legal advisors estimate that: (i) these judicial proceedings are expected to be terminated in 2023, and (ii) in the event of an unfavorable decision to the Company, which is not expected, these contingencies could be settled for up to 50% of the amounts in dispute. This estimate is based on the probability of loss of the Company’s defense theory taking into consideration the case law at the administrative and judicial levels.

 

 

80


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

The Company offered assets for pledge in the amount of R$60 million, supporting exclusively the amounts involved in the lawsuits.

 

(vi)             IOF

 

The Company is a party to claims for the collection of IOF tax debits in administrative proceedings and lawsuits, which claim: (i) non-payment of IOF on operations relating to Advances for Future Capital Increase (AFAC) and checking accounts conducted by the merged companies Quattor Participações S.A. and Quattor Química S.A., which were considered loans by tax authorities; and (ii) requirement to pay IOF/credit on international fund transfers between the Company and CPN Incorporated through a checking account contract and single cash management related to the period from May 2002 to April 2004.

 

The current value of these notices on December 31, 2017, was R$175 million.

 

The Company’s external legal advisors estimate that the claims in the judicial sphere will be concluded by 2022.

 

The Company offered a guarantee of R$61 million, which supports the amount involved exclusively in the claims.

 

(vii)           PIS and COFINS sundry

 

The Company is involved in collection actions related to PIS and COFINS assessments in the administrative and judicial courts, which discuss the alleged undue offsetting of credits arising from other administrative proceedings and lawsuits, including: (i) Income Tax prepayments; (ii) FINSOCIAL; (iii) tax on net income (ILL); (iv) PIS-Decrees; and (v) the COFINS tax arising from the undue payment or payment in excess.

 

On December 31, 2017, the adjusted amounts involved of these assessments total R$134 million.

 

The Company’s external legal advisors estimate that: (i) these judicial proceedings are expected to be terminated in 2022; and (ii) in the event of an unfavorable decision to the Company, which is not expected, these contingencies could be settled for up to 50% of the amounts in dispute. This estimate is based on the probability of loss of the Company’s defense theory taking into consideration the case law at the administrative and judicial levels.

 

The Company offered assets in guarantee, in the amount of R$134 million, that cover the entire amount of the claims.

 

(viii)         IRRF, IR and CSL – Commission expenses

 

In December, 2017 the Company received a tax deficiency notice from the Federal Revenue Service arising from: (i) the disallowance of commission expenses paid by Braskem in 2011; (ii) the disallowance of commission expenses paid by Braskem Inc. in 2013 and 2014; (iii) lack of payment of withholding income tax (IRRF) on the payments referred to in the previous item; and (iv) the disallowance of advertising expenses incurred in 2013.

 

81


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

On December 31, 2017, the restated amount of taxes and tax effects from disallowances of income tax losses and social contribution tax loss carryforwards through said tax deficiency notice is R$116 million.

 

The assessment of success in this claim is based on the following: (i) the expenses incurred in 2011 already are subject to the statute of limitations. Furthermore, the tax credit recognized by the Tax Authority considered the sum of the disallowances disputed in other administrative proceedings that are pending a final decision, which do not belong in the claim in question; (ii) the expenses incurred by Braskem INC already were paid by the Company itself, which led only to the reduction of its tax loss backlog, without the need to pay additional taxes; (iii) the IRRF claimed by the Tax Authority aims to reach a taxpayer located abroad, which as such is not subject to Brazilian tax law; and (iv) the disallowed advertising expenses are related to the Company’s business activities.

 

The Company’s external legal advisors estimate that the administrative proceeding should be concluded in 2022.

 

There are no judicial deposits or any other type of guarantee for this procedure, since it is still being discussed at the administrative level.

 

(ix)             IRPJ and CSLL – Exchange variation on naphtha imports

 

In December 2017, the Company received a tax deficiency notice related to the disallowance of exchange variation expenses between the due date of commercial invoices and the effective payment of obligations related to naphtha imports. The Company disallowed expenses in calendar year 2012, since they were considered unnecessary, which caused adjustments in the tax loss and in social contribution tax loss carryforwards.

On December 31, 2017, the restated value of this deficiency notice amounted to R$104 million.

 

The Company’s external legal advisors estimate that the administrative proceeding should be concluded in 2022.

 

There are no deposits or any other type of guarantee for these procedures, since they are still being discussed at the administrative level.

 

(x)               Isolated fine – failure to ratify DCOMPS

 

In December 2016, the Company was notified of isolated fines corresponding to 50% of non-cumulative COFINS tax credits – Exports, which were offset with federal taxes and not approved by the Federal Revenue Service.

 

The matter is assessed as having a possible chance of loss due to favorable court precedents on the matter.

 

On December 31, 2017, the restated value of these deficiency notices amounted to R$95 million.

 

The Company’s external legal counsels estimate that the conclusion in the administrative level will occur in 2020.

 

No deposit or other form of security was accrued for most of these claims, as they are still being discussed administratively.

 

82


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

(xi)             Income Tax and Social Contribution – Reduction of tax losses and social contribution tax loss carryforwards

 

The Company also received a tax-deficiency notice due to the inclusion in the income and social contribution tax calculation base of interest and exchange variation expenses incurred in calendar-year 2008 related to obligations assumed in business combinations.

 

On December 31, 2017, the inflation-adjusted amount of tax effects from disallowances of income tax losses and social contribution tax loss carryforwards through said tax deficiency notices is R$53 million.

 

The Company’s external legal advisors estimate that the administrative proceeding should be concluded in 2022.

 

There are no deposits or any other type of guarantee for these procedures, since they are still being discussed at the administrative level.

 

(c)                Corporate

 

The Company currently is subject to the liquidation of an award related to an lawsuit filed in 1988, which sentenced Polialden Petroquímica S.A., merged into Braskem, to pay its non-controlling preferred shareholders the distribution of the remaining profits of the company.

 

The purpose of the liquidation is to determine the value of the award calculated in accordance with the sentence, which will occur through an arbitration procedure, as determined by the court, and was appealed against by the judgment winner, which is pending trial. The procedure is awaiting the beginning of the expert analysis. 

 

Based on the understanding of the Company's external legal advisors, as of December 31, 2017, the registered amount is R$13 million while the possible likelihood of loss is R$161 million.

 

(d)       Other lawsuits

 

(i)                 Social Security Contributions – Withholding of 11%

 

The Company was assessed by the Federal Revenue Service for allegedly withholding social security at the rate of 11% on the gross amount of invoices, bills or trade notes related to services executed through assigned labor, in the period from February 1999 to June 2002, amounting to R$51 million, on December 31, 2017.

 

The Company's legal advisors, in view of prior decisions by the Administrative Council of Tax Appeals (CARF) and the evidence provided by the Company, assess as possible the chances of loss at the administrative level. The conclusion is supported, among other things, by the following: (i) the time-barring of a portion of the debits; (ii) the mismatch between the service provided and the tax substitution system under Article 31 of Federal Law 8,212/1991; (iii) the lack of the requirements to characterize assignment of labor, and other matters that would have to be evidenced through a tax diligence.

 

The Company’s external legal advisors estimate that the administrative proceeding should be concluded in 2019.

 

83


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

(ii)               Social security – hazardous agents

 

In August 2017, the Company received a deficiency notice from Brazil’s Federal Revenue Service requiring the payment of a premium for Labor Accident Risk (“RAT”) to fund the special retirement plan due to the alleged exposure of its workers to hazardous agents in the period from January 2013 to December 2015. The total amount involved in the notice, as of December 31, 2017, is R$324 million.

 

The Company is a party to other actions in administrative proceedings and lawsuits, which claim: (i) payments related to deficiency notices from August 2007 for said additional contribution for RAT and a financial penalty for not informing on the GFIP form the alleged exposure in the period from April 1999 to February 2006; and (ii) the requirement in a tax foreclosure from May 2017 of said additional payment for RAT in the periods from November 2000 to January 2001 and from November 2001 to June 2002. The total amount involved in these proceedings, as of December 31, 2017, is R$37.8 million.

 

The Company’s external legal advisors estimate that the administrative proceedings should be concluded in 2021, while the only lawsuit should be concluded in 2027.

 

There are no deposits or other forms of guarantees for the processes under discussion in the administrative proceedings and the Company offered a guarantee in the form of a performance bond in the amount of R$3.6 million supporting exclusively the amount involved in the lawsuit.

 

23.3          Global Settlement with authorities

 

(a)        Global Settlement with authorities

 

The Leniency Agreement (“Agreement”) entered into in December 2016 with the Federal Prosecution Office (“MPF”) and with U.S. and Swiss authorities (“Global Settlement”), in the approximate amount of US$957 million (approximately R$3.1 billion) was officially ratified as follows:

 

    1.      

In Brazil, the Agreement was ratified by the 5th Coordination and Review Chamber of the MPF on December 15, 2016, with ratification by the 13th Federal Court of Curitiba on June 6, 2017.

2.      

The agreement with the U.S. Department of Justice (“DoJ”) was confirmed by a U.S. court ruling on January 26, 2017.

3.      

The agreement with the Securities and Exchange Commission (“SEC”) was confirmed on February 28, 2017.

4.      

The agreement with Swiss authorities did not require ratification to produce effect.

 

Of the aggregate amount of the Global Settlement, the Company already has paid approximately R$1.6 billion, as follows:

 

    1.      

US$94,894 (R$296,591) to the DoJ, paid on February 8, 2017;

2.      

US$65,000 (R$206,460) to the SEC, paid on April 27, 2017;

3.      

CHF30,240 (R$104,307) to the Swiss Office of the Attorney General, paid on June 27, 2017;

4.      

R$736,445 to the MPF, paid on July 6, 2017;

5.      

R$267,985 to the MPF, paid on January 30, 2018.

 

The outstanding amount, of approximately R$1.5 billion, will be paid as follows:

 

84


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

    1.      

CHF64,260 to the Swiss Office of the Attorney General in four annual installments of CHF16.065 due on June 30 of each year as from 2018;

2.      

R$1.3 billion to the MPF in five annual installments adjusted for inflation by the variation in the IPCA inflation index due on January 30 of each year, with the next maturity in 2019. To guarantee payment of the installments coming due, Braskem gave as collateral assets from its property, plant and equipment corresponding to one annual installment.

 

Braskem is in compliance with its obligations under the Global Settlement and continues to collaborate with the authorities.

 

(b)       Reimbursement for damages and other considerations

 

A significant portion of the total amount of R$$2.2 billion of the Agreement entered with the MPF will be made available for use in reimbursing third parties for any damages caused by the wrongdoings. 

 

Under the Agreement, the MPF undertook to coordinate actions with other authorities or government agencies with which Braskem comes to negotiate for entering into agreements involving the facts uncovered in connection with the Agreement, the public prosecution offices of states and cities in Brazil, state-owned companies and state-controlled companies for entering into similar agreements with such organizations, including for the purpose of preventing duplicate restitution with regard to the amount paid under the Agreement.

 

The Agreement does not prevent any third party from filing proceedings to seek reimbursement for any damages caused by Braskem, which could result in payments other than those provided for in the Agreement. Therefore, the Company cannot guarantee that the total amount available for reimbursement will be sufficient to fully reimburse any third parties affected by the wrongdoings, which means that the Company may be subject to the payment of damages or financial penalties other than those provided for in the Global Settlement. In addition, other authorities with jurisdiction over the Company may seek to impose additional monetary sanctions or fines or commence new investigations against Braskem. Finally, as a result of the Global Settlement, the Company may be subject to increased operating costs in connection with its obligations to improve its governance and anti-corruption practices, including the cost of required external monitorship.

 

It is not possible to predict the impacts on Braskem of others investigations or any decision or action taken by authorities involving its largest shareholders, namely Odebrecht S.A. and Petróleo Brasileiro S.A. – Petrobras, or any of their subsidiaries.

 

(c)        Control deficiencies and Compliance Program

After the investigation and confirmation of wrongdoings, the Company identified material control deficiencies.

 

In 2016, it began developing a comprehensive Compliance Program to strengthen its governance with the goal of significantly reducing the possibility of other wrongdoings of the same kind from recurring. The Program also contains initiatives that were implemented throughout 2017.

 

As of the fiscal year ended December 31, 2017, a series of Compliance initiatives were implemented, including:

 

 

 

85


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

     (i)            

Increase in the number of Team Members in the Compliance Department, including hiring Compliance Officers to serve foreign countries;

(ii)          

Designation and engagement of independent monitors jointly with the DoJ and MPF, and beginning of analysis of the Company’s processes and documents by said monitors;

(iii)        

Review and approval of the following guiding documents: Policy on Compliance in Acting Ethically with Integrity and Transparency; Internal Audit Directive; Corporate Credit Card Directive; Procedure for payment of commissions to agents; Personnel Selection Directive (hiring of Members); Work travel guideline; Internal Controls Guideline and Ethics Line Investigation Protocols;

(iv)          

Continuing the training program with a focus on the Compliance System, applicable legislation and raising Team Member awareness;

(v)            

Setting a corporate target related to Compliance for all Leaders at the Company;

(vi)          

Approving the Directive and Procedure for Relations with Government Officials, which regulates interactions with politicians and executives at state-owned companies;

(vii)        

Formally and effectively participating in working groups: UN Anticorruption and ETHOS Integrity;

(viii)      

Improving the supplier registration and approval process by implementing a third-party risk and integrity assessment;

(ix)          

Developing the Communication Plan for disseminating the Company’s commitment to conducting its Business Ethically with Integrity and Transparency;

(x)            

Approving the Procedure for the Ethics Line, considering the formal process for handling reports of violations and investigation protocols;

(xi)          

Outsourcing of the Whistleblowing Channel and improving the tool for receiving reports of violations;

(xii)        

Mapping of risks and controls and beginning of assessment of the effectiveness of controls for the most relevant corporate processes in Brazil, United States, Mexico, Netherlands and Germany;

(xiii)      

Incorporating anti-corruption clauses in agreements with third parties;

(xiv)       

Implementing improvements to internal controls with a view to remediating deficiencies identified in the past (especially material deficiencies) and preventing future vulnerabilities;

(xv)         

Publishing the new version of the Code of Conduct in Brazil, Mexico and United States, and training Team Members;

(xvi)       

Defining the corporate methodology for Risk Management to be adopted in Brazil, United States, Mexico, Netherlands and Germany;

(xvii)     

Conducting Internal Audit works to address points of concern and recommendations for improvements to areas involved in the processes assessed.

 

 (d)      Class actions

On July 1, 2015, a putative class action lawsuit was filed in the United States District Court for the Southern District of New York against the Company and certain of its then-current and former officers. In the operative complaint, In Re Braskem Securities Litigation, the Lead Plaintiff, Boilermaker-Blacksmith National Pension Trust, alleges that the Defendants made misrepresentations or omissions that inflated the price of the Company’s stock in violation of U.S. securities laws.

 

After the judge rendered a decision on the motion to dismiss by the Company, granting it in part, the Company and the Lead Plaintiff signed a proposed settlement agreement ("Proposed Settlement"), to which the competent Court granted final approval and rendered a decision to dismiss the action and discharge the claims of the Class Members (as defined below).

 

Under the terms of the Proposed Settlement, Braskem will pay US$10 million to resolve all claims arising out of or relating to the subject matter of the class action of a settlement class consisting of all persons who purchased or otherwise acquired a legal or beneficial ownership interest in Braskem American Depositary Receipts (“ADRs”) between July 15, 2010 and March 11, 2015 (“Class Members”), inclusive, with the exception of any such claims belonging to purchasers who file valid and timely requests to opt out of the settlement class. The settlement amount was paid by Braskem into an escrow account (“Escrow Account”) on October 2, 2017 and the administrator of the Escrow Account shall arrange its distribution after the entry by the Court of a class distribution order, according to the allocation plan approved by the Court.

86


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

The Company maintains a provision of US$10 million (R$31,680), recorded on September 30, 2017 under “Other income (expenses), net”.

 

The Proposed Settlement was signed solely to avoid the risk, uncertainty and expenses of further litigation and does not represent the admission of any wrongdoing or liability by Braskem of unlawful practices or assumption of responsibility.

 

The Company may be named as a defendant in other legal actions. The Company may be required, in accordance with any applicable legal and regulatory limits, to indemnify directors, officers and employees that are defendants in this securities class action and any other related actions that may arise in the future. This litigation has required and may continue to require significant time and attention from the Company’s Management in the future.

 

24                Benefits offered to team members

24.1          Short-term benefits

 

Consolidated

 

Parent company

 

2017

 

2016

 

2017

 

2016

               

Health care

              140,553

 

              139,412

 

                99,519

 

                91,221

Private pension

                67,008

 

                61,593

 

                40,730

 

                33,299

Transport

                58,825

 

                55,223

 

                51,187

 

                49,141

Feeding

                30,916

 

                28,874

 

                24,738

 

                22,114

Training

                18,285

 

                20,589

 

                  9,986

 

                11,225

Other

                16,173

 

                13,237

 

                  4,093

 

                  3,147

 

            331,760

 

            318,928

 

            230,253

 

            210,147

24.2          Post-employment benefits

24.2.1    Retirement plans - defined benefit plans and health plants

Braskem America

 

The subsidiary Braskem America is the sponsor of Novamont, which is a defined benefit plan of the employees of the plant located in the State of West Virginia. At December 31, 2017, the plan has 39 active participants and 166 assisted participants (40 active participants and 164 assisted participants in 2016). The contributions by Braskem America in the year amount to R$4,069 (R$3,569 in 2016). The participants made no contributions in 2017 and 2016.

 

Braskem Alemanha and Braskem Holanda

 

The subsidiaries Braskem Alemanha and Braskem Netherlands are the sponsor of the defined benefit plans of its employees. At December 31, 2017, the plan has 133 active participants (128 in 2016) and no contributions were made by Braskem Alemanha and Braskem Holanda in 2017 and 2016. The participants made no contributions in 2017 and 2016.

87


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

 

Health plan

 

According to Brazilian laws, the type of health plan offered by the Company, named contributory plan, ensures to the participant who retires or is dismissed without cause the right to remain in the plan with the same assistance coverage conditions they had during the employment term, provided they assume the full payment of the plan (company’s part + participant’s part). This right is granted as follows:

 

The participant who was dismissed without cause has the right to remain in the health plan for more 1/3 (one-third) of the plan contribution period, considering the minimum six-month period and the maximum twenty-four-month period.

The participant who retires and contributes to the plan due to employment relationship over at least ten (10) years has the right to remain in the health plan for undetermined period. Should the participant have contributed for less than 10 years, they will have the right to remain ad a beneficiary for one (1) more year for each contribution year.

In addition to the right granted to the former participants who retired or were dismissed without cause, the Brazilian laws also establish rules for the amount charged by the plan based on beneficiaries’ age bracket. One of these rules define that the amount charged for the highest age bracket may not be six (6) times larger than the amount charged for the lowest age bracket. Thus, the amount charged from the lowest age bracket plans comprises a “subsidy” for highest age bracket plans. This subsidy is also supported by contributions from the Company. In other words, the amount charged from the participants included in the highest age brackets is not enough to cover their expenses.

 

For these plans, the Company actuarially measured its obligations for future subsidies, and arrived at the following results:

 

88


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

(i)                 Amounts in balance sheet 

 

   

 

 

 Consolidated

   

2017

 

2016

Defined benefit

       
 Novamont Braskem America  

                18,140

 

                20,285

 Braskem Alemanha and Netherlands  

                92,402

 

                69,952

   

              110,542

 

                90,237

Health care

       
 Bradesco saúde  

                83,233

 

                71,899

   

            193,775

 

            162,136

Benefit obligations

 

            (156,957)

 

            (129,617)

Health care

 

              (83,233)

 

              (71,899)

Total obligations

 

            (240,190)

 

            (201,516)

Fair value of plan assets

 

                46,415

 

                39,380

Funded status of the plan

 

            (193,775)

 

            (162,136)

Consolidated net balance (non-current liabilities)

 

          (193,775)

 

          (162,136)

 

(ii)               Change in obligations    

 

   

 

 

Consolidated

   

2017

 

2016

         
   Balance at beginning of year  

              201,516

 

              216,632

 Health care  

                11,334

 

                  2,203

 Current service cost  

                  5,058

 

                  4,576

 Interest cost  

                  4,139

 

                  3,983

 Benefits paid  

                (3,399)

 

                (3,156)

 Actuarial losses (gain)  

                  9,661

 

                  3,590

 Exchange variation  

                11,881

 

              (26,312)

 Balance at the end of the year  

            240,190

 

            201,516

 

(iii)             Change in fair value plan assets

 

         

2017

 

2016

               
 

Balance at beginning of year

   

                39,380

 

                46,395

 

Actual return on plan assets

   

                  5,115

 

                     221

 

Employer contributions

   

                  4,069

 

                  3,569

 

Benefits paid

     

                (2,915)

 

                (3,087)

 

Exchange variation

   

                     766

 

                (7,718)

 

Balance at the end of the year

   

              46,415

 

              39,380

 

 

89


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

(iv)             Amounts recognized in profit or loss 

 

     

Consolidated

     

2017

 

2016

           
 

Health care

 

11,334

 

2,203

 

Current service cost

 

5,058

 

4,576

 

Interest cost

 

4,139

 

3,983

 

Expected return on plan assets

 

(28)

 

(31)

 

Actuarial losses

 

6,069

 

2,472

     

26,572

 

13,203

 

(v)               Actuarial assumptions 

 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(%)

   

 

 

 

 

 

 

2017

 

 

 

 

 

 

 

2016

   

Health

 

United

         

Health

 

United

       
   

insurance

 

States

 

Germany

 

Netherlands

 

insurance

 

States

 

Germany

 

Netherlands

                                 

Discount rate

 

5.45

3.70

2.00

2.00

 

4.18

4.35

2.00

 

 n/a

Inflation rate

 

4.50

 n/a

 n/a

 n/a

 

6.00

 n/a

2.00

 

 n/a

Expected return on plan assets

 

 n/a

 n/a

 n/a

 n/a

 

 n/a

 n/a

 n/a

 

 n/a

Rate of increase in future salary levels

 

 n/a

 n/a

2.50

2.50

 

 n/a

 n/a

3.00

 

 n/a

Rate of increase in future pension plan

 

 n/a

 n/a

1.75

1.75

 

 n/a

 n/a

1.75

 

 n/a

Aging factor

 

2.50

 n/a

 n/a

 n/a

 

2.50

 n/a

 n/a

 

 n/a

Medical inflation

 

3.50

 n/a

 n/a

 n/a

 

3.50

 n/a

 n/a

 

 n/a

Duration

 

18.84

 n/a

 n/a

 n/a

 

29.24

 n/a

 n/a

 

 n/a

 

(vi)             Hierarchy of fair value assets

 On December 31, 2017, the balance of the fair value of assets is represented by the assets of the Novamont defined benefit plan, which has a level-1 fair value hierarchy.

 

(vii)           Sensitivity analysis

 

      Impact on the defined benefit obligation
   

 

 

 

 

Premise change

 

 

 

 

 

Premise increase

 

 

 

 

 

Premise reduction

   

Health

 

United

         

Health

 

United

         

Health

 

United

       
   

insurance

 

States

 

Germany

 

Netherlands

 

insurance

 

States

 

Germany

 

Netherlands

 

insurance

 

States

 

Germany

 

Netherlands

Discount rate

 

1.0%

 

1.0%

 

0.5%

 

0.5%

 

9,025

 

7,045

 

9,480

 

452

 

(11,019)

 

(8,630)

 

(10,582)

 

(500)

Real medical inflation

 

1.0%

 

n/a

 

n/a

 

n/a

 

11,923

 

 n/a

 

 n/a

 

 n/a

 

(7,946)

 

 n/a

 

 n/a

 

 n/a

Rate of increase in future salary levels

 

n/a

 

n/a

 

1%

 

1%

 

 n/a

 

 n/a

 

4,522

 

255

 

 n/a

 

 n/a

 

(4,259)

 

(243)

Rate of increase in future pension plan

 

n/a

 

n/a

 

0%

 

0%

 

 n/a

 

 n/a

 

2,709

 

126

 

 n/a

 

 n/a

 

(2,629)

 

(123)

Life expectancy

 

n/a

 

n/a

 

1 year

 

1 year

 

 n/a

 

 n/a

 

2,217

 

122

 

 n/a

 

 n/a

 

(2,314)

 

(127)

Mortality rate

 

n/a

 

10%

 

n/a

 

n/a

 

 n/a

 

1,889

 

 n/a

 

 n/a

 

 n/a

 

(2,072)

 

 n/a

 

 n/a

                                                 
                                                 
                           

Health insurance - Impact on cost of services and interests costs

                           

Premise change

 

Premise increase

 

Premise reduction

                           

Cost of

 

Iterests

 

Cost of

 

Iterests

 

Cost of

 

Iterests

                           

services

 

costs

 

services

 

costs

 

services

 

costs

Discount rate

                         

1.0%

 

1.0%

 

177

 

145

 

(221)

 

(138)

Real medical inflation

                         

1.0%

 

1.0%

 

245

 

1,216

 

(151)

 

(810)

 

 

90


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

24.2.2    Retirement plan - defined contribution

The Parent Company and the subsidiaries in Brazil sponsor a defined contribution plan for its employees managed by ODEPREV, a private pension plan entity. ODEPREV offers its participants, which are employees of the sponsoring companies, an optional defined contribution plan in which monthly and additional participant contributions and monthly and annual sponsor contributions are made to individual pension savings accounts. For this plan, the sponsors pay contributions to private pension plan on contractual or voluntary bases. As soon as the contributions are paid, the sponsors do not have any further obligations related to additional payments.

 

At December 31, 2017, the number of active participants in ODEPREV totals 5,280 (5,147 in 2016). The contributions made by the sponsors in the year amount to R$38,332 (R$30,500 in 2016) and the contributions made by the participants amounted to R$60,038 (R$52,741 in 2016).

 

25                Equity

 

(a)                 Capital

 

On December 31, 2017, the Company's subscribed and paid up capital stock amounted to R$8,043,222 and comprised 797,257,604 shares with no par value, distributed as follows:

 

   

Amount of shares

           

Preferred

     

Preferred

           
   

Common

     

shares

     

shares

           
   

shares

 

%

 

class A

 

%

 

class B

 

%

 

Total

 

%

                                 

Odebrecht

 

     226,334,623

 

        50.11

 

       79,182,498

 

        22.95

   

     305,517,121

 

        38.32

Petrobras

 

     212,426,952

 

        47.03

 

       75,761,739

 

        21.96

   

     288,188,691

 

        36.15

ADR

(i)

 

       56,088,424

 

        16.26

   

       56,088,424

 

          7.04

Other

 

       12,907,077

 

          2.86

 

     132,743,203

 

        38.54

 

    578,330

 

      100.00

 

     146,228,610

 

        18.34

Total

 

  451,668,652

 

    100.00

 

  343,775,864

 

       99.71

 

  578,330

 

    100.00

 

  796,022,846

 

       99.85

Treasury shares

 

 

 

 

 

         1,234,758

 

          0.36

 

 

 

 

 

         1,234,758

 

          0.15

Total

 

  451,668,652

 

    100.00

 

  345,010,622

 

    100.07

 

  578,330

 

    100.00

 

  797,257,604

 

    100.00

  

(i)        

American Depositary Receipts traded on the New York Stock Exchange (USA);

 

(b)               Capital reserves

 

This reserve includes part of the shares issued in Subsidiary’s several capital increases. This reserve can be used to absorb losses, to redeem, reimburse or purchase shares, and to incorporate into the capital stock.

 

(c)               Legal reserve

 

Under Brazilian Corporation Law, companies must transfer 5% of net profit for the year to a legal reserve until this reserve is equivalent to 20% of the paid-up capital. The legal reserve can be used for capital increase or absorption of losses.

 

(d)               Share rights

 

Preferred shares carry no voting rights but they ensure priority, non-cumulative annual dividend of 6% of their unit value, according to profits available for distribution. The unit value of the shares is obtained through the division of capital by the total number of outstanding shares. Only class “A” preferred shares will have the same claim on the remaining profit as common shares and will be entitled to dividends only after the priority dividend is paid to preferred shareholders. Only class “A” preferred shares also have the same claim as common shares on

91


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

the distribution of shares resulting from capitalization of other reserves. Only class “A” preferred shares can be converted into common shares upon resolution of majority voting shareholders present at a General Meeting. Class “B” preferred shares can be converted into class “A” preferred shares at any time, at the ratio of two class “B” preferred shares for one class “A” preferred share, upon a simple written request to the Company, provided that the non-transferability period provided for in specific legislation that allowed for the issue and payment of such shares with tax incentive funds has elapsed. In August 2016, 15,288 class “B” preferred shares were converted into 7,644 class “A” preferred shares, and in December 2015, a total of 200 class “B” preferred shares were converted into 100 class “A” preferred shares.

 

In the event of liquidation of the Company, class “A” and “B” preferred shares will have priority in the reimbursement of capital.

Shareholders are entitled to receive a mandatory minimum dividend of 25% on profit for the year, adjusted under Federal Law 6,404/76.

 

(e)               Profit allocation and payment of dividends

 

Under the Company’s bylaws, profit for the year, adjusted according to Federal Law 6,404/76, is appropriated as follows:

 

(i)       

5% to a legal reserve;

 

(ii)     

25% to pay for mandatory, non-cumulative dividends, provided that the legal and statutory advantages of the Class “A” and “B” preferred shares are observed. When the amount of the priority dividend paid to class “A” and “B” preferred shares is equal to or higher than 25% of profit for the year calculated under Article 202 of Federal Law 6,404/76, it is the full payment of the mandatory dividend.

 

Any surplus remaining after the payment of the priority dividend will be used to:

 

·      

pay dividends to common shareholders up to the limit of the priority dividends of preferred shares; and

 

·      

if there still is any surplus, distribute additional dividends to common shareholders and class “A” preferred shareholders so that the same amount of dividends is paid for each common share or class “A” preferred share.

 

 

 

92


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

(e.1)    Profit or loss for the year

 

In a meeting held on November 28, 2017, the Board of Directors approved the prepayment of dividends in the amount of R$1,000,000, which was made on December 12, 2017. The amount was sufficient to meet the minimum mandatory dividends for fiscal year 2017.

 

     

2017

       

Net income for the year of Company's shareholders

   

                4,082,990

Amounts recorded directly to retained earnings

     
   Legal reserves distribution    

                 (204,150)

 Tax incentive reserve distribution    

                   (71,745)

 Realization of additional property, plant and equipment    

                     27,810

 Prescribed dividends    

                          482

     

                3,835,387

Destinations:

     
 Total proposed dividends, paid in advance in December 2017  

 (i)

              (1,000,000)

 Additional dividends proposed  

 (ii)

              (1,500,000)

 Portion allocated to unrealized profit reserves  

 (iii)

              (1,335,387)

     

              (3,835,387)

       

Composition of the total proposed dividends

     
 Minimum dividends - 25% adjusted net income    

                 (958,847)

 Additional proposed dividends    

                   (41,153)

 Total dividends paid in December 2017    

              (1,000,000)

 Additional dividends proposed    

              (1,500,000)

Total dividends

   

              (2,500,000)

 

(i)     

Per-share dividend of R$1.25671835741 per common and class “A” preferred share and R$0.60624979930 per class “B” preferred share.

(ii)   

Such dividends will be submitted to shareholders for approval at a Shareholders’ Meeting.

(iii) 

The retained earnings reserve was accrued based on the capital budget, in accordance with Article 196 of Federal Law 6,404/76, to be allocated to future investments. Such retention will be subject to approval by shareholders convened in a Shareholders’ Meeting.

 

(e.2)    Dividend payment from previous years

 

The Annual Shareholders’ Meeting held on April 6, 2016 approved the declaration of dividends related to fiscal year 2015 in the amount of R$ 1,000,000, the payment of which commenced on April 15, 2016, of which R$567,620 was paid to holders of common shares and R$432,020 and R$360 to holders of class “A” and class “B” preferred shares, respectively. This payment fully settles the dividend for the class "B" preferred shares, which was calculated in accordance with the Bylaws.

 

On September 27, 2016, the Board of Directors’ Meeting approved the payment of interim dividends for fiscal year 2015, in the amount of R$1,000,000, which was paid as of October 11, 2016. The Company paid R$567,819 to common shareholders and R$432,181 to class “A” preferred shareholders.

 

93


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

(f)                 Equity valuation adjustments – Equity

 

      Consolidated
   

Attributed to shareholders' interest

       
   

Equity valuation adjustments

 

Other comprehensive income

       
   

Goodwill on the

 

Deemed cost

 

Defined

         

Foreign

               
   

acquisiton of a

 

and additional

 

benefit

 

Foreign

     

currency

 

Gain (loss)

 

Total

       
   

subsidiary under

 

indexation

 

plans actuarial

 

sales

 

Fair value

 

translation

 

on interest

 

Braskem

 

Non-controlling

   
   

commom control

 

on PP&E

 

Gain (loss)

 

hedge

 

of hedge

 

adjustment

 

in subsidiary

 

shareholders'

 

interest in

   
   

(i)

 

(i)

 

(ii)

 

(iii)

 

(iii)

 

(iv)

 

(v)

 

interest

 

subsidiaries

 

Total

On December 31, 2015

 

 

         234,904

 

            (39,232)

 

  (9,666,973)

 

  (685,396)

 

  1,105,391

 

           (9,404)

 

     (9,060,710)

 

            (476,708)

 

  (9,537,418)

                                         

Additional indexation

                                 
 

Realization by depreciation or write-off assets

 

            (41,268)

           

            (41,268)

   

         (41,268)

 

Income tax and social contribution

 

             14,032

           

              14,032

   

           14,032

     

Deemed cost of jointly-controlled investment

 
 

Realization by depreciation or write-off assets

 

              (1,461)

           

              (1,461)

   

           (1,461)

 

Income tax and social contribution

 

                  496

           

                   496

   

                496

             

 

 

Foreign sales hedge

             
 

Exchange rate

     

      2,625,551

       

         2,625,551

 

              (498,767)

 

      2,126,784

 

Transfer to result

     

      1,342,785

       

         1,342,785

 

                  14,959

 

      1,357,744

 

Income tax and social contribution

     

    (1,406,740)

       

       (1,406,740)

 

                145,326

 

    (1,261,414)

                 

Fair value of Cash flow hedge

             
 

Change in fair value

       

     247,815

     

            247,815

 

                     (736)

 

         247,079

 

Transfer to result

       

      (19,434)

     

            (19,434)

 

                (12,135)

 

         (31,569)

 

Income tax and social contribution

       

      (79,194)

     

            (79,194)

 

                    3,861

 

         (75,333)

       

Fair value of cash flow hedge from jointly-controlled

       

        (3,309)

     

              (3,309)

   

           (3,309)

                 

Actuarial loss with post-employment benefits, net of taxes

   

                (4,119)

         

              (4,119)

   

           (4,119)

                 

Foreign currency translation adjustment

 

 

 

       

         63,697

   

              63,697

 

                275,599

 

         339,296

                                         

On December 31, 2016

 

 

         206,703

 

            (43,351)

 

  (7,105,377)

 

  (539,518)

 

  1,169,088

 

           (9,404)

 

     (6,321,859)

 

            (548,601)

 

  (6,870,460)

                                         

Additional indexation

                                     
 

Realization by depreciation or write-off assets

 

 

            (40,678)

   

            (40,678)

 

 

 

         (40,678)

 

Income tax and social contribution

 

 

             13,831

   

              13,831

 

 

 

           13,831

       

Deemed cost of jointly-controlled investment

   
 

Realization by depreciation or write-off assets

 

              (1,459)

         

              (1,459)

   

           (1,459)

 

Income tax and social contribution

 

                  496

         

                   496

   

                496

     

Foreign sales hedge

 
 

Exchange rate

   

         (42,507)

       

            (42,507)

 

                118,179

 

           75,672

 

Transfer to result

   

      1,145,602

       

         1,145,602

 

                  40,924

 

      1,186,526

 

Income tax and social contribution

   

       (355,960)

       

          (355,960)

 

                (47,731)

 

       (403,691)

     

Fair value of Cash flow hedge

 
 

Change in fair value

     

     876,636

     

            876,636

 

                    6,513

 

         883,149

 

Transfer to result

     

    (287,576)

     

          (287,576)

 

                    9,632

 

       (277,944)

 

Income tax and social contribution

     

    (198,343)

     

          (198,343)

 

                  (4,844)

 

       (203,187)

     

Fair value of cash flow hedge from jointly-controlled

     

         3,534

     

                3,534

   

             3,534

     

Actuarial loss with post-employment benefits, net of taxes

   

                (8,654)

         

              (8,654)

   

           (8,654)

         

Goodwill on the acquisition of a subsidiary
   under common control

                 (488,388)

     

          (488,388)

 

 

 

       (488,388)

     

Foreign currency translation adjustment

 

         51,445

 

 

 

              51,445

 

                (52,047)

 

              (602)

                                         

On December 31, 2017

               (488,388)

 

         178,893

 

            (52,005)

 

  (6,358,242)

 

  (145,267)

 

  1,220,533

 

           (9,404)

 

     (5,653,880)

 

            (477,975)

 

  (6,131,855)

 

(i)

Transfer to retained earnings as the asset is depreciated or written-off/sold.

(ii)

Transfer to retained earnings when the extinction of the plan.

(iii)

Transfer to the income statement when maturity, prepayment or loss of efficacy for hedge accounting.

(iv)

Transfer to the income statement when write-off of subsidiary abroad.

(v)

Transfer to the income statement when divestment or transfer of control of subsidiary.

 

26                Earnings per share

 

Basic and diluted earnings (loss) per share is calculated by means of the division of adjusted profit for the year attributable to the Company’s common and preferred shareholders by the weighted average number of these shares held by shareholders, excluding those held in treasury and following the rules for the distribution of dividends provided for in the Company’s bylaws, as described in Note 25(e), particularly in relation to the limited rights enjoyed by class “B” preferred shares. In view of these limited rights, this class of share does not participate in losses. In this case, the diluted result takes into account the conversion of two class "B" preferred shares into one class “A” preferred share, as provided for in the bylaws of the Company.

 

Class A preferred shares participate in dividends with common shares after the mandatory dividends has been attributed in accordance with the formula provided for in the Company’s bylaws, as described in Note 25(d) and there is no highest limit for their participation.

 

94


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

Diluted and basic earnings (losses) per share are equal when there is profit in the year, since Braskem has not issued convertible financial instruments.

 

As required by CPC 41 and IAS 33, the table below show the reconciliation of profit (loss) for the period adjusted to the amounts used to calculate basic and diluted earnings (loss) per share. 

 

   

Basic and diluted

   

2017

 

2016

         

Profit (loss) for the year attributed to Company's shareholders of continued operations

 

               4,074,114

 

                (442,430)

         

Distribution of dividends attributable to priority:

       

 

  Preferred shares class "A"  

                  208,416

 

 

 

  Preferred shares class "B"  

                         351

 

 

   

                  208,767

 

 

         

Distribution of 6% ​​of unit value of common shares

 

                  273,827

 

 

         

Distribution of plus income, by class:

       

 

  Common shares  

               2,039,334

 

 

 

  Preferred shares class "A"  

               1,552,186

 

 

   

               3,591,520

 

 

         

Reconciliation of income available for distribution, by class (numerator):

       

 

  Common shares  

               2,313,161

 

                (251,222)

 

  Preferred shares class "A"  

               1,760,602

 

                (191,208)

 

  Preferred shares class "B"  

                         351

 

 

   

               4,074,114

 

                (442,430)

         

Weighted average number of shares, by class (denominator):

       

 

  Common shares  

           451,668,652

 

           451,668,652

 

  Preferred shares class "A"

(i)

           343,775,864

 

           343,771,165

 

  Preferred shares class "B"  

                  578,330

 

 

   

           796,022,846

 

           795,439,817

         

Profit (loss) per share (in R$)

       

 

  Common shares  

                    5.1214

 

                  (0.5562)

 

  Preferred shares class "A"  

                    5.1214

 

                  (0.5562)

 

  Preferred shares class "B"  

                    0.6069

 

 

 

95


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

 

 

 

 

2017

   

Preferred shares Class "A"

   

Outstanding

 

Weighted

   

shares

 

average

 

 

 

 

 

Amount at beginning of year

 

    343,768,220

 

    343,768,220

 

 

 

 

 

   Conversion of preferred shares class "B" to "A"

 

                  7,644

 

                  2,945

 

 

 

 

 

Amount at the end of the year

 

    343,775,864

 

    343,771,165

 

27                Net sales revenues

 

     

 Consolidated

 

 Parent company

     

2017

 

2016

 

2017

 

2016

Sales revenue

               
 

Domestic market

 

             34,983,265

 

             32,293,042

 

             36,470,448

 

             33,653,625

 

Foreign market

 

             23,297,304

 

             23,084,703

 

               9,070,332

 

               9,281,920

     

             58,280,569

 

             55,377,745

 

             45,540,780

 

             42,935,545

Sales and services deductions

               

Taxes

               
 

Domestic market

 

              (8,663,707)

 

              (7,316,325)

 

              (8,869,233)

 

              (7,533,387)

 

Foreign market

 

                   (33,798)

 

                 (102,831)

 

Costumers rebates

               
 

Domestic market

 

                   (35,538)

 

                   (25,400)

 

                   (34,902)

 

                   (25,400)

 

Foreign market

 

                   (60,990)

 

                   (23,820)

 

                     (1,262)

 

                     (1,303)

Sales returns

               
 

Domestic market

 

                 (125,153)

 

                 (168,625)

 

                 (148,029)

 

                 (180,150)

 

Foreign market

 

                 (100,789)

 

                   (76,756)

 

                     (5,548)

 

                   (16,839)

     

              (9,019,975)

 

              (7,713,757)

 

              (9,058,974)

 

              (7,757,079)

                   

Net sales and services revenue

 

           49,260,594

 

           47,663,988

 

           36,481,806

 

           35,178,466

 

Sales revenues represent the fair value of the amount received or receivable from the sale of products and services during the normal course of the Company’s activities.

 

Revenues from sales of products are recognized when (i) the amount of sales can be reliably measured and the Company does not have control over the products sold; (ii) it is probable that the Company will received the economic benefits; and (iii) all legal titles, risks and benefits of product ownership are fully transferred to the client. The Company does not make sales with continued management involvement. Most of Braskem’s sales are made to industrial customers and, in a lower volume, to resellers.

 

The moment when the legal right, as well as the risks and benefits, are substantially transferred to the client is determined as follows:

 

(i)            

for contracts under which the Company is responsible for the freight and insurance, the legal right and the risks and benefits are transferred to the client as soon as the goods are delivered at the destination established in the contract;

(ii)           

for agreements under which the freight and insurance are a responsibility of the client, risks and benefits are transferred as soon as the products are delivered to the client’s carrier; and

(iii)         

for contracts under which product delivery involves the use of pipelines, especially basic petrochemicals, the risks and benefits are transferred immediately after the Company’s official markers, which is the point of delivery of the products and transfer of their ownership.

 

 

96


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

The cost of freight services related to sales, transfers to storage facilities and finished product transfers between Braskem establishments are included in cost of sales.

 

(a)               Net sales revenue by country

 

   

2017

 

2016

         

Brazil

 

         26,147,559

 

         24,640,077

United States

 

           8,539,972

 

           7,965,209

Argentina

 

           1,336,440

 

           1,244,267

United Kingdom

 

              202,830

 

              589,725

Germany

 

           1,192,287

 

           1,198,760

Mexico

 

           3,408,385

 

           2,075,695

Italy

 

              604,546

 

              667,265

Netherlands

 

              333,134

 

              262,289

Singapore

 

              542,866

 

           1,101,156

Switzerland

 

              415,729

 

              227,504

Colombia

 

              340,396

 

              369,359

Spain

 

              282,854

 

              342,154

Chile

 

              554,237

 

              522,796

Peru

 

              493,654

 

              397,186

Uruguay

 

              122,251

 

              122,783

Japan

 

              126,956

 

           1,631,564

Poland

 

              231,716

 

              252,508

Paraguay

 

              174,783

 

              185,432

France

 

              166,314

 

              236,727

Bolivia

 

              163,862

 

              211,382

Canada

 

              235,612

 

              242,492

South Korea

 

              339,430

 

              254,512

Other

 

           3,304,781

 

           2,923,146

   

      49,260,594

 

      47,663,988

 

 

97


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

(b)               Net sales revenue by product

 

       

2017

 

2016

             

PE/PP

     

         33,105,714

 

         30,790,364

Ethylene, Propylene

     

           3,351,805

 

           2,906,796

Naphtha, condensate and crude oil

     

              135,165

 

           2,582,257

Benzene, toluene and xylene

     

           2,683,406

 

           2,411,031

PVC/Caustic Soda/EDC

     

           3,066,879

 

           3,016,390

ETBE/Gasoline

     

           2,433,360

 

           2,058,952

Butadiene

     

           1,819,387

 

           1,315,892

Cumene

     

              578,482

 

              501,958

Solvents

     

              401,455

 

              379,745

Other

     

           1,684,941

 

           1,700,603

       

      49,260,594

 

      47,663,988

 

(c)                Main clients

 

In 2017 and 2016, the Company does not have any revenue arising from transactions with only one client that is equal to or higher than 10% of its total net revenue. In 2017, the most significant revenue from a single client amounts to approximately 2.2% of total net revenues of the Company and refers to the chemical segment.

 

28                Tax incentives

 

(a)               Income Tax

 

Since 2015, the Company obtained grant in lawsuits claiming the reduction of 75% of IR on income from the following industrial units: (i) PVC and Chlor-Alkali (Cloro Soda), established in the state of Alagoas; and (ii) basic petrochemicals unit, PE (2), PVC and Chlor-Alkali units, all established in the city of Camaçari (BA). The third PE plant built in Camaçari received a report allowing the granting of the tax incentives issued by the Northeast Development Agency (SUDENE) in 2017. The term of enjoyment is 10 years and in 2017 a benefit of R$71,745 was calculated.

 

(b)               PRODESIN - ICMS

 

The Company has ICMS tax incentives granted by the state of Alagoas, through the state of Alagoas Integrated Development Program – PRODESIN, which are aimed at implementing and expanding a plant in that state. This incentive is considered an offsetting entry to sales taxes (Note 27). In 2017, the amount was R$95,704 (R$78,824 in 2016).

 

98


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

29                Other income (expenses), net

 

 

 

Note

 

 

 

Consolidated

     

2017

 

2016

         

Adjusted

Participation of members in profits and results

 (i)

 

        (399,828)

 

        (361,796)

Expenses from fixed assets

 

 

        (205,929)

 

          (53,774)

Allowance for judicial and labor claims

 

 

        (119,919)

 

        (169,973)

Capital gain - sale of Quantiq

              5

 

         276,816

 

                   

Recovery of environmental damages

             

 

        (102,466)

 

        (182,600)

Leniency agreement

 23.3

 

                   

 

     (2,860,402)

Other

           

 

           71,922

 

        (277,409)

   

      (479,404)

 

  (3,905,954)

(i) In the fiscal year ended December 31, 2016, the amounts related to this item were reclassified from “costs of goods sold” (R$163,055), “selling and distribution expenses” (R$7,155) and “general and administrative expenses” (R$191,586) (Note 2.5(b)).

 

30                Financial results

 

     

 Consolidated

 

 Parent company

     

2017

 

2016

 

2017

 

2016

Financial income

               
 

Interest income

 

              512,051

 

              646,727

 

              475,496

 

              594,050

 

Other

 

                91,579

 

                43,395

 

                69,766

 

                38,402

     

            603,630

 

            690,122

 

            545,262

 

            632,452

                   

Financial expenses

               
 

Interest expenses

 

         (2,219,503)

 

         (2,447,481)

 

         (1,373,519)

 

         (1,918,164)

 

Monetary variations on fiscal debts

 

            (191,101)

 

            (249,578)

 

            (188,118)

 

            (237,578)

 

Discounts granted

 

            (137,389)

 

            (108,606)

 

            (134,757)

 

            (107,493)

 

Loans transaction costs - amortization

 

              (64,771)

 

              (56,020)

 

                (7,511)

 

                (5,448)

 

Adjustment to present value - appropriation

 

            (284,992)

 

            (507,744)

 

            (228,995)

 

            (466,141)

 

Other

 

            (849,461)

 

            (201,533)

 

            (694,362)

 

            (112,215)

     

       (3,747,217)

 

       (3,570,962)

 

       (2,627,262)

 

       (2,847,039)

                   

Exchange rate variations, net

               
 

On financial assets

 

              216,381

 

         (1,139,676)

 

              240,508

 

         (1,602,868)

 

On financial liabilities

 

         (1,015,143)

 

         (2,070,741)

 

         (1,118,662)

 

            (451,174)

     

          (798,762)

 

       (3,210,417)

 

          (878,154)

 

       (2,054,042)

                   
 

Total

 

       (3,942,349)

 

       (6,091,257)

 

       (2,960,154)

 

       (4,268,629)

   

   

 Consolidated

 

 Parent company

   

2017

 

2016

 

2017

 

2016

Interest income

               
   Held for sale  

              209,327

 

              331,811

 

              184,262

 

              316,384

 Loans and receivables  

              270,909

 

              273,355

 

              264,205

 

              263,158

   

              480,236

 

              605,166

 

              448,467

 

              579,542

 Other assets not classifiable  

                31,815

 

                41,561

 

                27,029

 

                14,508

Total

 

            512,051

 

            646,727

 

            475,496

 

            594,050

 

 

99


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

31                Expenses by nature and function

 

 

       

 Consolidated

 

 Parent company

       

2017

 

2016

 

2017

 

2016

           

Adjusted

     

Adjusted

Classification by nature:

               
 

Raw materials other inputs

 

         (29,364,996)

 

         (28,197,875)

 

         (24,004,220)

 

         (21,932,920)

 

Personnel expenses

 

           (2,173,640)

 

           (2,576,107)

 

           (1,687,930)

 

           (1,908,299)

 

Outsourced services

 

           (2,120,001)

 

           (2,135,412)

 

           (1,515,834)

 

           (1,466,718)

 

Depreciation, amortization and depletion

 

           (2,928,855)

 

           (2,677,672)

 

           (1,880,065)

 

           (2,052,972)

 

Freights

 

           (2,058,574)

 

           (1,918,973)

 

           (1,348,241)

 

           (1,372,171)

 

Costs of idle industrial plants

(i)

                (67,593)

 

                (60,944)

 

                (41,898)

 

                (23,115)

 

Other income (expenses), net

 

           (1,227,829)

 

           (4,175,836)

 

              (796,814)

 

           (3,280,188)

 

Total

 

       (39,941,488)

 

       (41,742,819)

 

       (31,275,002)

 

       (32,036,383)

                     

Classification by function:

               
 

Cost of products sold

 

         (36,400,748)

 

         (34,985,569)

 

         (28,929,876)

 

         (27,003,424)

 

Selling and distribution

 

           (1,459,608)

 

           (1,403,673)

 

              (925,663)

 

              (971,422)

 

General and administrative

 

           (1,434,272)

 

           (1,285,613)

 

              (865,085)

 

              (719,270)

 

Research and development

 

              (167,456)

 

              (162,010)

 

              (105,286)

 

              (104,832)

 

Other income (expenses), net

   

              (479,404)

 

           (3,905,954)

 

              (449,092)

 

           (3,237,435)

 

Total

 

       (39,941,488)

 

       (41,742,819)

 

       (31,275,002)

 

       (32,036,383)

 
(i) For comparability purposes, the Company is presenting the amount of "Costs of idle industrial plants" for the year 2016, reclassified from "Other income (expenses), net".

 

32                Segment information

 

As of December 31, 2017, Braskem’s organizational structure was formed by the following segments:

 

·      

Chemicals: comprises the activities related to the production of ethylene, propylene butadiene, toluene, xylene, cumene and benzene, as well as gasoline, diesel and LPG (Liquefied Petroleum Gas), and other petroleum derivativesand the supply of electric energy, steam, compressed air and other inputs to second-generation producers located in the Camaçari, Triunfo, São Paulo and Rio de Janeiro petrochemical complexes.

 

·      

Polyolefins: comprises the activities related to the production of PE and PP in Brazil.

 

·      

Vinyls: comprises the activities related to the production of PVC, caustic soda and chloride in Brazil.

 

·      

United States and Europe:operations related to PP production in the United States and Europe, through the subsidiaries Braskem America and Braskem Alemanha, respectively.

 

·      

Mexico:comprises the activities relation to the production of PE in Mexico, through the subsidiary Braskem Idesa.

 

(a)               Presentation, measurement and conciliation of results

 

Information by segment is generated in accounting records, which are reflected in the consolidated financial statements.

 

The eliminations stated in the operating segment information, when compared with the consolidated balances, are represented by transfers of inputs between segments that are measured as arm’s length sales.

 

The operating segments are stated based on the results of operations, which does not include financial results, and current and deferred income tax and social contribution expenses.

 

100


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

The Company does not disclose assets by segment since this information is not presented to its chief decision maker.

 

(b)               Results by segment

 

 

     

 

 

 

 

 

 

 

 

 

 

 

 

2017

                 

Operating expenses

   
     

Net

 

Cost of

     

Selling, general

 

Results from

 

Other operating

   
     

sales

 

products

 

Gross

 

and distribuition

 

equity

 

income

 

Operating

     

revenue

 

sold

 

profit

 

expenses

 

investments

 

(expenses), net

 

profit (loss)

Reporting segments

                         
 

Chemicals

(i)

      25,179,288

 

     (20,530,084)

 

       4,649,204

 

             (773,396)

 

                   

 

              (197,275)

 

      3,678,533

 

Polyolefins

      19,650,398

 

     (15,571,505)

 

       4,078,893

 

          (1,321,575)

 

           

 

              (177,518)

 

      2,579,800

 

Vinyls

        3,066,879

 

       (2,605,618)

 

          461,261

 

             (162,989)

 

              

 

              (163,374)

 

         134,898

 

USA and Europe

        9,854,496

 

       (7,419,261)

 

       2,435,235

 

             (582,672)

 

         

 

                (21,279)

 

      1,831,284

 

Mexico

        3,600,820

 

       (2,097,471)

 

       1,503,349

 

             (283,318)

 

    

 

                 27,914

 

      1,247,945

Total

61,351,881

 

   (48,223,939)

 

13,127,942

 

        (3,123,950)

 

 

            (531,532)

 

9,472,460

   

                         

Other segments

             83,720

 

            (65,743)

 

            17,977

 

               (13,391)

 

                 

 

                  (2,430)

 

             2,156

Corporate unit

      

 

     

 

          

 

               (61,384)

 

               39,956

 

                 54,558

 (ii)

           33,130

   

                       

Braskem consolidated before   
   eliminations and reclassifications

61,435,601

 

   (48,289,682)

 

13,145,919

 

        (3,198,725)

 

39,956

 

            (479,404)

 

9,507,746

   

                         

Eliminations and reclassifications

    (12,175,007)

 

       11,888,934

 

        (286,073)

 

               137,389

 

     

 

                 

 

       (148,684)

   

                         

Total

49,260,594

 

   (36,400,748)

 

12,859,846

 

        (3,061,336)

 

39,956

 

            (479,404)

 

9,359,062

   

                         
   

                         
   

 

 

 

 

 

 

 

 

 

 

 

 

2016

   

           

Operating expenses

   
   

Net

 

Cost of

     

Selling, general

 

Results from

 

Other operating

   
   

sales

 

products

 

Gross

 

and distribuition

 

equity

 

income

 

Operating

   

revenue

 

sold

 

profit

 

expenses

 

investments

 

(expenses), net

 

profit (loss)

Reporting segments

                     

Adjusted

 

Chemicals

(i)

      25,062,602

 

     (20,248,175)

 

       4,814,427

 

             (680,083)

 

           

 

              (409,920)

 

      3,724,425

 

Polyolefins

      20,307,367

 

     (15,980,935)

 

       4,326,432

 

          (1,284,665)

 

          

 

              (199,098)

 

      2,842,670

 

Vinyls

        3,016,390

 

       (2,815,184)

 

          201,206

 

             (236,771)

 

              

 

                (71,880)

 

       (107,444)

 

USA and Europe

        8,896,071

 

       (6,080,722)

 

       2,815,349

 

             (497,810)

 

        

 

                (71,000)

 

      2,246,540

 

Mexico

        1,586,927

 

       (1,152,047)

 

          434,880

 

             (231,795)

 

             

 

                  (4,805)

 

         198,282

Total

   58,869,357

 

   (46,277,063)

 

  12,592,294

 

        (2,931,124)

 

             

 

            (756,703)

 

   8,904,473

   

                       

Other segments

             12,202

 

            (14,760)

 

            (2,558)

 

                 (1,876)

 

               

 

                (20,864)

 

         (25,298)

Corporate unit

                     

 

             

 

      

 

               (33,582)

 

               30,078

 

           (3,128,387)

 (iii)

    (3,131,893)

   

                         

Braskem consolidated before   
   eliminations and reclassifications

58,881,559

 

   (46,291,823)

 

12,589,736

 

        (2,966,582)

 

30,078

 

        (3,905,954)

 

5,747,282

   

                         

Eliminations and reclassifications

    (11,217,571)

 

       11,306,254

 

            88,683

 

               115,286

 

                      

 

                     

 

         203,965

                               

Total

 

47,663,988

 

   (34,985,569)

 

12,678,419

 

        (2,851,296)

 

30,078

 

        (3,905,954)

 

5,951,247

 

(i)      

The Basic Petrochemicals Segment changed its name to the Chemicals Segment, seeking to adopt nomenclature more closely aligned with the segment’s markets.

(ii)    

Includes gain from sale of the former “Chemical distribution” segment in the amount of R$276,816 (Note 3).

(iii)   

Inclusion of the provision for the Leniency Agreement in the amount of R$2,860,402 (Note 29).

 

101


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

(c)                Long-lived assets by segment 

 

     

2017

 

2016

Reporting segments

       
 

Chemicals

 

                11,136,125

 

                11,417,669

 

Polyolefins

 

                  5,072,162

 

                  5,162,075

 

Vinyls

 

                  2,433,882

 

                  2,621,376

 

USA and Europe

 

                  2,587,302

 

                  2,015,492

 

Mexico

 

                10,733,277

 

                10,607,951

Total

 

             31,962,748

 

             31,824,563

 

Other segments

 

                     526,359

 

                     321,234

Total

 

             32,489,107

 

             32,145,797

 

33                Insurance coverage

 

Braskem carries insurance policies to cover the domestic and international operations of its plants, as detailed below, in addition to other insurance policies, which include general civil liability, the civil liability of directors and offices, domestic and international charter operations, charter's liability, etc.

 

The company believes its Insurance Program is consistent with the standards adopted by petrochemical companies operating globally.

 

The All Risks Program provides coverage for material damages and consequent loss of profit of all Braskem plants through an “All Risks” program.

 

The program is divided into three different policies that ensure coverage of the operations in Brazil, Mexico and the United States/Germany. These policies are valid through October 2018.

 

The following table presents additional information on the policies in force. Each has maximum indemnity limits (“MIL”) per event to cover possible claims in view of the nature of the Company’s activities and benchmarks, as well estimated maximum loss studies prepared by external advisors. 

 

       

Maximum indemnity limit

 

Amount insured

   

Maturity

 

US$ million

 

US$ million

Units in Brazil

 

October 10, 2018

 

3,375

 

24,509

Units in United States and Germany

 

October 10, 2018

 

330

 

1,991

Units in Mexico

 

October 10, 2018

 

3,153

 

5,947

Total

         

32,447

 

The risk assumptions adopted are not part of the audit scope and, therefore, were not subject to review by our independent accountants.

 

These policies provide coverage for material losses arising from accidents related to fire, explosion and machinery breakdown, etc., and consequential loss of profit, with maximum indemnity periods ranging from 12 and 33 months, depending on the plant and/or coverage.

 

Braskem also carries an insurance policy against general civil liability that covers damages caused to third parties from its operations and products, including any losses caused by sudden pollution.

 

102


 
 

Braskem S.A.

 

Management notes to the financial statements

at December 31, 2017

All amounts in thousands, except as otherwise stated

 

The Company’s new projects are covered by specific Engineering Risk policies and/or construction and assembly clauses included in the Operational Risks policies.

 

 

 

 

 

 

103


SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: March 29, 2018
  BRASKEM S.A.
 
 
  By:      /s/     Pedro van Langendonck Teixeira de Freitas
 
    Name: Pedro van Langendonck Teixeira de Freitas
    Title: Chief Financial Officer

 

FORWARD-LOOKING STATEMENTS

This press release may contain forward-looking statements. These statements are statements that are not historical facts, and are based on management's current view and estimates offuture economic circumstances, industry conditions, company performance and financial results. The words "anticipates", "believes", "estimates", "expects", "plans" and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the declaration or payment of dividends, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the current views of management and are subject to a number of risks and uncertainties. There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors could cause actual results to differ materially from current expectations.